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ABSTRACT 
 
COMPARATIVE STUDIES OF HEALTH AND MORTALITY 
Jessica Y. Ho 
Irma T. Elo 
This dissertation consists of three comparative studies of health and mortality which 
address major topics in the field: persistent mortality disparities within the U.S., how 
mortality in the U.S. compares to other high-income countries, and early life 
determinants of adult morbidity in developing countries. The design of these studies is 
predicated on the belief that we can draw meaningful inferences from comparisons across 
populations.  
Chapter I examines the contribution of smoking to black-white mortality differences 
above age 50 from 1980-2005. This study shows that smoking-attributable mortality 
accounted for 20-40% of the black-white mortality gap among males between 1980-2005, 
but accounted for almost none of the black-white mortality gap among females. The 
results support the hypothesis that later initiation and lower rates of smoking cessation 
among black men may contribute to their higher levels of smoking-related mortality 
relative to white men.  
Chapter II provides a comprehensive assessment of U.S. mortality relative to other high-
income countries. This study demonstrates that mortality differences below age 50 
account for the majority of the gap in life expectancy at birth between American males 
and their counterparts in other high-income countries. Among females, this figure is 41%. 
The major causes of death responsible for Americans’ excess years of life lost below age 
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50 are unintentional injuries, noncommunicable diseases, perinatal conditions, and 
homicide. This study also finds that the U.S.’s unique pattern of age-specific mortality 
rankings holds for birth cohorts whose mortality experience spans the period 1935-2005.  
Chapter III explores the association between two measures of early life conditions and 
adult morbidity in six countries. The findings from this study indicate that those born 
during the autumn in Ghana, Mexico, Russia, and South Africa and during the monsoon 
in India experience a health advantage. In China, the autumn-born experience a health 
disadvantage. This study also finds that pre- and postnatal rainfall and temperature 
conditions are associated with adult health outcomes, particularly height and blood 
pressure. The results provide support for the hypotheses that early life disease and 
nutritional conditions are important influences on later life health. 
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CHAPTER I. The Contribution of Smoking to Black-White Differences 
in Mortality1 
 
Introduction 
Black-white mortality differentials in the United States are sizeable and persistent, and 
pose a significant, longstanding public health concern. The black-white gap in life 
expectancy at birth has fluctuated over time, reaching a recent peak of 8.5 years for men 
and 5.8 years for women in 1993 before declining to 5.2 years for men and 3.6 years for 
women in 2008 (National Center for Health Statistics [NCHS] 1997; Arias 2012). In 
contrast, after about 1990 the black-white gap in life expectancy at age 50 stagnated for 
males, and it declined only slightly for females (Figure 1.1). Given that 88% of black 
males, 93% of white males, 93% of black females, and 96% of white females survived to 
age 50 in 2008 (Arias 2012), an improved understanding of the factors contributing to 
this persistent black-white disparity in mortality at older ages is needed.  
Despite the large literature on black-white health disparities, the reasons for their 
persistence have not been fully resolved (e.g., Smedley, Stith, and Nelson 2003; Williams 
et al. 2010). In this study, we focus on the contribution of smoking to black-white 
differences in mortality at ages 50 and above. Smoking is the leading preventable cause 
of premature morbidity and mortality in the United States and has strong links to chronic 
diseases that are prevalent at older ages (U.S. Department of Health and Human Services 
[DHHS] 2000). For example, in 1980, 87%-95% of lung cancer deaths occurred above 
age 50 among black and white males and females. By 2005, these percentages had 
                                                           
1
 Material from this chapter has appeared in Ho JY and Elo IT. 2013. “The Contribution of Smoking to 
Black-White Differences in U.S. Mortality.” Demography 50(2): 545–568. 
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increased to 92%-96% (NCHS 2010a). Cohort smoking histories and period data on 
smoking behavior – smoking prevalence, intensity, cessation, and duration – suggest that 
the magnitude of smoking-attributable mortality at these ages may differ between blacks 
and whites, especially among males. Consistent with this speculation are the higher death 
rates from lung cancer and other smoking-related chronic diseases among blacks than 
whites (Haiman et al. 2006; Harper et al. 2007).   
In this study, we integrate multiple approaches and data sources to provide a 
comprehensive assessment of the contribution of smoking to black-white mortality 
differences. To the best of our knowledge, no previous study has examined the 
contribution of smoking-attributable deaths to mortality trends among blacks or to trends 
in black-white mortality differences at older ages. Identifying whether smoking is a major 
contributor to black-white mortality differences is important. Smoking is a potentially 
modifiable health behavior, and lung cancer risk is sensitive to smoking intensity, 
duration, and time since quitting. Furthermore, determining the proportion of excess 
mortality due to smoking among blacks and whites will improve our understanding of its 
role in mortality trends and differentials. We find that smoking has contributed to the 
black-white gap in life expectancy at age 50 for males, accounting for 20%-40% of the 
gap between 1980 and 2005, but not for females. Smoking also explains a larger portion 
of the sex gap in life expectancy at age 50 for blacks than for whites. Estimates of the 
fraction of deaths attributable to smoking above age 50 are slightly greater for black 
males than for white males, and among males, current smoking status explains about 20% 
of the black excess risk in all-cause mortality above age 50 in the absence of adjustment 
for socioeconomic characteristics. These findings contribute to our understanding of the 
3 
 
role of smoking in driving contemporary mortality trends and differentials and reinforce 
the need for interventions that better address the needs of all groups. 
 
Background 
Black-White Differences in Smoking-Related Mortality 
Smoking substantially increases the risk of death from cardiovascular diseases, including 
hypertension, ischemic heart disease, cerebrovascular disease, and atherosclerosis, and 
respiratory diseases such as pneumonia, influenza, bronchitis, emphysema, and chronic 
airway obstruction (DHHS 1989; DHHS 2001; Rogers et al. 2005). Smoking is also a risk 
factor for 15 cancer sites (Doll et al. 2005; IARC 2004).2 For cancers of the esophagus, 
kidney, lung, larynx, oral cavity, pancreas, pharynx, and urinary bladder, estimates of the 
excess risks associated with smoking range from factors of 3 to 20 (IARC 2004). 
Furthermore, estimates based on the Cancer Prevention Study II (CPS-II), a prospective 
cohort study in the United States, suggest that at least 25% of deaths from nine cancers 
(bladder, esophagus, kidney, larynx, lip, lung, oral cavity, pancreas, pharynx) are 
attributable to smoking (DHHS 1989; Preston, Glei, and Wilmoth 2010). One recent 
study estimates that smoking cessation was responsible for at least 40% of the decline in 
male cancer mortality between 1991 and 2003 (DeLancey et al. 2008).  
It is well-known that blacks suffer disproportionately from smoking-related diseases, 
with the exception of chronic obstructive pulmonary disease (COPD) (Burns et al. 1997; 
DHHS 1998; Haiman et al. 2006; Novotny et al. 1988; Williams and Collins 1995). 
                                                           
2
 These 15 sites are the kidney, larynx, liver, lung, myeloid leukemia, nasal cavity and paranasal sinuses, 
nasopharynx, oro- and hypopharynx, esophagus, oral cavity, pancreas, stomach, ureter, urinary bladder, and 
uterine cervix (IARC 2004). 
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Many of these smoking-related diseases have been implicated in the black-white gap in 
life expectancy. For example, Harper et al. (2007) identified cardiovascular diseases 
(heart disease, hypertension, stroke, and other cardiovascular diseases) as the leading 
causes of black-white differences in life expectancy at birth in 2003. Together, these 
causes accounted for 1.9 years of the 6.3 year gap in male life expectancy and 1.9 years 
of the 4.5 year gap in female life expectancy. Total cancer-related mortality explained 
close to an additional year of the black-white life expectancy gap among men, and 
slightly over half a year among women (Ibid.). Data from the Surveillance, Epidemiology 
and End Results (SEER) cancer registry show that in 2007, blacks had higher death rates 
than whites from most smoking-related cancers, with the exception of cancers of the 
kidney and urinary bladder among males and cancers of the lung and bronchus among 
females.3 Data on smoking-related cancer incidence and survival are generally consistent 
with racial disparities in cancer mortality, with blacks having higher incidence and lower 
survival rates than whites (Clegg and Ries 2007; Edwards et al. 2010; Wong et al. 2009). 
Furthermore, blacks appear to be at greater risk of lung cancer than whites at lower levels 
of cigarette consumption (Haiman et al. 2006). 
 
Black-White Differences in Smoking Behavior 
Burns et al. (1997) have made the best reconstruction of cohort smoking histories by race 
and sex using data from the National Health Interview Survey (NHIS), including an 
adjustment for differential mortality by smoking status. For birth cohorts born between 
1920 and 1945, black males were slightly more likely to be ever-smokers than white 
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 These are age-adjusted death rates for the population aged 50+. SEER provides statistics for the following 
smoking-related cancer sites: kidney, larynx, liver, lung and bronchus, oral cavity and pharynx, esophagus, 
pancreas, stomach, urinary bladder, and cervix uteri. 
5 
 
males. In contrast, white women from these birth cohorts were more likely than black 
women to be ever-smokers (Figure 1.2) (Ibid.). Burns et al. (1997) also found that black 
males had substantially lower smoking cessation rates than white males, with smoking 
cessation beginning 10 to 20 years later among blacks than whites. Figure 1.3 shows 
annual quit rates among three 10-year cohorts of black and white males born between 
1920 and 1949, which overlap with the cohorts in this analysis (those aged 50+ in 1980-
2005 or aged 50-84 in 1997-2003). For each birth cohort, quit rates were substantially 
lower among blacks than whites. Similarly, smoking cessation among black females was 
lower than among white females (Ibid.). These differences in smoking cessation are 
unlikely to be due to differences in the desire to quit because surveys show that blacks 
appear as or more likely than whites to want to quit smoking (DHHS 1998).  
Figure 1.4 shows current smoking prevalence (percent current smokers) at each age 
among two 5-year birth cohorts for black and white males. For the 1920-1924 birth 
cohorts, white males were slightly more likely to be current smokers until age 28, when a 
crossover occurred. Between ages 28 and 66, black males were more likely to be current 
smokers at every age, and the black-white difference widened with age, reaching a peak 
of 16% when males in these cohorts reached their late fifties and early sixties. For the 
1940-1944 birth cohort, the crossover occurred earlier and widened more rapidly, 
maintaining a black-white gap of at least 10% for 16 years (between ages 30 and 46). We 
show only two cohorts here for clarity; the same general pattern of black-white 
differences in current smoking prevalence widening dramatically with age was observed 
for all of the cohorts born between 1920 and 1949. 
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The cohort smoking data are fairly consistent with period data on smoking prevalence, 
cessation, and duration: in general, whites are more likely to be ever smokers and have 
higher smoking intensities, whereas the prevalence of smoking cessation is much lower 
among black smokers (DHHS 1998; Fiore et al. 1989; Gilpin and Pierce 2002; King et al. 
2004; NCHS 2010b; Siahpush et al. 2010). For example, Giovino et al. (1994), utilizing 
data from the NHIS, found that in the late 1980s and early 1990s, a larger percentage of 
whites than blacks of both sexes reported being ever smokers, but a higher percentage of 
black males than white males reported being current smokers. The authors further 
showed that between 1965 and 1991 the quit ratio (the percentage of adult ever smokers 
who were former smokers) was higher for whites than for blacks by 9.7%-16.8% (both 
sexes combined). More recent studies have documented a similar pattern (Gilpin and 
Pierce 2002), and King et al. (2004) showed that the racial disparity in the quit ratio 
persisted through 2000. These patterns have resulted in longer durations of smoking 
among blacks than whites. Using data from the 2003, 2006, and 2007 Tobacco Use 
Supplements from the Current Population Survey, Siahpush et al. (2010) estimated that 
the median duration of smoking among non-Hispanic black ever-smokers was 30 years, 
compared to 28 years among non-Hispanic whites (both sexes combined). Longer 
smoking durations and lower smoking cessation rates among blacks relative to whites 
may help explain their higher lung cancer death rates and higher mortality from other 
smoking-related diseases. Duration of smoking has been found in some studies to be a 
stronger predictor of lung cancer risk than the number of cigarettes smoked per day (Bach 
et al. 2003; Flanders et al. 2003; IARC 2004; Lubin and Caporaso 2006). Several studies 
have found that smoking cessation is beneficial at any age, with the reduction in the risk 
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of lung cancer mortality being particularly large for smokers who quit before middle age 
(Halpern, Gillespie, and Warner 1993; Peto et al. 2000). Smoking cessation has also been 
found to decrease the excess risks of stroke, COPD, myocardial infarction, and coronary 
heart disease (Kawachi et al. 1993; Kawachi et al. 1994; Oza et al. 2011; Rosenberg et al. 
1985; Rosenberg, Palmer, and Shapiro 1990).  
 
Black-White Differences in Nicotine Metabolism 
Compared to whites, blacks smoke fewer cigarettes but inhale more deeply, are more 
likely to smoke menthol cigarettes and cigarettes with higher tar yields, achieve higher 
net indexes of smoke exposure, and may be at risk of greater physical dependence and 
exposure to more smoke toxins (Chen 1993; Sellers 1998). These differences may be due 
in part to differential environmental and occupational exposures and their interactions 
with biological mechanisms in how nicotine and other substances in tobacco smoke are 
metabolized (Williams at al. 2010). Pharmacogenetic differences in nicotine metabolism 
can affect the risk of becoming a smoker, amount smoked, degree of physical 
dependence, and absorption, distribution, excretion, and metabolism of carcinogens in 
tobacco smoke (Sellers 1998). 
The measurement of cotinine, a nicotine metabolite, is a specific and sensitive test for 
exposure to tobacco smoke and can be used to distinguish active and passive smokers 
from nonsmokers (IARC 2004). It is used as a marker of both tobacco use and exposure 
to environmental tobacco smoke (ETS) because it has a longer half-life than nicotine 
(Caraballo et al. 1998). Using data from the Third National Health and Nutrition 
Examination Survey (1988-1991), Caraballo et al. (1998) found that black smokers had 
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significantly higher serum cotinine levels than white or Mexican American smokers at all 
intensities of cigarette smoking. This finding held even after adjustment for other sources 
of nicotine, such as the number of cigarettes smoked per day and exposure to ETS at 
home and at work, as well as age, sex, and body weight. It has been suggested that racial 
differences in serum cotinine levels may be attributable to racial differences in the 
accuracy of self-reported smoking. The authors of this study found that black and white 
self-reported smokers had serum cotinine levels consistent with their reported smoking 
levels, suggesting that their results were not biased by reporting differences between 
groups (Ibid.). 
Pérez-Stable et al. (1998) examined the potential mechanism underlying higher cotinine 
levels among blacks in their hospital-based study of 40 black smokers and 39 white 
smokers. The participants received infusions of deuterium-labeled nicotine and cotinine, 
allowing for the accurate determination of daily nicotine intake from smoking. The 
authors found that although black smokers in this study smoked fewer cigarettes per day, 
they had higher overall levels of serum cotinine than white smokers. They attributed this 
difference to slower clearance of cotinine and higher intake of nicotine per cigarette 
smoked among blacks. A greater intake of nicotine and carcinogens from tobacco smoke 
per cigarette may be a partial explanation for the elevated burden of smoking-related 
diseases among blacks (Ibid.; Haiman et al. 2006). 
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Socioeconomic Status, Residential Context, Health Care, and Black-White Differences in 
Smoking-Attributable Mortality 
Although racial identity is often conceptualized as an individual determinant of health 
and mortality, race captures important macro-level influences that condition individuals’ 
life chances in the United States (e.g., Massey and Denton 1993; Smelser, Wilson and 
Mitchell 2000). Furthermore, U.S. racial classifications reflect prevailing political, 
ideological, and social forces rather than meaningful biological differences (Omi and 
Winant 1994; Williams et al. 2010; Zuberi 2001). Black-white differences in 
socioeconomic status (SES), residential context, and access to health care are prominent 
explanations for black-white differences in health and mortality (Hayward et al. 2000; 
Howard et al. 2000; Smedley, Stith and Nelson 2003; Williams et al. 2010), and they are 
also likely to contribute to black-white differences in smoking-attributable mortality at 
older ages.  
Racial/ethnic differences in smoking behavior have been largely explained by 
racial/ethnic differences in SES (Flint and Novotny 1997; Kiefe et al. 2001; King 1997; 
King et al. 2004; Novotny et al. 1988). The benefits of smoking cessation may be viewed 
as marginal by low SES blacks due to their greater exposure to other health-eroding 
circumstances such as lack of material resources, residence in segregated neighborhoods, 
and the cumulative impact of disadvantage over the life course (Hayward et al. 2000; 
Link and Phelan 1995; Pampel, Krueger, and Denney 2010; Williams et al. 2010; Yao 
and Robert 2008). Smoking may serve as a “self-medicating mechanism” and a “form of 
relaxation” among low-income groups in the face of high levels of financial and other 
sources of stress (Cutler and Lleras-Muney 2008; Lawlor et al. 2003; Lutfey and Freese 
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2005; Pampel, Krueger, and Denney 2010). There is also evidence that cigarette 
companies target advertising toward black communities (Altman, Schooler, and Basil 
1991; Landrine et al. 2005). The treatment effects of smoking cessation interventions 
appear to be weaker for blacks than for whites (Murray et al. 2001), and success in 
quitting smoking has been found to be higher among higher SES individuals, a pattern 
that holds for most racial/ethnic groups (Barbeau, Krieger, and Soobader 2004; Barbeau 
et al. 2005).  
Researchers have speculated that smoking may be more harmful for low SES relative to 
high SES individuals because of their already poorer health status, whereas others have 
made the opposite argument – that because the baseline health stock of low SES 
individuals has already been diminished due to limited resources, the marginal impact of 
unhealthy behaviors like smoking is smaller for low SES than high SES individuals 
(Blaxter 1990; Pampel and Rogers 2004). That smoking might have a differential impact 
on mortality by SES and/or by race/ethnicity could also result in part from differential 
access to health care and the quality of that care. For example, smoking is a contributing 
factor to many forms of heart disease, the management of which is enhanced by high 
quality health care (Smedley, Stith, and Nelson 2003; Williams et al. 2010). Recent 
evidence points to the possibility that smoking is more detrimental to the health of 
disadvantaged groups. For example, Pampel and Rogers (2004), using data from the 1990 
NHIS Health Promotion and Disease Prevention Supplement, concluded that smoking 
was more predictive of morbidity among low than high SES individuals, whereas no such 
interaction was found for mortality or between smoking and race/ethnicity for either 
morbidity or mortality controlling for socioeconomic status. Using the same data source, 
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Krueger and Chang (2008) found that high levels of former smoking increased the impact 
of stress on mortality for low SES individuals, but the interaction between smoking and 
stress was not significant for middle or high SES individuals. 
 
AIMS OF THIS STUDY 
In this study, we examine the contribution of smoking to black-white differences in 
mortality above age 50 using two complementary methods and data sources. First, we use 
indirect estimation techniques (Preston, Glei, and Wilmoth 2010) and vital statistics and 
census data from 1980-2005 to quantify the overall contribution of smoking-attributable 
mortality to trends in black and white mortality at ages 50 and above and to trends in the 
black-white gap in life expectancy at age 50. The indirect method has the potential for 
generating more reliable estimates of smoking-attributable mortality than direct methods 
relying on self-reported smoking behavior measured at a single point in time (Ibid.). 
Second, we use the National Health Interview Survey (NHIS) data from 1997-2003 
linked to the National Death Index (NDI) through the end of 2006 to examine the extent 
to which differences in smoking behavior explain black-white differences in mortality 
and whether smoking exhibits a different association with mortality among blacks and 
whites (Denney et al. 2010; Flanders et al. 2003; IARC 2004; Pampel and Rogers 2004). 
Together, these estimates provide a comprehensive picture of the contribution of smoking 
to black and white mortality trends and to black-white mortality differences at older ages. 
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Data and Methods 
I. Indirect Estimation of Smoking-Attributable Mortality, 1980-2005 
Data  
In the first part of the analysis, we use vital statistics data on deaths and population 
estimates available from the National Cancer Institute’s SEER database 
(http://seer.cancer.gov/). These data are used to calculate age-specific death rates from 
lung cancer and from all other causes combined by race, sex, and 5-year age groups (50-
54 to 85+). These data include all blacks and whites regardless of whether individuals 
identified as Hispanic because of the uneven quality of Hispanic ethnicity reporting in 
vital statistics and census data over the study period. States began to include a Hispanic-
origin item on the death certificate in 1985, but this item was not reported by all 50 states 
and the District of Columbia until 1997 (NCHS 2006). We test the sensitivity of our 
results to the inclusion of Hispanic blacks and whites using the NHIS in the second part 
of the analysis (see below and Table A1.1). 
 
Methodology  
We use an indirect estimation method developed by Preston, Glei, and Wilmoth (2010) to 
estimate smoking-attributable mortality. The method is based on an assumption that lung 
cancer death rates can be used as a proxy to estimate the impact of smoking on mortality 
from all other causes of death (Preston, Glei, and Wilmoth 2011). The high proportion 
(approximately 90%) of lung cancer deaths attributable to smoking and the quality of 
lung cancer reporting on death certificates in the United States give us confidence that 
lung cancer mortality accurately proxies the impact of smoking on mortality from other 
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causes (Ibid.; Percy, Miller, and Ries 1990; Percy, Stanek, and Gloeckler 1981). Lung 
cancer is one of the most accurately reported cancers on the death certificate, and the 
quality of its reporting on death certificates has been high since at least the 1970s, a 
decade prior to the beginning of our study period (Ibid.).  
In this model, age-specific lung cancer death rates are used to predict age-specific 
smoking-related mortality from all other causes of death. The model produces age- and 
sex-specific coefficients that, along with information on lung cancer death rates among 
non-smokers, can be used to estimate the fraction of deaths from all other causes that are 
attributable to smoking. Preston, Glei, and Wilmoth (2010) estimated this model using 
data from 21 developed countries for the period 1950-2006. The same model was 
subsequently applied by Fenelon and Preston (2012) to state-level data from the United 
States for the period 1996-2004. In this paper, we performed all analyses using the 
estimated age- and sex-specific coefficients from the above two studies and concluded 
that the results were not sensitive to the choice of the coefficients. The results reported 
here are based on the coefficients published in Fenelon and Preston (2012). Both Preston, 
Glei and Wilmoth (2011) and Fenelon and Preston (2012) demonstrated that this method 
produces results very similar to those obtained from an older, widely-used method 
developed by Peto et al. (1992).  
To apply this method, we first estimated the fraction of deaths due to lung cancer in a 
specific age group that is attributable to smoking (AL) as follows: 
 
  λ
                                                                                                              1
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where   is the observed race-sex-specific lung cancer death rate and λ is the expected 
sex-specific lung cancer death rate among non-smokers, which is taken from the Cancer 
Prevention Study II (Preston, Glei, and Wilmoth 2010).    
Second, we estimated the fraction of deaths from all other causes in a specific age group 
that is attributable to smoking () as follows: 
  1  ′ 
                                                                                              2
  
where ′  are the age-sex-specific model coefficients from Fenelon and Preston (2012) 
and  and λ are as defined above.  
The overall attributable fraction of deaths from all causes that is due to smoking, , was 
then calculated as: 
                                                                                                          3
 
for each sex-race-age group, where  is the observed number of deaths from lung 
cancer,  is the observed number of deaths from all other causes, and  is the observed 
number of deaths from all causes combined (Preston, Glei, and Wilmoth 2010). Thus, the 
fraction of all deaths above age 50 that is attributable to smoking (), is: 
 
∑ 
∑ 
 ∑ 

                                                               4
 
where  is the overall fraction of deaths attributable to smoking in age group ! and  is 
the number of deaths from all causes in age group !. 
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To translate smoking-attributable mortality by age into implications for life expectancy at 
age 50, we obtained adjusted age-specific death rates (i.e., death rates from which 
smoking-attributable mortality is removed), "#, as follows: 
"#  "1  
                                                                                                     5
 
where ! = 50-54, 55-59, …, 80-84, 85+ and " is the age-specific death rate from all 
causes combined. 
We then used standard life table procedures to calculate life expectancy at age 50 by race 
and sex with and without the inclusion of smoking-attributable deaths to determine the 
extent to which smoking contributes to the black-white gap in life expectancy at age 50 
and whether this contribution has changed over time (Preston, Heuveline, and Guillot 
2001). In these calculations, we used race-age-sex-specific  %&' and ∞" values from 
published U.S. life tables constructed for each year by NCHS (CDC/NCHS 2010) 
because estimates of old age mortality based on vital statistics and census data without 
adjustment are likely to be flawed (Elo 2001; Preston and Elo 2006). Our estimates of life 
expectancy at age 50 using all-cause mortality are very close to the published U.S. life 
table values.  
In addition to comparing differences in smoking-attributable mortality between blacks 
and whites, we examine within-group differences in levels of smoking-attributable 
mortality for males and females and translate these differences into implications for the 
sex gap in life expectancy at age 50. This allows us to investigate how the impact of 
smoking on the sex gap in life expectancy at age 50 has changed over time and whether 
the magnitude of its contribution differs between blacks and whites. 
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II. Estimates of Smoking-Attributable Mortality Based on the NHIS, 1997-2003  
Data 
In the second part of the analysis, we used data from seven waves of the National Health 
Interview Survey (1997-2003), including the Sample Adult supplement, which collects 
information on smoking behavior for individuals ages 18+. These data have been linked 
to the NDI through the end of 2006. The NHIS is the most comprehensive, nationally 
representative data source for the study of socioeconomic and behavioral determinants of 
mortality in the United States and has been widely used for these purposes in previous 
studies (e.g., Hummer et al. 1999; Krueger and Chang 2008; Pampel and Rogers 2004; 
Rogers et al. 2005). The NHIS has several strengths for this analysis. The survey has a 
large sample size with an oversample of blacks, Hispanics, and Asians; provides high-
quality information on the health and socio-demographic characteristics of respondents; 
is representative of the U.S. civilian noninstitutionalized population; and has achieved a 
lengthy mortality follow-up while maintaining a close correspondence between the 
survival experience of race-age-sex groups of NHIS cohorts and the U.S. population 
(CDC/NCHS 2009; Ingram, Lochner, and Cox 2008).  
We restrict our sample to individuals aged 50-84 at the time of the survey, an age range 
similar to that employed in the indirect estimation of smoking-attributable mortality. 
These ages accounted for over 98% of the black-white difference in life expectancy at 
age 50 for both males and females in 1980 and 2005 (calculations by the author). We 
further limit the sample to non-Hispanic whites and non-Hispanic blacks, although we 
also test the sensitivity of our results by including all whites and blacks without the 
exclusion of Hispanics. We focus this part of the analysis on males since smoking-
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attributable mortality appears to make a larger contribution to black-white differences in 
mortality among males than females (see Figure 1.6 below).  
The pooled 1997-2003 NHIS adult sample consists of 30,422 non-Hispanic white and 
non-Hispanic black males aged 50-84. We dropped 1,677 individuals who were ineligible 
for mortality follow-up due to a lack of information necessary for the linkage to the NDI 
or who were missing information on date of birth from this sample. We also excluded 
1,087 males due to missing information on smoking behavior and 494 males due to 
missing information on other explanatory variables. The final sample consists of 23,701 
non-Hispanic white males and 3,463 non-Hispanic black males aged 50-84 at the time of 
the interview, of whom 4,831 died during the follow-up period.4 
 
Explanatory Variables 
Our smoking variable distinguishes between never5, current, and former smokers, taking 
into account smoking intensity (number of cigarettes smoked per day) among current 
smokers and time since stopping smoking among former smokers. Time since quitting is 
calculated from respondents’ reported number of years since quitting. Among current 
smokers, we differentiate light smokers (who reported smoking less than 1 pack per day) 
from heavy smokers (who reported smoking 1 or more packs per day). Individuals who 
reported smoking two or more packs per day were rare in this sample of older adults. The 
smoking variable is coded as follows: never smoker, former smoker who quit 30+ years 
                                                           
4
 Sample sizes and number of deaths for other comparison groups (black and white males including 
Hispanics, non-Hispanic black and white females, and black and white females including Hispanics) used 
in sensitivity analyses are reported in Table A1.2. 
5
 In the NHIS, ever smokers are defined as those who reported smoking at least 100 cigarettes in their 
lifetimes. 
18 
 
ago, former smoker who quit 20-29 years ago, former smoker who quit 10-19 years ago, 
former smoker who quit 5-9 years ago, former smoker who quit < 5 years ago, current 
smoker who smoked < 1 pack per day, and current smoker who smoked 1+ packs per 
day.  
Most individuals (86.1%) began smoking by age 20 and nearly all (98.9%) had begun by 
age 30. Most current smokers were long-time smokers, with 93% having smoked for over 
30 years (tabulations by the author). Thus, being a current smoker captures not only 
current smoking intensity but also long smoking duration. Furthermore, recent quitters 
(former smokers who had quit less than 10 years ago) were also long-time smokers, with 
99% having smoked for more than 20 years. Smoking duration has been found to be a 
stronger predictor of lung cancer than the number of cigarettes smoked per day in several 
studies (Flanders et al. 2003; IARC 2004), and smoking-related mortality is known to 
vary by time since quitting (Ben-Shlomo et al. 1994; IARC 2004; Jacobs et al. 1999; Peto 
et al. 2000). Because smoking duration, intensity, and quit rates differ between blacks 
and whites, the smoking variable captures these differences in smoking behavior.  
We also control for other individual-level attributes which vary by smoking status and 
between blacks and whites, and which can confound the relationship between smoking 
and mortality. These include body mass index (BMI), which is coded using standard 
categories (underweight, BMI <18.5 kg/m2; normal, BMI 18.5-24.9 kg/m2; overweight, 
BMI 25.0-29.9 kg/m2; obese I, BMI 30.0-34.9 kg/m2, and obese II/III, BMI ≥35.0 kg/m2), 
and marital status, which is coded as never married, currently married, and 
widowed/divorced/separated. Our socioeconomic attributes include educational 
attainment (< 12 years, 12 years, 1-3 years of college, and 4+ years of college) and family 
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income. Because a large number of cases are missing information on family income in 
the NHIS, we used the imputed family income variable available from the Integrated 
Health Interview Series (IHIS) (Minnesota Population Center and State Health Access 
Data Assistance Center 2010).6 We converted the categorical family income variable into 
a linear variable by taking the midpoint of each income interval and dividing it by 
10,000. We estimated the value of the open ended category, which begins at $75,000, by 
estimating a median value for this category (Parker and Fenwick 1983; Rogers et al. 
2005).7 We include the natural log of family income in our models to capture the non-
linear income association with mortality. In addition, we control for region of residence 
(northeast, north central, south, and west) to account for differences in residential 
distribution between blacks and whites and for differential mortality by region of 
residence.  
 
Methods and Analytic Strategy 
We used Cox proportional hazards regression models to estimate all-cause mortality. We 
focus on all-cause mortality because smoking, as discussed above, is a contributing factor 
for mortality from multiple causes of death. In addition, our indirect estimation of 
                                                           
6
 This variable was created using multiple imputation methods first developed by Rubin (1987). Imputation 
of family income was restricted to families containing at least one adult earner, and observed personal 
earnings were used as the lower bounds in these imputations. A large number of variables were used in the 
imputation, including variables pertaining to geographic location, household composition, employment, 
race/ethnicity, education, and reported health conditions or disability of family members. 
7
 The median value in the open ended category is estimated using the Pareto curve. The slope of this curve, 
v, is estimated as [log(nt + nt-1) - log(nt)] / [log(xt) - log(xt-1)], where nt  is the number of people in the open 
ended (last) income category, nt-1 is the number of people in the next-to-last income category, xt is the 
lower bound of the open ended income category, and xt-1 is the lower bound of the next-to-last income 
category. The median value for the open ended category is then estimated as 10^(0.301/v)*xt. 
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smoking-attributable mortality captures mortality from all smoking-related causes. Our 
Cox proportional hazards model takes the form of: 
log +,
  log +,
   -.  / 010  / 2343,
30
                                    6
 
where +,
 is the unspecified baseline hazard function; , measures age; ! refers to the 
individual; 1 to smoking behavior; 4 to other explanatory variables, including baseline 
age and race/ethnicity; and . refers to the survey year. Individuals who were alive on 
December 31, 2006 were censored on this date (Allison 1995). Age was used as the 
analysis time, which allows for unrestricted non-linearity in its effects and, in the 
construction of the partial likelihood, makes comparisons only among people of the same 
age. Hazard ratios were calculated based on exponentiated coefficients from the 
proportional hazards models (78  ). We used t-tests to assess the significance of 
individual coefficients. In the estimation, we took into account the complex sample 
design of the NHIS to obtain corrected standard errors. All models were weighted and 
estimated using Stata 11.  
We estimated three models: Model 1 estimates the magnitude of the excess mortality 
among non-Hispanic black males controlling for age at baseline, survey year, BMI, and 
race. Model 2 adds smoking behavior to Model 1 to assess whether controlling for 
smoking helps explain the black-white difference in mortality. In Model 3, we introduce 
marital status, education, family income, and region of residence. These further 
adjustments allow us to assess whether introducing these additional controls further 
modifies the black and smoking status coefficients. We then interact race with smoking 
status to examine whether smoking has a differential impact on mortality among non-
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Hispanic whites and non-Hispanic blacks. Finally, we used the hazard ratios from the 
Cox proportional hazards models to calculate population attributable risk fractions (PAF) 
due to smoking and compare these fractions to those obtained using the indirect 
estimation method described above. 
To calculate the PAFs, we used the following equation recommended for use with a 
multicategory exposure variable and in the presence of confounding (Rockhill, Newman 
and Weinberg 1998):  
9:   ∑ ;< =>>?@>>? A  1   ∑
BC?
>>?                                                            7

33   
where ! refers to smoking category, ;< is the fraction of total deaths occurring in the !th 
smoking category, and 88 is the hazard ratio from Model 3 for the !th smoking category. 
The PAF provides an estimate of the proportion of deaths that could be avoided if 
smoking were eliminated from the population (Flegal et al. 2005; Mehta and Chang 
2009). In practice, the PAF estimates the proportion of deaths that could be avoided if all 
current and former smokers experienced the mortality risks of never smokers.  
 
Results 
I. Indirect Estimates of Smoking-Attributable Mortality, 1980-2005 
 Table 1.1 and Figure 1.5 show the percentage of deaths attributable to smoking 
by race and sex between 1980 and 2005. Among males, this fraction increased until 
around 1990, and it was higher among black males than white males throughout the 
period. This black-white difference reached a peak (7.2%) around 1990, when 32.3% of 
deaths among black males and 25.1% of deaths among white males above age 50 were 
attributable to smoking. This gap subsequently declined to 3.7% by 2005, when 24.2% 
22 
 
and 20.5% of deaths were attributable to smoking among black males and white males, 
respectively.   
Smoking-attributable deaths made up a much smaller percentage of deaths among 
females than males, but their contribution rose steadily throughout the period, reflecting 
differential smoking histories (Burns et al. 1997; Preston and Wang 2006). In contrast to 
the case of males, smoking-attributable deaths made up a somewhat smaller percentage 
of all deaths among black females than among white females except in the early 1980s, 
when this percentage was slightly higher among black females (Table 1.1 and Figure 
1.5). For example, in 1980 the percentage of deaths attributable to smoking was 6.4% for 
white females and 6.8% for black females. By 2005, these percentages had increased to 
15.8% and 14.4%, respectively. 
Table 1.2 and Figure 1.6 illustrate the impact of smoking-attributable mortality on life 
expectancy at age 50 by race and sex and its contribution to black-white differences in 
life expectancy at age 50 over time. For example, for white males, smoking-attributable 
mortality reduced life expectancy at age 50 by 3.02 years in 1990 (29.78 without smoking 
versus 26.76 with smoking) and 2.41 years in 2005 (31.39 versus 28.98). For black 
males, smoking-attributable mortality reduced life expectancy at age 50 by between 4.47 
years in 1990 (27.03 versus 22.56) and 3.18 years in 2005 (28.29 versus 25.11). In the 
absence of smoking-attributable mortality, the black-white gap in male life expectancy at 
age 50 would have been about 1.44 years smaller in 1990 and 0.78 years smaller in 2005. 
Thus, smoking-attributable mortality accounted for about 34% (1.44/4.20) of the black-
white gap in male life expectancy at age 50 in 1990 and about 20% (0.78/3.87) of the gap 
in 2005. 
23 
 
Because smoking-attributable mortality made a smaller contribution to mortality above 
age 50 among females than among males, its contribution to life expectancy at age 50 
was also much smaller for females. In 1980, it accounted for 0.79 years of white female 
life expectancy and 0.86 years of black female life expectancy at age 50. By 2005, these 
figures had increased to 1.90 years and 1.83 years, respectively. Because the impact of 
smoking on life expectancy at age 50 was similar for white females and black females, 
the elimination of smoking-attributable deaths had little impact on the black-white gap in 
female life expectancy at age 50.     
Figure 1.6 also suggests that the contribution of smoking to sex differences in mortality 
differs between blacks and whites. The percentage of deaths attributable to smoking 
among males exceeds that among females for both blacks and whites; however, the 
magnitude of this difference is larger for blacks than for whites (Table 1.1). In 1990, the 
percentage of deaths attributable to smoking was roughly 12% for both black and white 
females, but these figures were 32.3% for black males and 25.1% for white males. The 
male-female difference in smoking-attributable mortality declined throughout the study 
period for both blacks and whites but remained larger for blacks in 2005 (a difference of 
9.8% among blacks versus 4.7% among whites).  
Table 1.3 and Figure 1.7 demonstrate the impact of smoking-attributable mortality on 
the sex gap in life expectancy at age 50 for blacks and whites. In the absence of smoking-
attributable mortality, the sex gap in life expectancy at age 50 for blacks would have been 
smaller by about 2.94 years in 1980 and 1.36 years in 2005, accounting for between 50-
55% of the gap between 1980-1990 and 28% of the gap in 2005. For whites, the sex gap 
in white life expectancy at age 50 would have been between 0.51 (2005) and 1.94 (1980) 
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years smaller in the absence of smoking between 1980 and 2005, and smoking-
attributable mortality accounted for approximately 14%-34% of the gap during this time 
period. Overall, the contribution of smoking-attributable mortality to sex differences in 
life expectancy at age 50 has been larger for blacks than whites. 
In summary, the results from indirect estimation of smoking-attributable mortality show 
that smoking had a sizeable impact on life expectancy at age 50 for blacks and whites 
between 1980 and 2005, especially among males. Smoking-attributable mortality has also 
contributed to the black-white gap in male life expectancy at age 50, but it has had a 
negligible impact on the black-white gap in female life expectancy at age 50. These 
estimates are consistent with black-white differences in mortality from most smoking-
related causes of death. However, differences in ever-smoking prevalence between black 
and white male birth cohorts do not appear to be especially large (Figure 1.2). Thus, it is 
somewhat puzzling why the contribution of smoking-attributable mortality to life 
expectancy at age 50 is larger for black males than for white males, whereas among 
women, the contribution of smoking-attributable mortality is very similar. In the second 
part of the analysis, we assess whether differences in smoking behavior, including 
smoking duration and smoking intensity (among current smokers), can help explain 
black-white differences in smoking-attributable mortality among males.  
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II. Smoking Behavior and Mortality Among Non-Hispanic Black and Non-Hispanic White 
Males: Results from the NHIS 
Table 1.4 provides sample characteristics for the entire male sample and for non-
Hispanic white and non-Hispanic black males separately.8 As expected, there were 
significant differences in smoking status between the two groups. For example, a higher 
percentage of blacks (35.7%) than whites (32.8%) were never smokers and current 
smokers (28.2% and 18.6%, respectively), whereas a larger percentage of whites (48.6%) 
than blacks (36.2%) were former smokers. Furthermore, 26.5% of whites had quit 20+ 
years ago compared with only 15.9% of blacks. These smoking patterns are consistent 
with results from prior studies summarized above: blacks were more likely to be current 
smokers and to have stopped smoking more recently relative to whites.  
There were also significant black-white differences in the other explanatory variables. 
Black males were on average slightly younger than white males, and they were less likely 
to be currently married and more likely to have been widowed, divorced, separated, or 
never married. About 35.7% of black males had less than high school education 
compared with 15.6% of white males, and blacks were less likely to have attended at 
least 4 years of college. Blacks also had significantly lower family incomes, and they 
were more likely to live in the south.   
Table 1.5 presents the hazard ratios from the multivariate models for black males relative 
to white males and for former and current smokers relative to non-smokers. All models 
control for age at baseline, BMI, and survey year. Model 2 adds the smoking status 
                                                           
8
 In this section, from this point forward “black” refers to non-Hispanic black males and “white” refers to 
non-Hispanic white males unless otherwise specified.  
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variable, and Model 3 adjusts for marital status, educational attainment, family income, 
and region of residence. In Model 1, the hazard of dying is about 50% higher for black 
males than for white males controlling for age at baseline, BMI, and survey year. The 
introduction of smoking status decreases this relative risk by 20%9, suggesting that 
smoking plays some role in the excess mortality of black males relative to white males at 
ages 50 and above. However, a far greater reduction is observed when we introduce 
controls for marital status, educational attainment, family income, and region of 
residence. The hazard ratio for non-Hispanic black males is reduced by 62%, from 1.39 
to 1.15. These results support the notion that socioeconomic circumstances are the key 
explanations for the high mortality of black males. 
As seen in Table 1.5, smoking is a highly significant predictor of mortality, even when 
controlling for potential confounding variables. The risks vary by time since quitting 
among former smokers and by smoking intensity among current smokers. Compared to 
never smokers, the hazard ratio is highest for current heavy smokers (2.66, Model 3), 
those who smoked 1+ packs per day. Current light smokers (< 1 pack per day) and former 
smokers who quit less than 5 years ago (2.28 and 2.37, respectively, Model 3) have 
similar relative risks compared to never smokers. The high risk of dying among recent 
quitters is consistent with other studies and may result from individuals quitting smoking 
due to illness (DHHS 1990). Among former smokers, the hazard ratios decline by time 
since quitting, and those who quit 30+ years ago experience risks that are not 
significantly different from those of never smokers. The introduction of other explanatory 
variables (Model 3 versus Model 2) results in small declines in the magnitudes of the 
                                                           
9
 (1.49-1.39)/(1.49-1.00)=0.20. 
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hazard ratios for the various smoking categories, but they remain highly significant (with 
the exception of the hazard ratio for those who quit 30+ years ago, which is not 
significant in either model).   
We speculated that the associations between smoking status and mortality might vary 
between blacks and whites. To test this possibility, we included interaction terms between 
race and smoking status in our main effects Model 3. These interaction terms were not 
jointly significant, providing no support for the hypothesis that the effects of smoking 
differ between black males and white males.  
Table 1.6 shows the population attributable risk fractions (PAF) due to smoking by 
smoking category for white and black males. Attributable risk fractions are presented as 
percentages, and they reflect the percentage of deaths that could be avoided if smoking 
were eliminated (Mehta and Chang 2009). The reference category for all estimates is 
never smokers. Because the effects of smoking did not vary between black males and 
white males, we re-estimated Model 3 without controlling for race and used the hazard 
ratios associated with the various smoking categories from this model to calculate the 
PAFs by smoking status.10  
Overall, we estimate that 29.4% and 33.1% of deaths were attributable to smoking among 
white males and black males, respectively. Among whites, the largest contribution is 
made by current heavy smokers (9.8%); the contributions of other smoking categories are 
only about half or less than half this size. In contrast, among blacks, the largest 
contribution is made by current light smokers (13.2%) followed by current heavy 
                                                           
10
 The results are essentially the same if we use coefficients from a model that includes race. 
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smokers (7.8%). The contributions of most other smoking categories are less than half the 
size of those made by current smokers.  
 
Discussion 
Smoking has significantly impacted American mortality and continues to be a leading 
cause of morbidity and mortality today. To the best of our knowledge, this is the first 
study to investigate the contribution of smoking-attributable deaths to mortality trends 
among blacks or to black-white mortality differences at older ages over time. We 
employed multiple methods and data sources to provide a comprehensive assessment of 
this contribution.  
We find that smoking has reduced life expectancy at age 50 considerably, especially 
among males. These reductions range from 3.02 years in 1990 to 2.41 years in 2005 
among white males, and from 4.47 years in 1990 to 3.18 years in 2005 among black 
males. Smoking has also contributed to the black-white gap in male life expectancy at 
age 50. This contribution reached its peak in 1985 and 1990 at 1.45 years (approximately 
34-40% of the black-white gap in male life expectancy at age 50), but has subsequently 
declined to 0.78 years (20% of the gap) by 2005. Trends in smoking-attributable 
mortality differ for females. The smoking epidemic began later among females, and this 
pattern is reflected in our results. Smoking-attributable mortality reduced life expectancy 
at age 50 for white females by only 0.79 years in 1980; the respective amount for black 
women was 0.86 years. By 2005, these contributions had increased to 1.90 years and 1.83 
years among white and black females, respectively. In earlier years, smoking made only a 
minor contribution to the black-white gap in female life expectancy at age 50, but in more 
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recent years smoking has had a more detrimental impact on mortality at older ages for 
white females than black females. 
We know of only one prior study that has estimated the contribution of smoking to 
mortality by race/ethnicity, in this case among eight population subgroups in the U.S. 
which were defined based on race and geography (Danaei et al. 2010). This study 
estimated relative risks associated with current and former smoking as well as other risk 
factors (e.g., obesity), and then used these relative risks to estimate the contribution of 
these risk factors to life expectancy at birth. The authors estimated that in the absence of 
smoking, white males stood to gain between 2.4-3.3 years in life expectancy at birth in 
2005 depending on the subgroup, whereas black males stood to gain between 2.6-3.1 
years. These estimates were 1.4-2.1 years for white females and 1.5-1.8 years for black 
females (Ibid.). Although these estimates apply to a single year (2005) and are not 
directly comparable to our results because we consider deaths and life expectancy gains 
only above age 50, they are generally consistent with our findings.  
Preston and Wang (2006) predicted that sex differences in mortality would narrow 
dramatically in coming decades. Our analysis also points to the importance of smoking in 
explaining sex differences in mortality and suggests that the contribution of smoking to 
the sex gap in life expectancy has differed between population subgroups in the U.S. over 
time. We found that the contribution of smoking-attributable mortality to the sex gap in 
life expectancy at age 50 has been larger among blacks than whites. While the sex gap in 
life expectancy at age 50 had already narrowed substantially among whites by 2005, 
given that smoking still accounted for roughly 30% of the sex gap among blacks (nearly 
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twice the corresponding figure for whites) in 2005, we may expect to see a continued and 
even more dramatic narrowing of the sex gap in life expectancy at age 50 among blacks. 
Based on the indirect estimation approach, we found that the percentage of deaths 
attributable to smoking above age 50 ranged from roughly 24%-29% among black males 
and 20%-23% among white males between 1997 and 2005. These estimates are 
consistent with those of Preston, Glei, and Wilmoth (2010), who estimated the smoking-
attributable fractions among all males to be 24% in both 1980 and 2003 (these figures 
would necessarily be more similar to the fractions for white males, given that they make 
up a larger proportion of the total male population).  
In the second part of our analysis, based on a regression approach and the NHIS data, we 
found that although the population attributable fractions of deaths due to smoking among 
black men (29.43%) and white men (33.08%) exceeded the estimates based on the 
indirect approach, the magnitude of the black-white difference was quite similar (3.65% 
compared to 4.89%, the black-white difference from the indirect approach in 2001, 
roughly the midpoint of the period 1997-2006). Although the fractions produced from 
direct estimation are somewhat larger than those produced from indirect estimation, they 
are in line with other published results. For example, Mehta and Chang (2009) found that 
smoking-attributable mortality was 50% for males and 35% for females using a sample 
aged 50-61 at baseline from the Health and Retirement Study (1992-2004), another 
nationally representative survey. 
We also demonstrate that smoking contributes to the relative differences in mortality 
among black males and white males at ages 50 and above. The black excess risk was 
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reduced by 20% when smoking status at the start of the mortality follow-up was included 
in the model. At the same time, the reduction in the black excess risk was much smaller 
than the reduction resulting from the inclusion of socio-demographic characteristics 
(62%). Thus, while black-white differences in smoking behavior contribute to black-
white disparities in male mortality, black-white differences in SES play a much larger 
role (see also Hayward et al. 2000). Finally, we speculated that the effects of smoking on 
mortality might differ between blacks and whites, but found no support for this 
hypothesis. This result is consistent with Pampel and Rogers (2004), who found that 
interactions between race and smoking status were not significant predictors of 
morbidity, mortality, or self-rated health. Danaei et al. (2010:4) reviewed several 
observational studies and trials and concluded that “the current evidence indicates that 
while the absolute effects (e.g., excess mortality rate) of risk factors vary by race, their 
proportional effects (i.e., relative risks) did not vary appreciably by race and ethnicity.”  
The deleterious effects of smoking change only modestly and are preserved after 
controlling for marital status, educational attainment, family income, and region. The 
excess risks associated with smoking are striking. Current smokers, 93% of whom have 
smoked for more than 30 years, are 2.3-3 times more likely to die than never smokers. 
Former smokers who have quit most recently have elevated risks that are slightly higher 
than those of current light smokers, with the risk diminishing considerably among former 
smokers as the time since quitting increases. In fact, those who stopped smoking 30 years 
prior to the baseline survey have mortality risks similar to never smokers. Most of these 
individuals had quit prior to age 40. These results are consistent with Peto et al. (2000), 
32 
 
who found that smokers who quit before middle age avoid over 90% of lung cancer risk 
attributable to smoking. 
Overall, the results from this study demonstrate that former smokers are a highly 
heterogeneous group and should be differentiated when estimating the effects of smoking 
on mortality. Simply comparing levels of ever-smoking prevalence without taking into 
account differences in smoking duration, intensity, and cessation can mask differences 
among subgroups, and using a never, former, and current smoker categorization may not 
be sufficient to adequately capture the impact of smoking on mortality. 
A number of factors may play a role in explaining why the burden of smoking-
attributable mortality is greater among black males than white males. Our analysis 
supports the hypothesis that longer smoking durations and substantially lower smoking 
cessation rates among blacks may be contributing to their higher burden of smoking-
related morbidity and mortality. Black-white differences in exposure to toxins per 
cigarette (reviewed above) and the types of cigarettes smoked may also be part of the 
explanation. Blacks are more likely to smoke cigarettes with high tar yields and 
mentholated cigarettes, although it has not been established whether mentholated 
cigarettes increase the risk of lung cancer and other smoking-related diseases. In addition, 
factors such as the experience of cumulative disadvantage over the life course and lack of 
access to timely and high quality health care and other resources are likely to result in 
higher mortality among black smokers, who may have lower success in quitting smoking 
and poorer outcomes once they have developed smoking-related diseases. 
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Strengths  
The main strengths of this study lie in the pairing of direct and indirect estimation 
approaches used to estimate smoking-attributable mortality and our efforts to include 
detailed information on individual smoking histories. The indirect estimation method has 
the potential to produce more accurate estimates of smoking-attributable mortality 
because it does not rely on self-reported smoking behavior at a single point in time. For 
example, Stringhini et al. (2010) found that compared to studies using repeated measures 
of health behaviors (including smoking), studies using only a single assessment of health 
behaviors tend to substantially underestimate the contribution of these health behaviors to 
social inequalities in mortality. In addition, it is relatively straightforward to estimate the 
impact of smoking-attributable deaths by age group on life expectancy at age 50 using 
this method. It is particularly instructive to do so because smoking-attributable mortality 
varies by age and deaths at different ages contribute differentially to life expectancy (i.e., 
deaths occurring at younger ages contribute more to life expectancy than those occurring 
at older ages). Life expectancy is also an intuitive and interpretable measure which allows 
us to explore more fully the contribution of smoking to black-white mortality 
differentials.  
In the first part of the analysis, which uses indirect estimation, we are able to address 
concerns of age misreporting at the older ages by borrowing life table quantities from the 
NCHS life tables for age groups above 85. We also examine the number of expected 
years lived between ages 50 and 84 (EFGEHFIFG ) as an alternate measure to life expectancy at 
age 50 which should be less affected by age misreporting at the oldest ages (results not 
shown). Our results are robust to the age range used in the analysis. They are also robust 
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to the use of model coefficients estimated based on U.S. data and data from multiple 
developed countries. Estimates of smoking-attributable mortality among older females 
are slightly lower using the Fenelon and Preston (2012) coefficients, which are based on 
U.S. data and which the authors recommend for analyses in the U.S. because of its more 
mature smoking epidemic relative to other developed countries.  
An additional strength is our ability to compare results obtained from the indirect 
estimation to those obtained from survey data with detailed information on smoking 
histories for a similar age range and overlapping study periods. Using the NHIS data, we 
can also control for potential confounders of the relationship between smoking and 
mortality. In addition, we are able to examine whether including or excluding Hispanics 
affects our conclusions. As noted above, we were unable to restrict our analyses to non-
Hispanic whites and non-Hispanic blacks in the vital statistics and census data. Our 
conclusions are unaffected by the inclusion of Hispanics, including estimates of the 
population attributable fraction of deaths due to smoking (see Table A1.1). While the 
coefficients on smoking status become slightly smaller, they remain very close to those 
obtained from regressions based on a sample of non-Hispanic whites and non-Hispanic 
blacks. Finally, our smoking status variable incorporates more information on smoking 
behavior than most other studies, which tend to control only for whether the individual is 
a never, former, or current smoker. We were able to capture both smoking duration and 
intensity among current smokers, as well as recency of quitting among former smokers. 
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Limitations 
There are also some potential limitations to our analysis. The indirect estimation method 
relies on the strength of the association between smoking and lung cancer mortality. If 
the quality of death certification for lung cancer varies between blacks and whites, some 
bias could be introduced. There is some evidence that racial identity may affect the 
classification of certain causes of death (e.g., cirrhosis and homicide) on death certificates 
(Noymer, Penner, and Saperstein 2011). However, because of the strong link between 
lung cancer and smoking and the high quality of death certification for lung cancer in the 
United States, we do not believe this should be a major problem. For example, despite 
their lower health care access (which may make them less likely to be diagnosed), black 
males have a higher incidence of lung cancer. Their higher mortality rates are also 
consistent with lower survival from lung cancer relative to white males. Together, these 
observations suggest that the bias in certification may not be large if present. Another 
potential source of bias may be introduced, however, if the coefficients used to estimate 
smoking-attributable mortality differ between blacks and whites. We do not expect this to 
be a major issue. 
Another concern is that the expected lung cancer death rates among non-smokers were 
drawn from the CPS-II, which had a study population composed of volunteers who were 
more likely to be white, middle-class, and college-educated than the general U.S. 
population. Thus, the method may produce overestimates of smoking-attributable 
mortality. However, the rates of lung cancer among non-smokers observed in this study 
were similar to those observed in other samples, and the CPS-II is likely to be the current 
best source of these estimates given that it “remains the largest epidemiological study of 
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its kind ever attempted in the history of medical science,” having enrolled a total of 1.2 
million participants (Klausner 1997: iv; Preston, Glei, and Wilmoth 2010).  
The primary limitation of the direct estimation approach based on the NHIS linked 
mortality files is the reliance on self-reported smoking information from a cross-sectional 
survey. It is possible that recall bias and misclassification of smoking status may result in 
underestimates of smoking-attributable mortality. Smoking status is measured only at 
baseline and therefore we do not know whether this behavior changed during the follow-
up period and how accurately it captures individuals’ past smoking behavior. For 
example, individuals entering the survey at ages 50 and above may now smoke fewer 
cigarettes than they did at points earlier in their lifetimes, and the number of cigarettes 
they currently report smoking may not reflect lifetime smoking intensity. It is possible 
that smokers have altered their smoking behavior over time in response to factors such as 
illness, changes in cigarette taxation levels, and changing tar and nicotine yields in 
manufactured cigarettes (Bach et al. 2003).  
The extent to which these factors vary between blacks and whites is fairly ambiguous. It 
may be the case that smoking information is more accurate for blacks than for whites 
since on average, black smokers start smoking at older ages and have quit more recently 
compared to whites. However, the implications for the direction of potential biases and 
how this would affect differences in smoking-attributable mortality between the groups is 
unclear. We were not able to control for intensity of smoking among former smokers, as 
the questions eliciting this information were not asked during the survey waves under 
consideration. We are also unable to control for other potentially relevant exposures such 
as cigars, smokeless tobacco, or occupational exposures using the NHIS. 
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Black-white differences in occupational exposures may contribute to higher smoking-
attributable mortality among blacks. For example, exposure to asbestos, certain metals, 
radon, and ionizing radiation elevates lung cancer risk (Tyczynski et al. 2003). Estimates 
of the attributable risk from occupational exposures are highly time- and context-specific. 
Most U.S. case-control studies estimate that the fraction of lung cancer attributable to 
workplace exposures lies in the range of 6-17% among males (Steenland et al. 2003). 
However, not all studies control for the confounding effects of smoking, and others have 
found an interaction between smoking and other lung carcinogens, particularly asbestos 
(Tyczynski et al 2003). Sample characteristics and sizes and the ability to capture the 
intensity and cumulative burden of exposures differ widely between studies (Ibid.; IARC 
1992). Although the contribution of occupational exposures to lung cancer is large 
relative to most other exposure classes, it is small compared to that of cigarette smoking 
in industrialized countries (Alberg and Samet 2003). There is wide agreement that 90% 
of lung cancer mortality in the U.S. is attributable to smoking (Oza et al. 2011; Tyczynski 
et al 2003). 
Finally, the PAF estimates are interpreted as the proportion of deaths that could be 
avoided if smoking were eliminated from the population; in other words, this is the 
proportion of deaths that could be avoided if all current and former smokers experienced 
the mortality risks of never smokers. However, even with the extensive demographic and 
socioeconomic controls included in the full model, unobserved heterogeneity between 
smokers and non-smokers may remain. It may be the case that smokers would experience 
worse health and higher mortality risks even if they had not smoked.  
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Conclusion 
Overall, our findings are highly consistent with the previous literature, which finds that 
blacks suffer disproportionately from smoking-related diseases despite lower levels of 
smoking prevalence and lower intensities of smoking among current smokers. Some have 
suggested that these trends are due to longer smoking durations and lower smoking 
cessation rates among blacks. This study, which builds both duration and time since 
quitting into the measure of smoking status, supports this hypothesis. It also emphasizes 
the need to consider additional factors beyond levels of smoking initiation and ever-
smoking prevalence (Figure 1.2) by using more detailed categorizations of smoking 
status. The elevated mortality risks among recent quitters and current smokers are 
substantial and highlight the need for smoking cessation interventions that better address 
the needs of all groups. 
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Tables 
Table 1.1. Percentage of Deaths Attributable to Smoking at Ages 50+ by Sex Using the 
Indirect Estimation Method, Blacks and Whites, United States, Select Years Between 
1980 and 2005  
 Male Female 
Year Whites Blacks Whites Blacks 
1980 22.8 28.3 6.4 6.8 
1985 24.0 30.8 8.8 9.0 
1990 25.1 32.3 12.0 11.7 
1995 23.8 30.5 14.2 12.9 
2000 22.0 27.0 15.3 13.4 
2005 20.5 24.2 15.8 14.4 
 
 
Table 1.2. Life Expectancy at Age 50 and the Black-White Gap in Life Expectancy at 
Age 50 With and Without Smoking-Attributable Deaths Using the Indirect Estimation 
Method, United States, Select Years Between 1980 and 2005 
 
Males 
 
With smoking 
 
Without smoking 
 
 
Year 
 
Whites 
 
Blacks 
Gap 
(W-B) 
 
Whites 
 
Blacks 
Gap 
(W-B) 
% Gap due to 
Smoking 
1980 25.21 21.69 3.52 27.95 25.49 2.46 30.15 
1985 25.80 22.15 3.65 28.68 26.48 2.20 39.73 
1990 26.76 22.56 4.20 29.78 27.03 2.76 34.34 
1995 27.41 23.11 4.30 30.26 27.22 3.05 29.09 
2000 28.23 24.30 3.93 30.83 27.85 2.98 24.17 
2005 28.98 25.11 3.87 31.39 28.29 3.09 20.12 
        
Females With smoking Without smoking  
 
Year 
 
Whites 
 
Blacks 
Gap 
(W-B) 
 
Whites 
 
Blacks 
Gap 
(W-B) 
% Gap due to 
Smoking 
1980 30.92 27.37 3.55 31.71 28.23 3.48 1.95 
1985 31.19 27.93 3.26 32.31 29.13 3.18 2.46 
1990 31.69 28.25 3.44 33.18 29.78 3.39 1.19 
1995 31.80 28.50 3.30 33.54 30.15 3.39 -2.76 
2000 32.06 29.17 2.89 33.94 30.91 3.03 -4.81 
2005 32.64 29.99 2.65 34.54 31.82 2.72 -2.66 
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Table 1.3. Life Expectancy at Age 50 and the Sex Gap in Life Expectancy at Age 50 
With and Without Smoking-Attributable Deaths Using the Indirect Estimation Method, 
United States, Select Years between 1980 and 2005 
 
Blacks 
 
With smoking 
 
Without smoking 
 
 
Year 
 
Females 
 
Males 
Gap 
(F-M) 
 
Females 
 
Males 
Gap 
(F-M) 
% Gap  
due to Smoking 
1980 27.37 21.69 5.68 28.23 25.49 2.74 51.66 
1985 27.93 22.15 5.78 29.13 26.48 2.65 54.17 
1990 28.25 22.56 5.69 29.78 27.03 2.75 51.64 
1995 28.50 23.11 5.39 30.15 27.22 2.94 45.57 
2000 29.17 24.30 4.87 30.91 27.85 3.06 37.28 
2005 29.99 25.11 4.88 31.82 28.29 3.52 27.84 
        
Whites With smoking Without smoking  
 
Year 
 
Females 
 
Males 
Gap 
(F-M) 
 
Females 
 
Males 
Gap 
(F-M) 
% Gap  
due to Smoking 
1980 30.92 25.21 5.71 31.71 27.95 3.77 34.02 
1985 31.19 25.80 5.39 32.31 28.68 3.63 32.66 
1990 31.69 26.76 4.93 33.18 29.78 3.39 31.22 
1995 31.80 27.41 4.40 33.54 30.26 3.28 25.40 
2000 32.06 28.23 3.84 33.94 30.83 3.11 19.00 
2005 32.64 28.98 3.66 34.54 31.39 3.15 13.95 
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Table 1.4. Descriptive Statistics, Means and Standard Deviations or Percentages for 
Individual-level Characteristics, Males, National Health Interview Survey, 1997-2003  
 Total Non-Hispanic Whites (91%) 
Non-Hispanic 
Blacks (9%) p-value 
Variable N=27,164 N=23,701 N=3,463  
 Smoking Behavior 
      Never smoker 
      Former smoker, quit 0-4 years ago 
      Former smoker, quit 5-9 years ago 
      Former smoker, quit 10-19 years ago 
      Former smoker, quit 20-29 years ago 
      Former smoker, quit 30+ years ago 
      Current smoker, <1 pack per day 
      Current smoker, 1+ packs per day 
 
33.1 
5.6 
4.4 
12.0 
11.7 
13.8 
7.3 
12.2 
 
32.8 
5.5 
4.4 
12.2 
12.0 
14.5 
6.2 
12.4 
 
35.7 
5.7 
4.5 
10.1 
8.8 
7.1 
18.1 
10.1 
0.0000 
     
Body Mass Index 
      Underweight, BMI < 18.5 
      Normal, BMI 18.5-24.9 
      Overweight, BMI 25-29.9 
      Obese I, BMI 30-34.9 
      Obese II and III, BMI 35+ 
 
0.7 
27.8 
46.7 
18.5 
6.3 
 
0.7 
27.6 
47.1 
18.5 
6.1 
 
1.0 
30.0 
42.8 
18.5 
7.8 
0.0000 
 
Socio-demographic Characteristics     
   Mean age at baseline (SD) 62.776 
(0.069) 
62.894 
(0.074) 
61.610 
(0.190) 0.0000 
   Marital status 
     Never married        
     Currently married 
     Widowed/divorced/separated 
 
5.0 
76.3 
18.7 
 
4.5 
78.1 
17.3 
 
9.5 
58.6 
32.0 
0.0000 
 
   Educational attainment 
       Less than high school 
       High school graduate 
       1-3 years of college 
       4+ years of college 
 
17.4 
31.4 
23.7 
27.5 
 
15.6 
31.5 
24.0 
28.9 
 
35.7 
30.0 
20.5 
13.9 
0.0000 
   
   Mean family income (10,000s) (SD) 
 
5.510 
(0.035) 
 
5.653 
(0.037) 
 
4.087 
(0.105) 
0.0000 
   Region 
      Northeast 
      North Central 
      South 
      West 
20.2 
26.6 
37.2 
16.0 
20.6 
27.4 
35.2 
16.8 
16.1 
18.4 
57.4 
8.1 
0.0000 
     
 
Mean Years of Follow-up 
      Alive (censored) 
      Dead 
      
 
6.130 
3.807 
 
6.136 
3.817 
 
6.071 
3.732 
 
Source: Author’s calculations based on 1997-2003 NHIS data linked to the National Death Index through 
2006; p-values correspond to t-tests and chi-square tests for the equality of means/distributions of variables 
between non-Hispanic black and white males.  
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Table 1.5. Hazard Ratios from Cox Regression Models Predicting Mortality, National 
Health Interview Survey, Non-Hispanic White and Non-Hispanic Black Males aged 50-
84, 1997-2003 (reference category in parentheses) 
 
 
Model 1 Model 2 Model 3 
Race (Non-Hispanic white)    
    Non-Hispanic black 1.49*** 1.39*** 1.15** 
 
Smoking Status (never smoker)    
     
    Former smoker, quit 30+ years ago 
 
 
1.06 
 
1.06 
 
    Former smoker, quit 20-29 years ago 
 
1.21** 
 
1.19** 
 
    Former smoker, quit 10-19 years ago 
 
1.70*** 
 
1.66*** 
 
    Former smoker, quit 5-9 years ago 
 
2.30*** 
 
2.14*** 
 
    Former smoker, quit 0-4 years ago 
 
2.57*** 
 
2.37*** 
 
    Current smoker, <1 pack per day 
 
2.52*** 
 
2.28*** 
 
    Current smoker, 1+ packs per day 
 
3.05*** 
 
2.66*** 
 
N (unweighted) 27,164 27,164 27,164 
    
Notes: All models control for survey year, age at baseline, and BMI. Model 3 also includes 
controls for marital status, educational attainment, family income, and region of residence.       
* p<0.05; ** p<0.01; *** p<0.001 
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Table 1.6. Distribution of Population Attributable Risk Fractions (PAF) by Smoking 
Status, National Health Interview Survey, Non-Hispanic White and Non-Hispanic Black 
Males aged 50-84, 1997-2003  
Reference: never smoker 
Non-Hispanic 
White Males 
Non-Hispanic 
Black Males 
     
    Former smoker, quit 30+ years ago 
 
0.77 0.33 
    Former smoker, quit 20-29 years ago 1.60 
 
0.94 
 
    Former smoker, quit 10-19 years ago 5.49 
 
4.27 
 
    Former smoker, quit 5-9 years ago 3.22 
 
2.50 
 
    Former smoker, quit 0-4 years ago 4.41 
 
4.02 
 
    Current smoker, <1 pack per day 4.13 
 
13.19 
 
    Current smoker, 1+ packs per day 9.82 
 
7.82 
 
Total 29.43 33.08 
Notes: Based on hazard ratios from a model controlling for survey year, age at baseline, BMI, 
marital status, educational attainment, family income, and region of residence.  
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Figures 
Figure 1.1. Black-White Gap in Life Expectancy at Birth and at Age 50 by Sex, 1980-
2006 
 
 Source: NCHS Life Tables 1980-2006. 
 
Figure 1.2. Ever-Smoking Prevalence at Age 40 by Sex and Birth Cohort, Blacks and 
Whites Born Between 1920 and 1949 
 
 Source: Burns et al. (1997). 
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Figure 1.3. Annual Quit Rates for Males by Birth Cohort, Blacks and Whites Born 
Between 1920 and 1949, 1930-1990 
 
 Source: Burns et al. (1997). 
 
Figure 1.4. Current Smoking Prevalence by Age and Birth Cohort, Black and White 
Males Born Between 1920-1924 and 1940-1944 
 
 Source: Burns et al. (1997). 
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Figure 1.5. Percentage of Deaths Attributable to Smoking Above Age 50 by Sex Among 
Blacks and Whites, United States, 1980-2005 
 
 Source: Calculations by the author. 
 
Figure 1.6. Black-White Gap in Life Expectancy at Age 50 With and Without Smoking-
Attributable Deaths by Sex, United States, 1980-2005 
 
 Source: Calculations by the author. 
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Figure 1.7. Sex Gap in Life Expectancy at Age 50 With and Without Smoking-
Attributable Deaths by Race, United States, 1980-2005 
 
Source: Calculations by the author. 
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CHAPTER II. International Comparisons of U.S. Mortality11 
 
Introduction  
Life expectancy in the United States is currently among the lowest of all high-income 
countries. Research and policy discussions have focused largely on cross-national 
mortality differences at older ages (e.g., at ages 50 and above). This chapter provides a 
comprehensive assessment of U.S. mortality relative to a set of 16 high-income peer 
countries in the most recent period for which data are available. In the first part of the 
analysis, I use cross-national mortality data to identify age and cause of death 
contributions to the U.S. mortality disadvantage. This study finds that mortality 
differences below age 50 account for 67% of the gap in life expectancy at birth between 
American males and their counterparts in the comparison countries. Among females, this 
figure is 41%. The major causes of death responsible for Americans’ excess years of life 
lost below age 50 are unintentional injuries, noncommunicable diseases, perinatal 
conditions, and homicide. Together, these causes account for 84% and 85% of the 
difference in years of life lost below age 50 between the U.S. and the mean of other 
countries for males and females, respectively. In the second part of the analysis, I 
examine how the age-specific mortality rates of cohorts of Americans born between 1850 
and 2004 compare to that of their counterparts in the comparison countries. Period 
rankings of U.S. death rates reveal a distinctive age pattern: American males and females 
perform very poorly before age 75, experiencing among the highest death rates among 
                                                           
11
 Material from this chapter has appeared in Ho JY. 2013. “Mortality Under Age 50 Accounts For Much of 
the Fact That US Life Expectancy Lags That of Other High-Income Countries.” Health Affairs 32(3): 459–
467. 
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the comparison countries, but perform exceptionally well at the oldest ages, experiencing 
among the lowest death rates among the comparison countries. I find that this pattern is 
replicated for over a century’s worth of American birth cohorts. This study highlights the 
importance of mortality at the younger ages and injury-related mortality as major 
contributors to low life expectancy in the United States and calls attention to an enduring 
pattern of Americans’ poor mortality performance prior to age 75 and improved 
performance thereafter which holds for both periods and cohorts. 
 
Background 
Americans reside in one of the richest and most technologically-advanced countries in the 
world, yet they are less healthy than their counterparts in other wealthy industrialized 
countries. Life expectancy in the United States is among the lowest of all high-income 
countries. Not only can Americans expect to live fewer years, on average, but they also 
experience a greater burden of disease during those years (Thorpe, Howard, and 
Galactionova 2007; Banks, Muriel, and Smith 2010; Martinson, Teitler, and Reichman 
2011). On the cusp of the 21st century, the United States ranks poorly in terms of both life 
expectancy at birth and mortality through most of the lifespan, and its position has been 
deteriorating over time (National Research Council [NRC] 2011).  
Life expectancy at birth in the United States has increased over time, but not as quickly 
as in its peer countries. Between 1960 and 2007, American males gained 9.0 years in life 
expectancy at birth, while males in a set of 16 peer countries12 gained 10.2 years on 
average. Over the same period, life expectancy at birth for American males went from 
                                                           
12
 These countries are: Australia, Austria, Canada, Denmark, Finland, France, Germany, Italy, Japan, the 
Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, and the United Kingdom. 
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being ranked 12th to 17th among this set of countries. American females gained 7.5 years 
in life expectancy at birth between 1960 and 2007, nearly three years less than females in 
the comparison countries, who gained an average of 10.2 years over the same period. Life 
expectancy at birth for American females has gone from being ranked 10th to 16th. 
Similarly, the rankings of U.S. age-specific mortality rates for both males and females 
have deteriorated over time, most dramatically for females between 1975 and 2005. The 
move towards poorer ranks has been equally striking for males, but the deterioration in 
their rankings was heavily concentrated in the decade between 1995 and 2005 (Ho and 
Preston 2010). 
In 2007, American males had the lowest life expectancy at birth (75.6 years) among the 
set of comparison countries (Table 2.1). This figure was 3.7 years lower than the world 
leader, Switzerland, and 2.2 years lower than the average of the comparison countries. In 
2007, American females had the second lowest life expectancy at birth (80.8 years), just 
ahead of Danish females. Their life expectancy was 5.2 years lower than Japanese 
females, the world leader, and 2.3 years lower than the average of the comparison 
countries.13 These life expectancy differences are non-trivial.  
The following thought experiment illustrates just how far Americans have fallen behind 
their peers in other high-income countries. Best-practice female life expectancy has 
increased at a rate of roughly 2.5 years per decade for the past 160 years (Oeppen and 
                                                           
13
 This picture remains largely unchanged in 2009, the latest year for which data for all 17 countries is 
currently available. Among males, Australia have overtaken Switzerland as the world leader at 79.7 years, 
3.6 years greater than life expectancy at birth among American males in 2009. The average difference in 
life expectancy at birth between American males and males in the comparison countries remained at 2.2 
years. Among females, Japan remained the world leaders in 2009. Their life expectancy exceeded that of 
American females by 5.4 years, and the average difference in life expectancy at birth between American 
females and females in the comparison countries increased to 2.4 years.  
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Vaupel 2002). Even if the U.S. were able to achieve this rate of increase and if the other 
countries did not experience any further gains in life expectancy, it would still take nearly 
15 years for males and over two decades for females to catch up to the current world 
leaders. The U.S. would require nearly a decade to catch up to the average of the other 16 
countries. Again, this exercise assumes that life expectancy in the comparison countries 
would remain at its current levels and that the U.S. would be able to match the best-
practice rate of increase in life expectancy. It seems highly unlikely that either condition 
would be met in reality. In the decade between 1997 and 2007, American males and 
females gained 1.8 and 1.0 years in life expectancy at birth, respectively, far less than the 
best-practice rate of 2.5 years per decade (Arias 2011). At these rates (and assuming no 
additional life expectancy improvements in the other countries), it would take the U.S. 
two and five decades to catch up to the world leaders for males and females, respectively. 
 
Proposed Explanations for Lagging Life Expectancy in the United States 
Over time, U.S. life expectancy has fallen further and further behind other developed 
countries, and mortality improvements have been slower for both males and females. 
This is occurring on the heels of phenomenal mortality declines experienced over the 
course of the 20th century, strong economic growth and performance, and among the 
highest levels of per capita health care spending in the world (Reinhardt, Hussey, and 
Anderson 2004). A substantial body of research has focused on addressing why the U.S. 
performs so poorly relative to other developed countries. By and large, these studies have 
investigated health and mortality differences at older ages. For example, the recent 
National Research Council Panel on Understanding Divergent Trends in Longevity in 
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High-Income Countries focused exclusively on ages 50 and above (NRC 2011). One of 
the most consistent findings from these studies has been that Americans experience a 
greater burden of disease than their European counterparts (Avendano et al. 2009; Banks, 
Muriel, and Smith 2010; Crimmins, Garcia, and Kim 2010; Martinson, Teitler, and 
Reichman 2011; Thorpe, Howard and Galactionova 2007).  
In general, explanations of the U.S. life expectancy disadvantage fall within the following 
categories: (1) poorer functioning of and lack of access to the U.S. health care system, (2) 
a greater prevalence of unhealthy behaviors in the U.S., (3) higher levels of income 
inequality and poverty coupled with weaker social safety nets in the U.S., and (4) lower 
levels or quality of social capital and interactions in the U.S. relative to other countries. 
Ideally, a tight linkage between the proposed mechanism and health and mortality should 
exist, and there should be a greater prevalence or severity of the factor in the United 
States. For several of these proposed explanations, much of the evidence base remains 
speculative due to the difficulty of establishing one or both of these conditions.  
 
Income Inequality and Social Safety Nets 
Whether differences in income inequality can explain differences in health across nations 
remains contested (e.g., Wilkinson 1992; Wilkinson 1996; Lynch et al. 2004; Beckfield 
2004). Higher levels of income inequality can be related to poorer national health through 
a purely mechanistic effect, also referred to as the aggregation effect or a statistical 
artifact. Drawing on the work of Preston (1975), Deaton (2002) points out that if the 
curvilinear relationship between income and health holds within as well as across 
countries, in the scenario where two countries have the same average income but 
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different distributions of income, all else being equal, the society with the higher level of 
income inequality would have poorer health due to purely mechanical effects. What 
remains debatable is whether income inequality itself affects health apart from the 
individual-level relationship between income and health.  
Given the levels of development the countries in this analysis have achieved, income 
inequality is hypothesized to act primarily through relative rather than absolute 
deprivation. People’s negative perceptions of their positions within the social hierarchy 
may be translated into negative emotions and poorer health through biological pathways 
induced by the stress response and psychosocial strain (Wilkinson 1992; Lynch et al. 
2000; Marmot 2005; Schnittker and McLeod 2005). Social comparisons may contribute 
to psychosocial strain and social isolation for lower-income residents of wealthier 
neighborhoods, and institutions like hospitals and schools may be of lower quality or 
more responsive to the needs and demands of wealthier residents (Vartanian and Houser 
2010). Income inequality is also hypothesized to act through decreased social capital and 
social cohesion and the adoption of negative health behaviors as coping mechanisms for 
stress (Wilkinson 1992; Lynch et al. 2000; Schnittker and McLeod 2005.). The neo-
material interpretation gives greater attention to structural factors and highlights potential 
linkages between income inequality and underinvestment in human resources such as 
education and medical expenditures (Davey Smith 1996). While underinvestment in these 
areas may help to explain within-country differences, it is unlikely that they can account 
for the U.S.’s poor life expectancy ranking. Compared to other high-income countries, 
the U.S. population is very well educated and has among the highest per capita health 
expenditures in the world (NRC 2011). A systematic review of 98 studies concluded that 
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income inequality does not explain international differences in population health (Lynch 
et al. 2004).  
Related explanations point to higher levels of poverty and weaker social safety nets in the 
U.S. relative to other high-income countries. For example, Canada experienced more 
rapid life expectancy gains than the U.S. during the 1980s despite similar or slightly 
worse macroeconomic conditions (in terms of GDP growth and unemployment rates). 
Dow and Rehkopf (2010) suggested that this may be related to stronger safety nets 
encompassing more generous unemployment benefits, sickness and maternity leave 
policies, and eligibility and benefits for means-tested cash assistance in Canada relative 
to the United States. Along with its weaker social safety nets, the U.S.’s labor and child 
support policies have also been suggested as important contextual factors that may 
contribute to its low life expectancy ranking (NRC 2011).  
 
Social Capital and Interactions 
There has been a recent resurgence of interest in whether differences in social capital, 
cohesion, interactions, and networks can explain cross-national differences in health (e.g., 
Lynch et al. 2000; Kennelly, O’Shea, and Garvey 2003; Mansyur et al. 2008). Two main 
avenues through which social networks are believed to influence health are the promotion 
of health-enhancing or risky health behaviors and the provision of financial, instrumental, 
or emotional resources and support (Berkman and Glass 2000). While the social capital 
and social cohesion explanation is usually presented as a corollary of the psychological 
consequences of income inequality (Kennelly, O’Shea, and Garvey 2003), the neo-
materialist perspective suggests that differences in social capital may be more strongly 
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related to material conditions than psychosocial factors. For example, some studies have 
found that proposed indicators of social capital such as levels of trust, belonging to 
organizations, and doing unpaid work for such organizations are more strongly related to 
GDP per capita than to income inequality (Lynch et al. 2000).  
Establishing the linkage between social interactions and health is further complicated by 
issues of reverse causality and endogeneity. In general, the current body of evidence does 
not support differences in social capital and networks as an explanation of cross-national 
health differentials. Both Kennelly, O’Shea, and Garvey (2003) and the NRC (2011) 
concluded that there is no evidence for a positive effect of social capital on population 
health. The findings from studies of cross-national differences in social networks are 
complex. In a comparison of the U.S. and England, Banks et al. (2011) found no evidence 
of weaker networks or less support in the U.S. than England among older adults; instead, 
social support and networks are similarly distributed in the two countries. They also 
found that the quality of social relationships differed between the countries, but not in a 
way that suggested a clear-cut U.S. advantage or disadvantage – for example, Americans 
appear to receive more positive and negative support from their children relative to their 
English counterparts (Ibid.).  
 
Health Care System 
The performance of the U.S. health care system is often blamed for its low life 
expectancy ranking (Nolte and McKee 2008; Muennig and Glied 2010). The main 
critiques of the U.S. health care system include lack of universal access, fragmented 
delivery of care, high costs of care, inefficiency, and a greater focus on specialist rather 
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than primary care. Evidence regarding the adequacy of primary care in the U.S. is mixed: 
Macinko, Starfield, and Shi (2003) find that the U.S. scores in the bottom of a group of 
18 Organisation for Economic Co-operation and Development (OECD) countries for 
primary care, but the U.S. also appears to perform well in terms of pneumonia and 
influenza vaccination and cancer screening for the older population (Howard, 
Richardson, and Thorpe 2009; Preston and Ho 2011). 
A nuanced view must be taken of what, precisely, lies within the jurisdiction of the health 
care system. For example, if personal health practices are unusually deleterious, a country 
could still exhibit poor measured health even if the health care system is performing 
exceptionally well in identifying and treating disease. Compared to other OECD 
countries, the U.S. health care system typically functions well in the identification and 
treatment of cancer and heart disease, the two leading causes of death at older ages (NRC 
2011). This conclusion was based in part on an analysis of diseases for which effective 
methods of identification and treatment have been developed and where behavioral 
factors do not play a dominant role. Results from other studies (Ho and Preston 2010, 
Banks, Muriel, and Smith 2010) are consistent with these findings. For example, in their 
comparison of disease prevalence, incidence, and mortality between the U.S. and 
England, Banks, Muriel, and Smith (2010) conclude that their findings support higher 
quality medical treatment in the U.S. than in England. Relative to the English, Americans 
become sicker at earlier ages and spend more money treating their greater burden of 
disease, but this does, on average, have payoffs in reducing mortality. In addition, Wang 
et al. (2007) and Crimmins, Garcia, and Kim (2011) find that aggressive treatment and 
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identification has resulted in cholesterol and blood pressure being well-controlled in the 
U.S. relative to other countries.  
Unlike the other high-income countries included in this analysis, the U.S. does not have 
universal health care. Roughly 16.7% of the U.S. resident population was estimated to 
lack insurance coverage in 2009 (De Navas-Walt, Proctor, and Smith 2010). It is possible 
that lack of access to timely and high quality health care is contributing to excess 
mortality in the U.S. relative to other countries. For example, the uninsured are more 
likely to forego care and less likely to receive preventive services. The salience of this 
factor varies with age – access alone is less likely to matter for adults over the age of 65 
due to coverage under Medicare, but it may be more important at the younger ages, 
which are a key focus of this chapter.  
 
Health Behaviors 
It has been suggested that health behaviors such as smoking, diet, and lack of physical 
activity or sedentary lifestyle may account for the poorer health status of Americans. 
These behaviors are grounded in contextual influences including national policies 
regarding cigarette and gasoline taxation, availability and quality of public transportation 
systems, and food policies (NRC 2011). In general, studies agree that while a greater 
prevalence of some deleterious health behaviors in the U.S. is an important part of the 
explanation, they are not the whole explanation. Among the most important of these 
behaviors is smoking. During the 20th century, Americans had a history of heavier 
smoking relative to other developed countries. Preston, Glei, and Wilmoth (2011) found 
that smoking accounts for 41% and 78% of the gap in life expectancy at age 50 between 
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the U.S. and 9 high-income countries among males and females, respectively. The U.S. 
has among the highest prevalence of obesity among OECD countries (OECD Health Data 
2012). While estimates of mortality attributable to obesity remain highly variable, studies 
have suggested that it may be a substantial contributor to the U.S. shortfall in life 
expectancy at age 50 (Preston and Stokes 2011). Evidence on whether cross-national 
differences in diet and physical activity can explain life expectancy differentials remains 
inconclusive. This is in large part related to measurement issues, reporting differences 
across countries, and a paucity of high quality, international data on physical activity 
(NRC 2011).  
 
Contribution 
Recent studies of the U.S. life expectancy disadvantage have concentrated largely on 
mortality at older ages. Examining differences at older ages makes sense given that in 
2008, 92% of male newborns and 95% of female newborns in the U.S. could expect to 
survive to age 50 (Arias 2012). However, the importance of mortality differences at 
younger ages should not be dismissed in explaining life expectancy differences between 
the United States and other developed countries. The life course approach posits that 
reducing premature mortality at the younger ages may have important consequences for 
health and mortality at the older ages, and these effects may accumulate over time (Elo 
and Preston 1992; Kuh and Ben-Shlomo 1997; Hayward and Gorman 2004). It is likely 
that common factors are contributing to the U.S. life expectancy shortfall across all ages, 
and looking across a wider age range may help us identify these factors. In addition, 
Americans have the highest or second-highest mortality rates in every age group below  
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50 among a set of 17 high-income countries. In contrast, recent research has shown that 
the U.S. performs very well in terms of mortality at the older ages (e.g., at ages above 75) 
in cross-national comparisons (Ho and Preston 2010). Together, these observations 
suggest the need for an increased focus on mortality conditions at the younger ages. A 
rich body of literature has examined youth health and mortality, and particularly the 
burden of injury-related deaths, within the United States. For example, it is well-known 
that the U.S. experiences high infant mortality rates and high death rates from homicide 
and HIV. In this chapter, I draw on these studies to provide a comprehensive assessment 
of the relative importance of the main causes of death operating at younger ages in 
explaining cross-national mortality differences.  
This study examines how U.S. mortality compares to that of a set of high-income peer 
countries in a very recent period, 2006-2008. First, I use decomposition methods to 
answer the question, “How much of the gap in life expectancy at birth between the 
United States and other developed countries is due to mortality differences below age 
50?” Next, I use cause-deleted life table techniques to identify the major causes of death 
contributing to Americans’ excess years of life lost below age 50. Finally, I examine two 
indicators of age-specific mortality performance for U.S. birth cohorts born between 
1850 and 2004 relative to their counterparts in the comparison countries.  
 
Data and Methods 
Comparison Countries 
In these analyses, I compare the U.S. to a set of 16 high-income comparison countries: 
Australia, Austria, Canada, Denmark, Finland, France, Germany, Italy, Japan, the 
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Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, and the United Kingdom. 
This group of countries is a subset of OECD countries chosen for best comparability to 
the United States.14 The main criteria for inclusion in the sample were that the countries 
had to have sufficient population size to ensure stability of estimates (above 4.5 million), 
achieved high levels of development for a long period of time, and maintained acceptable 
levels of data quality and availability. These countries transitioned from high to low 
mortality regimes in the same period as the U.S. and share more similar cause-of-death 
profiles compared to countries that transitioned more recently or are still in the process of 
transitioning. High-income countries that were excluded from the sample fail to fulfill 
one or more of these conditions. For example, Belgium has typically had data issues and 
its latest year of available data is 2005, which is outside the recent three-year span used in 
the first part of the analysis; Greece and Korea are not included in the Human Mortality 
Database; and several other countries are former Soviet countries whose mortality 
experience has been somewhat unique. 
 
I. Age- and Cause-Specific Contributions to the U.S. Life Expectancy Shortfall, 2006-
2008 
 Data 
Three main data sources were used for this analysis: the Human Mortality Database 
(HMD), the World Health Organization (WHO) Mortality Database, and Statistics 
Canada. Country- and sex-specific life table all-cause death rates %"'’s) for age groups 
0-1, 1-4, 5-9, 10-14, …, and 45-49 were drawn from the HMD. Deaths from all causes 
                                                           
14
 The U.S.’s low life expectancy ranking is not a result of the selection of countries used in this study. 
Among all 34 OECD countries, life expectancy at birth in the United States was ranked 24th for males and 
27th for females in 2005 (HMD 2012; OECD 2010). 
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and from the codes making up the cause of death categories of interest for the same age 
groups were obtained from the WHO Mortality Database to produce the proportion of 
deaths in each age group due to the causes of interest %' /%'), where ! indicates a 
specific cause of death category. Since the latest year of mortality data available from the 
WHO differed across countries, the latest year of data available between 2006 and 2008 
was extracted for each country in order to cover the most recent period possible and to 
maximize coverage of comparison countries (see Table A2.1 for the country-year pairs 
used in this analysis and their corresponding life expectancies). The results are not 
sensitive to the choice of year used. When the analysis was repeated using data from 
2006 for each country, the results were nearly identical to those reported here.15  
These data were then aggregated according to the major cause of death categories of 
interest (see Table A2.2 for the list of categories and corresponding ICD-10 codes). 
These categories were specified per the Global Burden of Disease Study (GBD) 
classification (Mathers, Lopez, and Murray 2006) and the standard categories used in the 
U.S. National Vital Statistics Reports (NVSR) (e.g., Xu et al. 2010). The proportions of 
total deaths attributable to each cause category were taken from the WHO and applied to 
the HMD all-cause age-specific death rates to obtain age-specific death rates by cause, 
sex, and country. 
 Special Cases: Canada and Switzerland 
For Canada, the latest year mortality data were available from the WHO Mortality 
Database was 2004. I used mortality data for 2007 from Statistics Canada. These data 
were aggregated using the same cause of death categorizations specified in Table A2.2 
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 Portugal was excluded from this robustness check since its 2006 cause of death data were not available. 
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and merged with the master data set. For Switzerland, cause of death data were coded 
using less detailed four-digit numeric codes denoting larger cause of death categories 
instead of the customary four-digit alphanumeric codes available for the other 16 
countries. It was not possible to extract all codes for certain cause of death categories for 
Switzerland. In cases where it was possible to use identical cause of death codes, 
Switzerland was included in the computation of the mean of the comparison countries, 
excluding the United States. Thus, the U.S. was compared to a composite of comparison 
countries calculated as the average of either 15 or 16 countries. The results were not 
sensitive to the inclusion or exclusion of Switzerland.  
 
 Methods 
 Age Decomposition 
Decomposition methods can be used to determine the contribution of mortality 
differences in specific age groups to differences in life expectancy at birth between two 
populations (Preston, Heuveline, and Guillot 2001). The following identity was used to 
estimate the contribution of mortality differences at ages below 50 and at ages above 50 
to the difference in life expectancy at birth between the U.S. and each of the comparison 
countries, as well as between the U.S. and the composite of the other countries: 
 
1
    K   ;50
 M , 
where the contribution of mortality differences above age 50 is the weighted difference 
between the two populations’ life expectancy at age 50 (), and the weight is the mean 
of the two countries’ probability of survival to age 50 (;50
) (Ho and Preston 2010). 
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This method produces results nearly identical to those obtained using Arriaga (1984)’s 
decomposition. The difference in life expectancy at birth between the U.S. and each of 
the individual comparison countries, as well as the difference in life expectancy at birth 
between the U.S. and the mean of the comparison countries, were decomposed using both 
methods. Three different ways of generating a composite life table for the mean of the 
comparison countries were used:  
1. Taking the mean of the individual countries’ N',  %K', and O' columns, 
2. Deriving a mean life table from the mean of the individual countries’ N' and  %&' 
columns, and 
3. Deriving a mean life table from the mean of the individual countries’  %"' 
and %&' columns. 
When the decomposition methods were applied to each of these three composites, highly 
similar results are obtained. Weighting the  %"' values by population size would be 
inappropriate in these and the subsequent analyses since the country, not the individual, is 
considered to be the unit of analysis. 
 
Cause-Deleted Life Tables 
The remainder of this portion of the analysis focuses on ages below 50 because I find that 
mortality differences at these ages make substantial contributions to Americans’ overall 
life expectancy shortfall relative to the comparison countries among both males and 
females and because cross-national mortality differences at these ages are relatively 
understudied. In addition, the main assumption used to generate the cause-deleted life 
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tables (Chiang’s assumption) becomes much more tenuous at the older ages due to 
competing risks.  
Cause-deleted life table methods were used to estimate what temporary life expectancy – 
the expected number of years lived between ages 0 and 50 out of a maximum possible 50 
years – would be in the absence of a particular cause of death (Preston, Heuveline, and 
Guillot 2001). This approach uses Chiang’s assumption, which assumes that the force of 
decrement function from cause ! is proportional to the force of decrement function from 
all causes combined in each age interval.  
The proportion of deaths due to a specific cause of death category in the age group P to 
P  Q was calculated as: 
 
2
 %' /%' , where !=communicable and nutritional conditions, HIV, …, and 
homicide. 
Country-, year-, age-, and sex-specific survival probability ( %;') and mean age at death 
( %&') columns were drawn from the HMD. The cause-specific proportions from the 
WHO were used to generate the 8 quantities: 
 
3
 8  1  %' /%'.  
The following life table columns were then generated to produce cause-deleted life tables 
(life tables in the absence of a specific cause of death category !) for each country and 
separately by sex: 
 
4
 %M ;'   %;'
>R?  
 
5
 %M N'%  MN'ST U %M ;'  
 
6
 %M <'  MN' U 1 %M ;'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7&
 %M &'  Q  8 U %V'/%M V'
 M %&'  Q
 for P = 0, 1, 5, 45. 
 
7W
 %M &'   
F
XYU FM CZRF ?   [.U FM CZ?   
F
XYU FM CZ]F?
 FM CZ?
 for P = 10 to 40. 
 
8
 %M K'  Q U MN'%  %M &' U%M <'.  
Temporary life expectancy between ages 0 and 50 in the absence of a specific cause of 
death was obtained by summing the number of life-years that would have been lived 
between those ages in the absence of that particular cause ( %M K'’s). Years of life lost 
below age 50 due to each specific cause ! were calculated as: 
 
9
 ∑  %M K''  ∑  %K'' .  
These quantities were then used to calculate the percentage contributions of specific 
causes of death to the total difference in years of life lost below age 50 between the U.S. 
and the comparison countries. All analyses were performed for each country and 
separately for males and females. 
 
II. Cohort Rankings and Ratios of Age-Specific Death Rates 
In the second part of the analysis, I compare 5-year birth cohorts born between 1850 and 
2004 in the United States to their mirror birth cohorts in the other 16 high-income 
countries. I assess the mortality performance of these birth cohorts observed during the 
period 1960-2005.  
For each country, period age-specific death rates are drawn from the HMD and aligned to 
correspond to each 5-year birth cohort. For example, the death rates of the 1900-1904 
birth cohort correspond to the period death rates for age group 55-59 in 1960, 60-64 in 
1965, 65-69 in 1970, …, 95-99 in 2000, and 100-104 in 2005. The cohort death rate 
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series is constructed this way for all other birth cohorts. Due to issues of data availability 
and the fact that we have yet to observe the full mortality experience of the youngest birth 
cohorts, many of these age-specific profiles are necessarily incomplete. I use the 
maximum amount of data possible for each birth cohort ages 0-4 and 105-109. Cohorts 
born in the first half of the 20th century have the most complete series.  
For each cohort, the age-specific death rates are ranked from 1 to 17, such that the 
country with the lowest mortality rate in each age group receives a rank of 1 and the 
country with the highest mortality rate in each age group receives a rank of 17. In 
addition, the ratio of the U.S. death rate to the average of the other 16 death rates is 
calculated for each birth cohort-age-specific death rate. The presentation of the ratios 
provides an alternate measure of the U.S.’s mortality performance that allows for a 
greater sense of the variation in the death rates. 
 
Results  
Ia. Age-Specific Contributions to the U.S. Life Expectancy Shortfall, 2006-2008 
There is a tendency to overlook mortality at younger ages since by and large, these high-
income countries have long completed their epidemiological transitions, and most deaths 
in these countries now occur at ages above 50. However, the decomposition results 
indicate that mortality differences below age 50 are crucial in explaining life expectancy 
differentials between the United States and other high-income countries.  
On average, life expectancy at birth for American males is 2.2 years lower than the 
comparison countries. Figure 2.1 shows the contribution of specific age groups to this 
2.2-year difference. All of the U.S. life expectancy disadvantage for American males is 
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concentrated entirely below age 80. The contributions of ages 80 and above are all 
negative, indicating that in these age groups, American males experience lower death 
rates than males in the comparison countries. Differences in infant mortality account for 
12% of the male life expectancy gap, and half of the gap is accounted for by mortality 
differences between ages 0 and 39. Mortality differences between ages 20 and 69 are 
particularly important in explaining the male life expectancy gap. Each of the age groups 
in this age range contribute between 6.3%-10.4% of the gap in life expectancy at birth.  
Life expectancy at birth for American females is 2.3 years lower than the average of the 
comparison countries. The life expectancy disadvantage for females is concentrated 
entirely below age 85 (Figure 2.2). On average, mortality for American females at ages 
85 and above is lower than in the comparison countries. Compared to males, we see that 
among females, mortality differences between ages 40 and 79 account for the bulk of the 
gap in life expectancy at birth. Differences in infant mortality account for 10% of the gap, 
and half of the gap is accounted for by mortality differences between ages 0 and 54.  
These figures showed the contribution of specific age groups to the gap in life expectancy 
at birth between the United States and the average of the comparison countries. In this 
case, mortality differences below age 50 accounted for 67% and 41% of the U.S. shortfall 
in life expectancy for males and females, respectively. We are also interested in whether 
this holds if we compare the United States to each of these countries individually.  
Figures 2.3 and 2.4 show the relationship between the size of the gap in life expectancy 
at birth between the U.S. and each of the comparison countries and the percentage 
contribution of mortality differences below age 50. For example, life expectancy for 
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Swedish males is 3.3 years higher than that of American males, and differences in 
mortality below age 50 between the two countries accounted for 59% of this 3.3-year 
gap. Mortality below age 50 accounts for over half of the gap in life expectancy at birth 
between American males and males in 14 of the 16 comparison countries. For the 
remaining two countries, Australia and Canada, the contribution of mortality below age 
50 is 41% and 49%, respectively. Thus, ages below 50 make a substantial contribution to 
the gap in male life expectancy at birth between the U.S. and other developed countries. 
These ages account for two-thirds of the gap on average, and their contribution is always 
in excess of two-fifths of the gap for all the comparison countries.  
For females, the U.S. shortfall in life expectancy at birth is less concentrated at ages 
below age 50, with the contribution of mortality differences at these ages ranging 
between 22%-80%. However, mortality differences at these ages remain important 
contributors. Mortality differences below age 50 account for over a third of the life 
expectancy gap between American females and females in 11 of the 16 comparison 
countries. They are particularly important contributors to the difference in life expectancy 
at birth between American females and females in the United Kingdom, the Netherlands, 
and Germany, accounting for 80%, 62%, and 60% of these gaps, respectively.  
One intuitive way of interpreting these results is that even if life expectancy at age 50 
were equalized among all countries, on average 67% and 41% of the gap in life 
expectancy at birth between the U.S. and other countries would remain.16 Thus, it is clear 
that, particularly for males but also for females, mortality at ages below 50 should not be 
overlooked in examining differences in life expectancy between the U.S. and other high-
                                                           
16
 This assumes that changing mortality at ages above 50 would not affect mortality at ages below 50. 
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income countries.17 It is also interesting to note that a negative relationship exists 
between the size of the gap in life expectancy at birth and the contribution of mortality 
differences below age 50. This correlation is -0.84 for males and -0.88 for females. In 
other words, the larger the difference in life expectancy at birth between the U.S. and any 
given country, the smaller the proportion of the gap that is attributable to ages below 50. 
 
Ib. Cause of Death Contributions to the U.S. Excess in Years of Life Lost Below Age 50, 
2006-2008 
Given the importance of mortality differences below age 50 in explaining the gap in life 
expectancy at birth between the U.S. and other developed countries, I now focus on 
identifying the primary causes of death responsible for Americans’ excess mortality in 
this age range. Males and females in the United States lose the most years of life below 
age 50 in this set of high-income countries (Figures 2.5 and 2.6). American males lose 
1.36 years below age 50 compared to the comparison country average of 0.77 years, 
while American females lose 0.80 years below age 50 compared to the comparison 
country average of 0.45 years. As expected, females lose fewer years of life before age 50 
than males. Compared to the best performers, Swedish males and females, Americans are 
losing over twice as many years of life below age 50. Notably, the other English-speaking 
countries (Australia, Canada, and the United Kingdom) are clustered at the left side of 
these figures, indicating that they, along with the U.S., tend to lose more years of life at 
younger ages than the other comparison countries. This has two implications: first, 
factors common to social structures in these countries may be contributing to this 
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 This finding is robust to analyses that incorporate a larger set of 21 comparison countries (Belgium, 
Ireland, Iceland, Luxembourg, and New Zealand are the additional countries).  
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phenomenon. For example, the U.S., Canada, and Australia have been classified as liberal 
welfare states, which are characterized by weaker social safety nets and private provision 
of services compared to corporatist-statist or social democratic regimes (Esping-
Anderson 1990). Second, studies comparing the United States and the United Kingdom 
are examining differences between the U.S. and one of its nearest, relatively low-
performing neighbors. These studies often find large health differences (Banks, Muriel, 
and Smith 2010; Martinson, Teitler, and Reichman 2011), suggesting that comparisons 
between the U.S. and its higher-performing peers would be even more dramatic. 
The cause-deleted life table results for males are shown in Figures 2.7a and 2.7b. 
Compared to the mean of the other countries, American males lose more years of life 
below age 50 from communicable diseases, and the differential is similar for HIV and all 
other communicable diseases. They also lose more years of life below age 50 from 
noncommunicable diseases. Looking at specific noncommunicable diseases, American 
males do well where cancer is concerned but worse for diabetes, cardiovascular diseases, 
respiratory diseases, digestive diseases, genitourinary diseases, and congenital anomalies 
at these ages. The largest differential between the U.S. and the mean of other countries 
exists for unintentional injuries, which is composed of transport and non-transport 
injuries. The U.S. performs poorly for both of those subcategories. Most transport injuries 
are motor vehicle accidents. Nontransport injuries consist of deaths from accidental 
poisoning and exposure to noxious substances (i.e., accidental drug overdose), falls, 
accidental firearm discharge, accidental drowning, and exposure to smoke, fire, and 
flames. Table 2.2 shows the breakdown of nontransport deaths occurring among 
American males at all ages and below age 50. In 2007, 64% of nontransport injuries 
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below age 50 were due to accidental drug overdose. Another 20% of these deaths were 
due to falls, accidental firearm discharge, accidental drowning, and exposure to smoke, 
fire, and flames, with falls and accidental drowning being the largest contributors. 
American males also lose more years of life below age 50 from intentional injuries, 
which consist of suicide and homicide. The differential in homicide mortality is 
particularly large. Finally, American males also lose more years of life below age 50 
from perinatal conditions and drug-related causes compared to males in the comparison 
countries. 
Figures 2.8a and 2.8b present the contribution of various causes of death to years of life 
lost below age 50 for females. On average, American females also lose more years of life 
at these ages from communicable diseases and noncommunicable diseases than their 
counterparts in the comparison countries. This differential exists for cancer, diabetes, 
cardiovascular disease, endocrine disorders, digestive diseases, genitourinary diseases, 
musculoskeletal diseases, and congenital anomalies. Differences in years of life lost 
below age 50 between the U.S. and the mean of other countries for unintentional injuries 
are substantial and similar in magnitude for transport and nontransport injuries. Deaths 
from accidental drug overdose accounted for 72% of nontransport deaths among 
American females below age 50 in 2007 (Table 2.2). Another 15% of nontransport 
deaths at these ages were distributed roughly equally among falls, accidental drowning, 
and exposure to smoke, fire, and flames. American females also lose more years of life 
below age 50 from intentional injuries. This difference comes entirely from homicide 
since they lose fewer years of life from suicide. Finally, American females lose more 
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years of life before age 50 from drug-related causes, maternal conditions, and perinatal 
conditions.  
These findings are best summarized in Figures 2.9 and 2.10, which show the 
contributions of mutually exclusive and exhaustive causes to the difference in years of 
life lost below age 50 between the U.S. and the mean of other countries (0.59 years for 
males and 0.35 years for females). Among males, unintentional injuries (transport and 
nontransport injuries, 34%), intentional injuries (homicide and suicide, 23%), 
noncommunicable diseases (18%), and perinatal conditions (13%) are the largest 
contributors to the difference in years of life lost below age 50 between the U.S. and the 
mean of the comparison countries. Together, these four categories account for 88% of 
American males’ excess years of life lost below age 50. Unintentional injuries are the 
largest contributing category, with transport and nontransport injuries contributing 18% 
and 16%, respectively. Just under half of the noncommunicable disease contribution 
comes from cardiovascular disease. Communicable and nutritional conditions, including 
HIV, and suicide make relatively small contributions to the American males’ excess in 
years of life lost below age 50. 
Among females, unintentional injuries (30%), noncommunicable diseases (29%), and 
perinatal conditions (19%) are the main contributors to Americans’ excess years of life 
lost below age 50. Along with homicide (7%), these causes of death account for 85% of 
the difference in excess years of life lost below age 50 between the U.S. and the 
comparison countries. Suicide is not included in this figure since American females 
actually perform better than their counterparts in other developed countries where suicide 
mortality is concerned. As was the case for males, transport and nontransport injuries 
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make substantial contributions (16% and 14%, respectively), accounting for just under a 
third of American females’ excess years of life lost below age 50. Noncommunicable 
diseases contribute another third of American females’ excess years of life lost below age 
50, with just under a third of this contribution coming from cardiovascular disease. 
American females perform poorly in terms of most noncommunicable diseases, 
particularly respiratory diseases and digestive diseases.  
In summary, transport injuries, nontransport injuries, and perinatal conditions are key 
contributors to U.S. excess years of life lost between ages 0 and 50 for both males and 
females. The contribution of cardiovascular disease is similar for males and females, at 
about a tenth. Differences between males and females are observed for homicide and 
noncommunicable diseases besides cardiovascular disease: homicide makes a larger 
contribution for males, while noncommunicable diseases matter relatively more for 
females. 
While there are advantages to comparing the United States to the average of the 
comparison countries, it is also interesting to examine the contributions of the causes of 
death to the difference in years of life lost below age 50 between the U.S. and each of the 
individual comparison countries. Tables A2.3 and A2.4 show these comparisons for 
males and females, respectively. Overall, communicable diseases, suicide, and maternal 
conditions (among females) do not emerge as important contributors in any cases. In 
general, the contributions of cardiovascular disease and all noncommunicable diseases 
are similar to the mean scenario. One notable exception is the United Kingdom-U.S. 
comparison, where the total contribution of noncommunicable disease is smaller than in 
the mean case (3% vs. 18% among males and 15% vs. 29% among females). Among 
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males, suicide is more somewhat important than in the mean case for the differences 
between the U.S. and Italy, Portugal, and Spain, although its contribution never exceeds 
15%. Homicide is an important contributor in all cases for males, with its contribution 
ranging between 15%-25%. Among females, the contributions are fairly similar to the 
mean case. The contributions of transport and nontransport injuries are also fairly similar 
to the mean, with the exceptions of Italy, where the contribution of transport injuries to 
the Italy-U.S. differences are roughly half the contribution of the mean-U.S. differences, 
and Finland, where the contribution of nontransport injuries to the Finland-U.S. 
differences are much smaller than in the mean-U.S. comparisons. The contributions of 
perinatal conditions in the individual comparisons are also similar to the mean scenario 
with the exception of the Canada-U.S. comparisons, where perinatal conditions make a 
much smaller contribution. Thus, while there is some heterogeneity when the individual 
country comparisons are considered, the main findings are robust: unintentional injuries, 
noncommunicable conditions, perinatal conditions, and homicide are the key contributors 
to the U.S. shortfall in years of life lost below age 50 in nearly all cases, while 
communicable diseases, suicide, and maternal conditions are not major contributors in 
any of the comparisons.  
 
II. Cohort Rankings and Ratios of Age-Specific Death Rates 
Figure 2.11 shows the ranking of U.S. age-specific mortality rates between ages 0 and 
109 among the 17 countries. Until roughly age 75, American males and females perform 
poorly, ranking last or close to last in every age group. After age 75, the U.S. rankings 
improve dramatically until American males and females experience the second lowest 
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death rates at ages 95 and above. This pattern was first documented by Ho and Preston 
(2010), who considered four possible explanations for the unique pattern of U.S. 
mortality rankings at ages 40 and above. They concluded that the evidence most strongly 
supports the hypothesis that the U.S. health care system performs especially well for 
older patients. This pattern and the poor performance of the U.S. is not due to higher 
mortality experienced by disadvantaged minority groups. Non-Hispanic whites are 
arguably the most privileged racial/ethnic group in the United States, and when the 
rankings are repeated using the U.S. non-Hispanic white population, the picture remains 
the same. It is crucial to address the large and persistent racial and socioeconomic health 
inequalities that exist in the U.S. However, alone they are not sufficient to explain to 
explain the U.S.’s low life expectancy ranking. 
Figure 2.12 shows the ratio of U.S. mortality rates to the average of the other 16 
comparison countries by age. The pattern is roughly similar for males and females: the 
ratio is highest at the infant and young adult ages, peaking at just under 2 for males aged 
20-24 and females aged 25-29. The male ratio lies above the female ratio until age 25-29; 
between ages 25 and 85 the female ratio lies above the male ratio. The ratios for both 
males and females decline between roughly ages 25 and 85, with a hump for females 
between ages 60-70 that disappears once smoking-attributable mortality is removed 
among all countries (Ho and Preston 2010). The ratios fall below one at age 80 for males 
and age 85 for females, and remain below one through the highest age group (105-109).  
In this analysis, I extend this work by exploring rankings and ratios for birth cohorts 
whose mortality is observed in the period 1960-2005. Examining the mortality experience 
of birth cohorts is particularly instructive because it allows for the comparison of 
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American cohorts who have experienced similar exposures at the same ages over the life 
course to their counterparts in other high-income countries. Figures 2.13 and 2.14 show 
the rankings for U.S. birth cohorts of males and females, respectively, among the set of 
17 countries. First, it is evident that the shape of these cohort patterns is very similar to 
that of the period figure shown in Figure 2.11. For these male and female birth cohorts, 
Americans perform exceptionally well at the oldest ages, exhibiting among the lowest 
mortality rates in this set of countries. Between roughly ages 30 and 74, however, nearly 
all cohorts rank in the bottom half of the 17 countries, with females doing somewhat 
worse than males. The most interesting divergence between the cohort and period 
rankings occurs at the younger ages, between ages 0 and 34. Cohorts born around the 
middle of the 20th century actually perform quite well in these younger age groups 
(Figures 2.13 and 2.14, panels B and C). In contrast, the patterns for cohorts born in the 
last quarter of the 20th century are very similar to the period pattern. They exhibit among 
the highest mortality rates in this set of high-income countries, as far as we are able to 
observe them. Overall, the rankings patterns are highly similar for males and females.  
Figures 2.15 and 2.16 show the ratios of U.S. age-specific death rates to the average of 
the other comparison countries for the same birth cohorts. The improvement in U.S. 
mortality relative to the comparison countries is echoed in these figures when the ratio 
drops below 1 around age 65, earlier than observed in the period figure. For both male 
and female birth cohorts, Americans at the oldest ages experience mortality rates up to 
20% lower than the average of the comparison countries. In the middle age range, this 
ratio decreases with age. Americans in these birth cohorts may experience mortality rates 
up to 40% higher than the average of the comparison countries in their thirties, but this 
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ratio gradually converges towards 1 with age. The patterns are noisier at the younger 
ages, but it is clear that all cohorts born between 1950 and 2004 experience elevated 
mortality rates relative to their counterparts in the comparison countries (Figures 2.15 
and 2.16, panel C). The ratios are highest in these adolescent and young adult ages, where 
American males and females in these birth cohorts experience death rates up to 80%-90% 
higher than their peers in the comparison countries. While the pattern in the ratios is 
roughly similar for males and females, the ratios are generally smaller in magnitude for 
females than males. In addition, the pattern in the ratios for birth cohorts born in the first 
half of the 20th century (Figure 2.16, panel B) is more differentiated among the female 
birth cohorts, with two sets of peaks observed at ages 20-29 and ages 60-69. This is 
particularly noticeable for the 1940-1944 and adjacent birth cohorts, which were the 
heaviest-smoking birth cohorts of American women (Preston and Wang 2006). 
 
Discussion 
This study demonstrates that deaths occurring at younger ages – below age 50 – account 
for 67% and 41% of the gap in life expectancy at birth between American males and 
females, respectively, and a set of high-income comparison countries. The main causes of 
death responsible for the U.S.’s excess years of life lost below age 50 are unintentional 
injuries (transport and nontransport injuries), noncommunicable diseases, perinatal 
conditions, and homicide. While unintentional injuries and perinatal conditions make 
similar contributions among both males and females, homicide is more important for 
males and noncommunicable diseases are more important for females. American females 
in this age range also experience an advantage in terms of suicide mortality relative to the 
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comparison countries, while American males do not. Cohort patterns of rankings and 
ratios illustrating the mortality performance of American birth cohorts born between 
1850 and 2004 relative to their counterparts in other high-income countries reveal that 
these cohorts consistently perform exceptionally well at the oldest ages and very poorly 
in the middle ages.  
 
Infant Mortality 
It is well-known that infant mortality rates in the U.S. exceed those in other developed 
countries. Previous observers have noted that variations in the definition of a live birth 
across countries may result in underestimates of infant mortality in other countries 
relative to the United States. Efforts to standardize the definition of live births and infant 
deaths across countries attenuate but do not eliminate the U.S. disadvantage in infant 
mortality (MacDorman and Mathews 2009; Joseph et al. 2012). MacDorman and 
Mathews (2009) concluded that the high percentage of preterm births (births that occur 
before 37 weeks of completed gestation) in the U.S. is a key contributor to its infant 
mortality disadvantage. They demonstrate that if the U.S. had the same distribution of 
births by gestational age as Sweden, its infant mortality rate would be 33% lower. 
Compared to European countries, the U.S. has very high rates of preterm births. In 2004, 
12% of all births in the U.S. were preterm births, while this figure ranged from 6.3% 
(Sweden and France) to 11% (Austria) among the 12 comparison countries considered in 
a recent U.S. National Center for Health Statistics Data Brief (Ibid.).18 Observers have 
noted that neonatal intensive care units in the U.S. perform very well in saving preterm 
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 Although preterm births have declined over time in the United States, the preterm birth rate remained at 
12% in 2010 (Martin et al. 2012). 
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and low birth weight babies. An examination of gestational age-specific infant mortality 
rates shows that the U.S. performs very well relative to other high-income countries for 
infants born between 24 and 37 weeks of gestation (MacDorman and Mathews 2009). For 
term infants (born at 37 or more weeks of gestation), however, U.S. infant mortality rates 
exceeded those of other European countries (Ibid.). The causes of preterm births are less 
well understood than the causes of intrauterine growth restriction. So far, the most 
important causes of preterm births that have been identified include genitourinary tract 
infections, multiple births, and smoking (Kramer et al. 2010).  
 
Homicide 
Homicide accounts for roughly a fifth of excess U.S. years of life lost below age 50 for 
males and less than a tenth for females. Gun ownership is much higher in the United 
States than other countries, although precise estimates are difficult to come by. The U.S. 
owns roughly 35%-50% of civilian-owned guns worldwide, with a lower bound estimate 
of 83 firearms per 100 for the U.S. compared to 31 per 100 for Switzerland, the 
comparison country with the second-highest rate of gun ownership (Small Arms Survey 
2007). Studies have documented that gun ownership and availability are associated with 
greater risk of violent death among both children and adults within the United States. 
(Kellermann et al. 1993; Cummings et al. 1997; Miller, Azrael, and Hemenway 2002). 
The U.S. is clearly an outlier in the percentage of its homicides that are due to firearm 
discharge. In 2007, about 73% of homicides occurring below age 50 in the U.S. were 
homicides by firearm. Among the comparison countries, the average was 25%, ranging 
from 1.5% in Japan to 52% in Italy. Homicide is the cause of death that has been most 
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strongly linked to income inequality and social disorganization (Lynch et al. 2004; 
Kennedy, Kawachi, and Prothrow-Stith 1996). Within the United States, homicide has 
also been linked to poverty, structural disadvantage, residential segregation, and 
community levels of social capital and trust (Massey 1995; Messner, Baumer, and 
Rosenfeld 2004).  
 
Unintentional Injuries 
One of the most striking findings from this study is the sizeable contribution of 
unintentional injuries, which make the largest single contribution of any cause of death 
category. Unintentional injuries account for nearly a third of U.S. excess years of life lost 
below age 50 among both males and females. Transport (mainly motor vehicle accidents) 
and nontransport (mainly accidental drug overdose) injuries make roughly equal 
contributions. A recent report by the Transportation Research Board (2010) found that 
the fatality rate per 100 million vehicle kilometers traveled is highly similar for the 
United States and a set of 15 comparison countries. In fact, until 2004, the fatality rate 
per 100 million vehicle kilometers traveled was lower for the U.S. than for the composite. 
The annual number of vehicle kilometers driven in the U.S. far exceeds that in the 
comparison countries, with the difference widening over time and reaching roughly 1.4 
trillion kilometers or over 870 billion miles driven in 2007 (Ibid.). The total population of 
these 15 comparison countries exceeds that of the U.S.; thus, the difference in annual 
kilometers driven per capita would be even more dramatic. The excess mortality from 
motor vehicle accidents in the U.S. is therefore attributable to a greater amount of driving 
rather than a higher fatality rate per mile driven. 
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Accidental drug overdose has increased dramatically since the early 1990s and 
particularly in the 2000s in the United States (Okie 2010). Accidental drug overdoses 
were responsible for 91% of unintentional poisoning deaths in the U.S. in 2009 (CDC 
2012). Prescription painkillers (e.g., methadone, hydrocodone, and oxycodone) were the 
most commonly implicated in overdose deaths, followed by heroin and cocaine (CDC 
2011). After opioid analgesics, benzodiazepines, antidepressants, and antiepileptic and 
antiparkinsonism drugs were the most commonly involved in pharmaceutical overdose 
deaths (Jones, Mack, and Paulozzi 2011).19 Nonmedical use of prescription drugs (use of 
drugs without a prescription, in ways other than prescribed, or solely for inducing an 
experience or feeling) is a significant contributor to these deaths. Trends in accidental 
drug overdose mirror increases in prescription drug use in the United States. Between 
1990 and 2008, spending on prescription drugs within the U.S. increased nearly sixfold, 
from $40.3 billion to $234.1 billion (Kaiser Family Foundation 2010). Although age-
specific death rates are highest between the ages of 20 and 60 (CDC and NCHS 2012), 
prescribing – particularly the use of stimulants, antidepressants, and antipsychotics – has 
also increased among children over the past decade (Horwitz 2010).  
The high burden of deaths from accidental drug overdose in the U.S. relative to the 
comparison countries is consistent with international estimates of drug use. Data from the 
WHO World Mental Health Surveys conducted between 2001-2005 suggest that the U.S. 
is an outlier in terms of lifetime incidence of drug use (Degenhardt et al. 2008). 
Compared to 7 other high-income countries, the U.S. had the highest levels of cocaine 
                                                           
19
 Three of these – benzodiazepines, antidepressants, and antiepileptic and antiparkinsonism drugs – are 
commonly prescribed for mental health conditions. Studies have documented that those with mental health 
disorders are at greater risk of heavy therapeutic use, nonmedical use, and overdose from prescription 
opioids (Becker et al. 2008).  
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use (16.2% versus 0.3%-4.1% among the comparison countries), despite its severe 
regulatory environment.20 Addressing drug use at young ages is important given that the 
median ages of drug use, abuse, and dependence all occur prior to age 20 and given its 
potential to negatively impact later life outcomes (Swendsen et al. 2008). 
 
Mental Health 
One observation about these main contributors to excess mortality below age 50 is their 
potential relationships with mental health. Similar to their poor performance on other 
indicators in this age range, Americans had the highest prevalence of having a mental 
disorder in the past year among 8 high-income countries according to surveys fielded 
between 2001-2003 (WHO World Mental Health Survey Consortium 2004). This finding 
held for anxiety, mood, impulse-control, and substance disorders (Ibid.). While these 
estimates are based on diagnostic interviews (rather than asking respondents whether they 
have ever been diagnosed with these conditions), controversy remains over the reliability 
of international rankings due to cross-national differences in the reporting of symptoms. 
Studies have found that a number of chronic physical conditions, including diabetes, 
hypertension, and heart disease, are associated with affective disorders (Scott et al. 2007). 
In addition, findings from longitudinal studies indicate that several mental disorders are 
associated with an increased risk of later substance use (Swendsen et al. 2010). These 
findings highlight the importance of considering a wide range of health outcomes and 
linkages among them.  
 
 
                                                           
20
 These seven countries are: Belgium, France, Germany, Italy, Japan, the Netherlands, and Spain. 
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Cohort Patterns 
The cohort patterns of international mortality rankings are generally consistent with the 
pattern observed in the most recent period, 2006-2008. Americans in these birth cohorts 
perform poorly in the middle ages but exceptionally well at the older ages, with the shift 
occurring between ages 60 and 75. In 2006-2008, the U.S. had among the highest death 
rates in the set of comparison countries at below age 30. In contrast, birth cohorts from 
the middle of the 20th century performed quite well at these ages, exhibiting a U-shaped 
pattern of rankings rather than the elongated S-shaped pattern of period rankings. While 
further work remains to be done to explain these trends, it is possible that the positive 
performance of these birth cohorts may be related to more favorable conditions in the 
United States relative to conditions in Europe during the first and second World Wars. 
Americans born in the latter half of the 20th century perform particularly poorly at the 
younger ages in terms of both low rankings (often experiencing the highest or second-
highest death rates in this set of countries) and high mortality ratios (reaching a maximum 
of 1.9 for both males and females). Among females, no birth cohorts since the 1965-1969 
birth cohort have been ranked in the top half of the comparison countries in the ages at 
which we are able to observe them. Among males, the picture is highly similar, with the 
exception of the 5-9 age group. All cohorts of American males born since 1975-1979 
have been ranked in the bottom half of the comparison countries. These trends are 
consistent with Heuveline (2002)’s assessment of the U.S. as an outlier among 
industrialized nations in terms of adolescent and young adult mortality. It also supports 
the conclusion drawn from the first set of analyses presented in this paper that greater 
attention should be paid to mortality conditions at younger ages in the United States. 
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Limitations 
There are some important limitations to this analysis. First, health is a multidimensional 
construct and covers many domains of life, including the physical, affective, cognitive, 
social, and functional. Mortality measures alone do not capture the full range of health. 
However, linkages between mental and physical health exist, and it is likely that 
conditions contributing to high levels of excess mortality are also contributing to greater 
morbidity in the U.S. population.  
Additionally, this study necessarily relies on the comparability of mortality data across 
countries. The set of countries under analysis are all high-income countries with well-
developed, complete vital registration systems (Mathers et al. 2005). The World Health 
Organization has made international recommendations regarding the coding of the 
underlying cause of death, which have helped standardize death certification across 
countries (Désesquelles et al. 2010). While some variation in coding practices remains, 
this is mitigated through the use of broader but still informative cause of death categories. 
It is not expected that minor variations in coding practices would change the results 
substantially.21 In addition, restricting the analysis to ages below 50 means that much of 
the difficulty associated with ascertaining cause of death among the elderly is avoided.  
In the second part of the analysis, which evaluates how U.S. mortality rates compare to 
those of the comparison countries between ages 0 and 109, age misreporting may be an 
issue. Preston, Elo, and Stewart (1999) found that for three typical patterns of age 
misreporting, age misstatement results in downwards-biased mortality estimates at the 
                                                           
21
 For example, it seems unlikely that a death from firearms would be classified under communicable and 
nutritional conditions or noncommunicable diseases rather than as a homicide. Deaths from drug-related 
causes are expected to fall under nontransport injuries (as an accidental poisoning) or noncommunicable 
diseases, both of which are important contributors. 
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oldest ages. If age misreporting is more severe in the United States than in the 
comparison countries, it is possible that the U.S.’s superior performance in rankings and 
ratios observed at the oldest ages may be artifactual.  
 
Conclusion 
We have arrived at a picture of how mortality in the United States compares to other high 
income countries in a recent period. American males and females have the lowest and 
second lowest life expectancy at birth, respectively, among a set of 17 high-income 
countries. Among males, the majority of the U.S. shortfall in life expectancy at birth is 
attributable to mortality differences below age 50, and these ages also account for a 
substantial proportion of the female disadvantage. The major causes of death contributing 
to excess years of life lost below age 50 in the U.S. relative to the comparison countries 
are: unintentional injuries (particularly accidental drug overdose and motor vehicle 
fatalities), noncommunicable diseases, perinatal conditions, and homicide. Diverse 
factors including increased prescribing, commuting patterns, public transportation 
systems, widespread automobile ownership, lower population density, health behaviors, 
access to health insurance, access to firearms, and residential segregation may be 
contributing to the U.S. mortality disadvantage at these ages.  
Identifying which ages and causes of death are most responsible for the U.S.’s low life 
expectancy ranking is essential for developing an informed analysis to adjudicate among 
the proposed explanations. Many of these explanations, at their core, are concerned with 
distinctive features of American society. It is likely that a comprehensive explanation lies 
at the intersection of a broad and diverse set of social forces. That the U.S. appears to 
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perform poorly across a diverse set of diseases and conditions suggests that attention 
should be paid to social and contextual factors that shape day-to-day life in the United 
States and have the potential to affect outcomes across many domains.  
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Tables 
Table 2.1. Life Expectancy at Birth, Difference with United States, and Ranking for 
Males and Females in 17 High-Income Countries, 2007 
 
Males  Females 
Country e0 
Difference 
with U.S. Rank  e0 
Difference 
with U.S. Rank 
Switzerland 79.32 3.68 1  84.09 3.31 3 
Australia 79.27 3.63 2  83.78 3.00 6 
Japan 79.20 3.56 3  85.98 5.20 1 
Sweden 78.96 3.32 4  82.95 2.17 7 
Italy 78.82 3.18 5  84.09 3.31 3 
Canada 78.35 2.71 6  82.95 2.17 7 
Norway 78.25 2.61 7  82.68 1.90 11 
Netherlands 78.01 2.37 8  82.31 1.53 13 
Spain 77.62 1.98 9  84.03 3.25 5 
United Kingdom 77.43 1.79 10  81.68 0.90 15 
France 77.41 1.77 11  84.43 3.65 2 
Austria 77.33 1.69 12  82.86 2.08 9 
Germany 77.11 1.47 13  82.44 1.66 12 
Denmark 76.13 0.49 14  80.53 -0.25 17 
Portugal 75.87 0.23 15  82.19 1.41 14 
Finland 75.86 0.22 16  82.86 2.08 9 
United States 75.64 
 
17  80.78 
 
16 
    
 
   Non-U.S. Average 77.81 2.17 
 
 83.12 2.34 
 
Source: Human Mortality Database (2012). 
 
Table 2.2. Nontransport Injuries by Type (%), Males and Females, United States, 2007 
 Males  Females 
 All Ages 
Below  
Age 50  All Ages 
Below  
Age 50 
Accidental drowning 5.8 8.3  2.5 5.2 
Accidental firearm discharge 1.2 1.7  0.2 0.6 
Accidental poisoning and 
exposure to noxious substances 42.3 63.8  33.5 72.0 
Exposure to smoke, fire, and 
flames 4.2 3.8  4.4 5.6 
Falls 25.0 6.6  36.2 3.8 
Residual 21.5 15.8  23.1 12.8 
Source: Author’s calculations based on World Health Organization (WHO) Mortality Database data. 
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Figures 
Figure 2.1. Contribution of Mortality Differences by Age (%) to the Gap in Life 
Expectancy at Birth Between the United States and the Average of 16 OECD Countries, 
Males, 2007 
 
Source: Author's analysis based on data from the Human Mortality Database (2012). 
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Figure 2.2. Contribution of Mortality Differences by Age (%) to the Gap in Life 
Expectancy at Birth Between the United States and the Average of 16 OECD Countries, 
Females, 2007 
 
Source: Author's analysis based on data from the Human Mortality Database (2012). 
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Figure 2.3. Contribution of Mortality Differences Below Age 50 (%) to the Gap in Life 
Expectancy at Birth Between the United States and 16 OECD Countries, Males, 200722 
 
Source: Author's analysis based on data from the Human Mortality Database (2012). 
 
  
                                                           
22
 The red triangle indicates the average of the 16 comparison countries. If a country lies above the blue 
50% line, over half of its advantage in life expectancy at birth relative to the U.S. is attributable to mortality 
differences below age 50. Percentages in excess of 100% result from cases where life expectancy at age 50 
is higher in the U.S. than in the comparison country. For example, if the U.S. experienced Finnish mortality 
rates above age 50 (i.e., if only differences in mortality below age 50 remained), the gap in life expectancy 
at birth between the U.S. and Finland would grow to 345% of its current value.  
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Figure 2.4. Contribution of Mortality Differences Below Age 50 (%) to the Gap in Life 
Expectancy at Birth Between the United States and 15 OECD Countries, Females, 200723 
 
Source: Author's analysis based on data from the Human Mortality Database (2012). 
  
                                                           
23
 The red triangle indicates the average of the 16 comparison countries. If a country lies above the blue 
50% line, over half of its advantage in life expectancy at birth relative to the U.S. is attributable to mortality 
differences below age 50. Denmark is not shown here since the life expectancy of American females 
exceeds that of Danish females. 
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Figure 2.5. Years of Life Lost Before Age 50, Males, 17 OECD Countries, 2006-2008 
 
Source: Author's analysis based on data from the Human Mortality Database (2012). 
 
Figure 2.6. Years of Life Lost Before Age 50, Females, 17 OECD Countries, 2006-2008 
 
Source: Author's analysis based on data from the Human Mortality Database (2012). 
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Figure 2.7a. Years of Life Lost due to Specific Causes of Death, Males, 2006-200824 
 
Source: Author's analysis based on data from the HMD (2012) and the WHO (2011). 
 
Figure 2.7b. Years of Life Lost due to Specific Causes of Death, Males, 2006-2008 
 
Source: Author's analysis based on data from the HMD (2012) and the WHO (2011).
                                                           
24
 The following causes of death categories are mutually exclusive: communicable diseases, 
noncommunicable diseases, perinatal conditions, unintentional injuries, and intentional injuries. Drug-
related causes overlap with some of these categories, notably noncommunicable diseases and unintentional 
injuries (see Table A2.2 for further detail). 
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Figure 2.8a. Years of Life Lost due to Specific Causes of Death, Females, 2006-200825 
 
Source: Author's analysis based on data from the HMD (2012) and the WHO (2011). 
 
Figure 2.8b. Years of Life Lost due to Specific Causes of Death, Females, 2006-2008  
 
Source: Author's analysis based on data from the HMD (2012) and the WHO (2011). 
                                                           
25
 The following causes of death categories are mutually exclusive: communicable diseases, 
noncommunicable diseases, perinatal conditions, unintentional injuries, and intentional injuries. Drug-
related causes overlap with some of these categories, notably noncommunicable diseases and unintentional 
injuries (see Table A2.2 for further detail). 
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 Figure 2.9. Contribution of Causes of Death 
Age 50 Between the U.S. and the Mean of Other Countries, Males, 2006
Source: Author's analysis based on data from the 
 
Figure 2.10. Contribution of Causes of Death 
Age 50 Between the U.S. and the Mean of Other Countries, Females, 2006
Source: Author's analysis based on data from the 
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Figure 2.11. Ranking of U.S. Age-Specific Death Rates Among 17 Countries, 2006-2008 
 
Source: Author's analysis based on data from the Human Mortality Database (2012). 
 
Figure 2.12. Ratio of U.S. Age-Specific Death Rates to Average of 16 Countries, 2006-
2008 
 
Source: Author's analysis based on data from the Human Mortality Database (2012).
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Figure 2.13. Cohort Rankings of U.S. Age-Specific Mortality Rates, Male Birth Cohorts Born Between 1850 and 2004 
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Figure 2.14. Cohort Rankings of U.S. Age-Specific Mortality Rates, Female Birth Cohorts Born Between 1850 and 2004 
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Figure 2.15. Cohort Ratios of U.S. Age-Specific Mortality Rates, Male Birth Cohorts Born Between 1850 and 2004 
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Figure 2.16. Cohort Ratios of U.S. Age-Specific Mortality Rates, Female Birth Cohorts Born Between 1850 and 2004 
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CHAPTER III. Season of Birth, Environmental Exposures, and Adult 
Health in Six Developing Countries 
 
Introduction 
Chronic disease has become increasingly important as a major cause of morbidity and 
mortality worldwide. Estimates from the Global Burden of Disease Study indicate that 
noncommunicable diseases accounted for approximately 65.5% of all deaths in 2010 
(Lozano et al. 2012). Out of the top 10 and 25 causes of death, five and 13, respectively, 
were noncommunicable diseases (Ibid.). Increasingly, researchers have taken a life 
course approach to unpacking the determinants of the development of chronic disease and 
adult mortality. Many studies have concentrated on the early life origins of adult health, 
how exposures experienced in utero or in infancy and early childhood affect morbidity 
and mortality later in life. 
However, the importance of environmental conditions experienced in early life for health 
over the life course remains relatively understudied. Infectious disease exposure and 
nutrition are two of the most important early life conditions thought to influence health 
and mortality in adulthood, and environmental conditions have the potential to influence 
both disease environment and nutritional intake in the prenatal and postnatal periods. For 
example, certain temperature and rainfall levels can produce conditions that are 
particularly conducive to the spread of infectious and parasitic diseases such as malaria, 
dengue, dysentery, cholera, and diarrheal diseases (Binka et al. 1994; Craig et al. 1999; 
Craig et al. 2004; McEniry and Palloni 2010). Rainfall and temperature levels also play a 
major role in determining crop yield and the quality of the harvest, which in turn affect 
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maternal and infant nutrition. Environmental conditions are likely to have exerted 
particularly strong effects in developing countries which, for much of the 20th century, 
lacked widespread access to refrigeration, clean water, and sanitation and experienced 
very high burdens of infectious and parasitic diseases. Several prior studies have 
examined the effects of extreme, one-time shocks such as famines, recessions, and 
pandemics experienced early in life on cardiovascular disease, disability, socioeconomic 
outcomes, and mortality in adulthood, primarily in the United States and other developed 
countries. In this chapter, I am interested in whether it is possible to detect the effects of 
exposure to routinely-experienced climate conditions early in life on later life health 
outcomes in developing countries. Developing countries, along with developed countries 
prior to the epidemiological transition, are the ideal settings to examine these associations 
because many of the mechanisms relating early life exposures and adult health operate 
only in conditions of high infectious disease burdens (Crimmins and Finch 2006).  
In part due to limited data availability, few direct tests of the effects of environmental 
conditions on later life health have been performed in developing countries. Other studies 
have used season of birth as a proxy for these exposures because there exists seasonal 
variation in disease prevalence and in food availability. While season and month of birth 
patterns in health and mortality in developed countries are well-documented, relatively 
less is known about whether these patterns exist in developing countries and whether they 
differ from those observed in developed countries. This study aims to fill these gaps in 
the existing literature by: (1) estimating the associations between season of birth and 
adult health outcomes in six developing and newly industrialized countries (India, China, 
Ghana, Mexico, Russia, and South Africa), and (2) testing whether environmental 
 103 
 
conditions (rainfall and temperature levels) experienced around the time of birth affect 
adult morbidity in India. These analyses have the potential to contribute to further 
theoretical refinements and to shed light on early life determinants of health among aging 
populations in developing countries.  
In four of these countries (Ghana, Mexico, Russia, and South Africa), I find that 
individuals born in the autumn may experience a health advantage relative to those born 
in the other three seasons. This is consistent with season of birth patterns in longevity 
observed in developed countries (Doblhammer 2004; Doblhammer and Vaupel 2001; 
Gavrilov and Gavrilova 2011). According to the existing literature, the primary 
explanations for this autumn-born advantage are reduced exposure to infectious diseases 
and more favorable maternal and fetal nutritional conditions during the third trimester 
(coinciding with the harvest season) for autumn-born individuals compared to those born 
in other seasons. In contrast, I find that in China, the autumn-born appear to experience a 
health disadvantage relative to those born in other seasons. In India, which has slightly 
different seasons due to the monsoon, individuals born during the monsoon season appear 
to be healthier than their counterparts born in other seasons.  
In India, I observe the most consistent associations between rainfall and temperature 
conditions prevailing during the pre- and postnatal periods and blood pressure and height 
in adulthood. Based on the existing literature, these are two of the health outcomes we 
would expect to be most strongly associated with early life conditions.26 In general, 
                                                           
26
 Barker’s fetal origins hypothesis and a substantial body of literature in this vein relates adverse early life 
conditions to an increased risk of cardiovascular disease and mortality from cardiovascular disease in 
adulthood. Three of the primary risk factors for cardiovascular disease are high blood pressure, high 
cholesterol, and diabetes. Unfortunately, no biological measures of the latter two risk factors are available 
in the datasets used in this chapter.  
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higher levels of rainfall and temperature around the time of birth appear to be deleterious 
for these adult health outcomes. Supplemental analyses of temperature and rainfall 
shocks and considering a longer post-birth window (up through 5 years after birth) 
support the importance of nutritional conditions during gestation and infectious diseases 
experienced during the weaning period for adult health outcomes.  
 
Background 
Early Life Conditions and Health Over the Life Course 
In recent decades, renewed interest in early life conditions was spurred in part by 
observations that adult risk factors could not entirely predict individual risks of 
developing chronic disease or account for between-group differences in chronic disease 
burdens (Kuh and Ben-Shlomo 1997). Although the life course framework encompasses 
exposures that accumulate throughout the life course (e.g., those that occur during 
gestation, childhood, adolescence, young adulthood, etc.), the most relevant frameworks 
for this chapter focus on conditions experienced during gestation and early infancy, 
regarded as a “critical period” of exposure. 
 
Prenatal Exposures: Nutrition and Infection 
Barker’s fetal origins hypothesis (Barker and Osmond 1986; Barker 1995; Barker et al. 
2002; Eriksson 2005) focuses on the relationship between early life nutritional conditions 
and later life health. This model posits that adverse nutritional conditions experienced in 
utero can “program” organ systems (referred to as developmental plasticity), 
predisposing the individuals experiencing unfavorable conditions during critical 
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developmental periods to develop cardiovascular disease in adulthood. Birthweight and 
length at birth are the most commonly used markers of fetal nutrition (Barker et al. 2002; 
Forsén et al. 1999; Roseboom et al. 2001). In its most specific form, undernutrition in 
mid- to late gestation leading to small size and low weight at birth, combined with catch-
up growth in childhood, increases the risk of adult coronary heart disease (CHD) (Barker 
1995; Eriksson 2005). For example, using data from a Helsinki hospital cohort born in 
1924-1933, Eriksson et al. (1999) and Barker et al. (2002) documented negative 
associations between birthweight and deaths from CHD and between birthweight and the 
incidence of CHD, type 2 diabetes, and hypertension. In both of these studies, individuals 
who had low birthweights and who experienced accelerated weight gain between ages 3-
11 had the worst health outcomes, experiencing the highest risk of dying from CHD and 
the highest incidence of CHD, type 2 diabetes, and hypertension (Ibid.).  
However, most other studies testing the Barker hypothesis focus on associations between 
measures of intrauterine conditions and adult health outcomes without considering 
compensatory growth in childhood. The majority of these studies examined effects of 
early life exposure to famines and to the 1918 influenza pandemic on later life outcomes 
since these two types of events are considered to be exogenous shocks or “natural 
experiments.” Findings from famine studies have been mixed, while findings from 
studies of the 1918 influenza pandemic generally support the deleterious impact of pre- 
and post-natal exposure to the pandemic on height, cardiovascular disease prevalence, 
disability, socioeconomic outcomes, and mortality in adulthood. The main strength of 
these studies is their use of large, unexpected health shocks to arrive at internally valid 
estimates of the long-run health impacts of early life exposures. However, the limitations 
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of these studies are that these shocks are often rare and extreme forms of exposures, and 
they often (but not always) rely on small, nonrepresentative (e.g., hospital-based) 
samples. In addition, there may be selection into conception during these adverse health 
conditions, mortality selection that occurs in utero due to the health shocks (influencing 
the composition of live births occurring in these periods), and mortality differences post-
birth that influence the composition of the populations surviving to older ages.    
 
Famine Studies 
Studies have considered the effects of early life exposure to five famines that occurred 
between the mid-1800s and mid-1900s on later life health outcomes: the 1846-1847 
Dutch Potato famine, the 1866-1868 Finnish famine, the 1941-1944 siege of Leningrad, 
the 1944-1945 Dutch famine, and the 1959-1961 Chinese famine. Using historical data 
from three provinces in the Netherlands, Lindeboom, Portrait, and van den Berg (2010) 
considered three cohorts: those who were born before, during, and after the Dutch Potato 
famine, when the potato, rye, and wheat crops failed. Individuals exposed to the famine at 
birth or for at least 6 gestational months had significantly lower life expectancy at age 50 
than individuals born before the famine, and the effects were stronger for men than 
women (Ibid.). Kannisto, Christensen, and Vaupel (1997) used vital statistics data to 
examine the long-run mortality impacts of the 1866-1868 Finnish famine, during which 
8% of the total population died. Similarly, they considered three groups of cohorts born 
immediately preceding, during, and immediately following the famine. They found no 
significant differences in older age mortality among these groups; in fact, “the survival 
curves for the famine cohorts and the control cohorts were virtually identical after 
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childhood” (Ibid., p. 989). Stanner et al. (1997) focused on the impact of intrauterine 
nutritional deprivation experienced during the 1941-1944 siege of Leningrad, where 
roughly 31-42% of the city’s population died (primarily of starvation), on diabetes and 
CHD in adulthood. They considered three groups: individuals exposed to the siege in 
utero, individuals exposed to the siege as infants, and an unexposed group of individuals 
born in the province of Leningrad but outside the siege limits during the same time 
period. Overall, this study found no evidence for long-term impacts of intrauterine 
malnutrition. Exposure to this famine was not associated with glucose intolerance, 
dyslipidaemia, hypertension, or cardiovascular disease in adulthood (Ibid.). Roseboom et 
al. (2001) and Painter et al. (2005) examined the impact of early life exposure to the 
1944-1945 Dutch famine on later life health and mortality, respectively, using the Dutch 
famine birth cohort study (based on all singleton live births occurring between November 
1, 1943 and February 28, 1947 in a hospital in Amsterdam). Official daily rations for the 
adult population fell from roughly 1800 calories to between 400-800 calories at the 
height of the famine (Roseboom et al. 2001). Roseboom et al. (2001) summarized a 
number of studies finding that individuals exposed to the Dutch famine in mid- to late 
gestation had reduced glucose tolerance and an increased risk of developing type 2 
diabetes, while those exposed in early gestation had worse lipid profiles, higher body 
mass index, an increased risk of developing CHD, and worse self-rated health. However, 
there was no impact of prenatal famine exposure on blood pressure in adulthood (Ibid.). 
In contrast, Painter et al. (2005) found no effect of prenatal famine exposure on all-cause 
or CHD mortality using the same dataset. None of the three groups of individuals who 
were exposed to the famine in early, mid, or late gestation had elevated mortality 
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compared to those born before or conceived after the famine (Ibid.). Finally, Chen and 
Zhou (2007) and Huang et al. (2010) examined the long-term health and economic 
consequences of the 1959-1961 Chinese famine, which resulted in 15-30 million excess 
deaths. Chen and Zhou (2007) used data from the China Health and Nutrition Surveys 
and found that cohorts born in rural China in 1959, 1960, and 1962 were shorter and had 
lower labor supply and income in adulthood (Ibid.). Based on a sample of Chinese 
women born in 1957-1963, Huang et al. (2010) found that rural cohorts exposed to the 
famine had lower height, lower BMI, and an increased risk of hypertension in adulthood 
compared to the unexposed 1963 birth cohort. 
In summary, studies of the 1866-1868 Finnish famine, 1941-1944 siege of Leningrad, 
and 1944-1945 Dutch famine found no support for the effects of prenatal exposure to 
famines on adult mortality (Finnish and Dutch famines) or on diabetes or cardiovascular 
disease (siege of Leningrad). However, studies found that early life exposure to the Dutch 
Potato famine of 1846-1847, the 1944-1945 Dutch famine, and the 1959-1961 Chinese 
famine had negative consequences for life expectancy at age 50, diabetes and CHD 
morbidity, and height and socioeconomic outcomes, respectively.  
 
1918 Influenza Pandemic Studies 
In the United States, the influenza pandemic infected approximately 30% of the 
population, with three waves occurring between March 1918 and March 1919  
(Myrskylä, Mehta, and Chang 2013). Influenza deaths peaked in October 1918 and 
remained elevated through the first quarter of 1919 (Almond 2006). Almond (2006) 
found evidence that individuals who were in utero during the pandemic had increased 
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rates of physical disability, reduced educational attainment, lower income, and higher 
transfer payments compared to the surrounding birth cohorts. Those who were born in the 
first two quarters of 1919 had lower high school graduation rates and higher disability 
rates compared to those born in the surrounding birth quarters (Ibid.).27 Using data from 
the National Health Interview Survey (NHIS), Mazumder et al. (2010) found that 
individuals born in 1919 had an increased prevalence of cardiovascular disease 
(particularly ischemic heart disease) and were shorter in adulthood compared to adjacent 
cohorts. The effects were strongest for those born during the first quarter of 1919. 
Myrskylä, Mehta, and Chang (2013) also used data from the NHIS to examine the effect 
of exposure to the pandemic on mortality but considered a more detailed coding of pre- 
and postnatal exposure to the three waves of the pandemic. Compared to unexposed 
cohorts (those born between 1920-1924), cohorts who were exposed in the third trimester 
and at birth to the influenza pandemic (those born in the second quarter of 1918 and the 
first quarter of 1919) experienced significantly elevated mortality from noncancer causes, 
the majority of which are due to cardiovascular and respiratory diseases (Ibid.). The main 
mechanisms suggested for these findings include elevated levels of maternal stress, 
infection, and nutritional deprivation; infection-related increases in chronic inflammation; 
deleterious effects on lung maturation; and elevated risk of preterm birth (Ibid.; 
Mazumder et al. 2010).   
 
 
                                                           
27
 Since individuals born in the first six months of 1919 could have been exposed to the height of the 
epidemic during the first, second, or third trimesters, it is difficult to tell if exposure during any specific 
trimester was most important. However, Almond (2006) notes that on average, welfare payments were 
highest for individuals who were in the first trimester during the peak of the pandemic. 
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Postnatal Exposures: Infections 
Specific examples of early-life infections that have been linked with later life morbidity 
include tuberculosis, hepatitis B, streptococcal infections, and diarrhea and enteritis (Elo 
and Preston 1992). Streptococcal infections cause both upper and lower respiratory tract 
infections. The former have been linked to acute rheumatic fever and rheumatic heart 
disease in adulthood through damage to the heart valves, while the latter have been linked 
to chronic obstructive lung disease through impaired lung development and function 
(Ibid.). Helicobacter pylori infection is spread through person-to-person, oral-oral, and 
fecal-oral modes of transmission and has been linked to peptic ulcer disease and stomach 
cancer (Go 2002). It is common among children living in crowded and unsanitary 
conditions (including contaminated food and water) in developing countries (Ibid.; Elo 
and Preston 1992; Monteverde, Noronha, and Palloni 2009). Height is a measure of both 
nutritional and infectious disease exposures in childhood. Studies conducted in 
Bangladesh, Brazil, the Gambia, and Guatemala have documented associations between 
chronic parasitic and gastrointestinal tract infections such as diarrheal diseases and 
dysentery and slower height increases (Stephensen 1999). The mechanisms operating in 
these cases are hypothesized to be both physiological scarring and malnutrition caused by 
infections (resulting from reduced food intake, reduced nutrient absorption, nutrient 
losses, increased metabolic requirements, and the diversion and reallocation of nutrients 
from routine developmental processes).  
More broadly, Finch and Crimmins (2004) relate exposure to infectious diseases and poor 
nutrition early in life to height, chronic disease morbidity, and mortality in adulthood. 
The primary mechanisms believed to be operating are chronic inflammation and energy 
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reallocation, which are set off by the adverse early life infections and in turn lead to 
lower height and the development of a diverse set of chronic diseases including heart 
disease, stroke, and cancer. One criticism of this hypothesis is that support for this 
mechanism remains restricted to a connection between inflammation caused by 
periodontitis and Chlamydia pneumonia infections in late childhood and early 
adolescence and adult coronary artery disease (Monteverde, Noronha, and Palloni 2009).  
Several studies have explored the impact of postnatal early life conditions on a wide array 
of adult health outcomes in both developed and developing countries. While most studies 
find that adverse childhood conditions increase the risk of morbidity, disability, negative 
socioeconomic outcomes, and mortality in adulthood, at times, the associations between 
early life conditions and adult health outcomes have operated in unexpected directions. 
For example, early infectious exposures are hypothesized to result in increased 
inflammation and the development of chronic conditions later in life. Thus, we would 
expect to observe a positive association between early infectious exposures and C-
reactive protein (CRP), a marker of inflammation. However, McDade et al. (2010) found 
that in the Philippines, higher levels of microbial exposures in childhood were associated 
with lower levels of adult C-reactive protein.  
 
Developed Country Studies 
Support for the chronic inflammation hypothesis proposed by Finch and Crimmins 
(2004) comes mainly from studies examining the association between early life mortality 
and adult mortality, most likely due to limited measures of infectious disease exposure in 
historical populations. These studies are often based on historical mortality data for 
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cohorts born in Europe (e.g., Sweden, France, Switzerland, and England) between the 
mid-1700s and early 1900s. Beltrán-Sánchez, Crimmins, and Finch 2012, Finch and 
Crimmins (2004), and Crimmins and Finch (2006) documented positive associations 
between early life cohort mortality and adult mortality levels but negative associations 
between early life cohort mortality and rates of mortality acceleration. Based on data 
from France and Sweden during the 19th century, Crimmins and Finch (2006) also found 
a strong inverse association between cohort childhood mortality and cohort adult height, 
such that taller cohorts had lower early-age mortality. Bengtsson and Lindstrom (2000) 
used Swedish parish data to examine the associations between four indicators of early life 
conditions (rye prices 9 months prior to birth as a proxy for maternal nutrition, mortality 
at ages 20-50 years for disease load of the mother, and mortality at ages 0-1 and 0-5 for 
disease load of the child) and adult mortality at ages 55-80 between 1760-1895. Out of 
these indicators, only mortality in the first year of life demonstrated a significant 
(positive) association with overall adult mortality and particularly mortality from airborne 
infectious diseases in adulthood (Ibid.). These results were supported by a follow-up 
study also using Swedish parish data (from 1766-1894) where the authors found that 
greater exposure to airborne infectious diseases in the first year of life (primarily from 
smallpox, whooping cough, pneumonia, and measles) was associated with higher 
mortality at ages 55-80 (Bengtsson and Lindstrom 2003). 
Using data from Denmark, England and Wales, Finland, the Netherlands, and Sweden, 
Myrskylä (2010) found weak positive associations between cohort mortality shocks 
experienced during the first year of life and mortality at older ages and stronger positive 
associations between period mortality shocks and mortality at older ages. Bozzoli, 
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Deaton, and Quintana-Domeque (2009) examined the association between postneonatal 
mortality (occurring between ages 1 month-1 year), used as a proxy for disease and 
nutritional conditions in childhood, and adult height among cohorts born between 1950-
1980 in the U.S., England, and 10 continental European countries. They find that 
postneonatal mortality predicts adult height in these countries, with mortality from 
pneumonia (versus mortality from congenital anomalies, intestinal disease, or other 
causes) emerging as the strongest predictor. The authors interpret their results as support 
for evidence of scarring and inflammation as key pathways linking early life conditions 
and later life outcomes (Ibid.).  
Studies focusing on more recent populations in developed countries have generally relied 
on individual-level datasets containing retrospective self-reports of specific diseases 
experienced in childhood or other markers of childhood disease and nutritional conditions 
(e.g., height). Using data from the Health and Retirement Study (HRS), Blackwell et al. 
(2001) examined the associations between infectious, non-infectious, and autoimmune 
childhood illnesses on adult chronic diseases. Infectious childhood illnesses were 
associated with significantly elevated risks of cancer, cardiovascular disease, lung 
conditions, and arthritis in adulthood, but not diabetes. Non-infectious childhood illnesses 
were only associated with a significantly elevated risk of cancer, and autoimmune 
childhood illnesses were never significant predictors of adult morbidity (Ibid.). Haas 
(2008), also using data from the HRS, found that poorer self-rated childhood health 
between birth and age 16 and poorer childhood socioeconomic conditions were 
associated with higher levels of functional limitations at baseline and worse trajectories 
(higher rates of increase) in functional limitations in adulthood.  
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Using height as a marker of childhood health, Case and Paxson (2010) examined the 
associations between height and schooling, employment, earnings, health, and cognitive 
ability in adulthood. Using five British and American surveys28, they found significant 
positive associations between height and educational attainment, employment, and 
earnings. Taller individuals in these samples had better self-rated health, were less likely 
to report being disabled, and had fewer functional limitations (Ibid.). 
 
Developing Country Studies 
Monteverde, Noronha, and Palloni (2009) used data from the Puerto Rican Elderly: 
Health Conditions survey (PREHCO) and Salud, Bienestar y Envejecimiento en América 
Latina y El Caribe (SABE), which was fielded in seven cities in Barbados, Argentina, 
Cuba, Mexico, Uruguay, Chile, and Brazil, to investigate the effects of early life 
conditions on disability in Latin America and the Caribbean. Deleterious early life 
conditions were based on retrospective reports of poor socioeconomic conditions, poor 
health, and infectious diseases (hepatitis, tuberculosis, rheumatic fever, chronic 
bronchitis, nephritis, typhus, polio, malaria, dengue, pneumonia, and asthma) experienced 
during the first 15 years of life. In Puerto Rico and the seven SABE cities, poor early 
conditions increased the probability of having mental, respiratory,  circulatory, and 
musculoskeletal chronic diseases among those aged 60 and above. These chronic 
conditions, in turn, were significant predictors of disability (Ibid.). Based on the Mexican 
Health and Aging Study (MHAS), Kohler and Soldo (2005) found that having a serious 
health condition before age 10 (tuberculosis, rheumatic or typhoid fever, polio, or any 
                                                           
28
 These surveys were: the National Child Development Study, the British Cohort Study, the Panel Study of 
Income Dynamics, Whitehall II, and the Health and Retirement Study. 
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other serious health problem) and going to bed hungry as a child were positively 
associated with having diabetes in adulthood. In contrast, having a toilet inside the house 
before age 10 (a proxy for early life exposure to infectious and parasitic diseases) 
lowered the risk of diabetes in adulthood (Ibid.). Also using the MHAS, Huang, Soldo, 
and Elo (2011) found that experiencing serious health conditions before age 10 and going 
to bed hungry as a child significantly increased the risk of lower-body functional 
limitations. This finding was robust to the inclusion of both childhood and adult 
socioeconomic conditions (Ibid.).   
The two frameworks discussed above propose a positive relationship between early life 
exposures and adult health, where health insults experienced in infancy and childhood 
lead to poorer health and elevated mortality in adulthood. However, the typology offered 
by Preston, Hill, and Drevenstedt (1998) allows for greater heterogeneity in the effects of 
early life conditions. Two of the four mechanisms, physiological scarring and correlated 
early-life and adult social environments, lead to positive relationships between mortality 
risks in childhood and adulthood. The majority of the pathways discussed in the 
preceding paragraph could be considered examples of physiological scarring. In contrast, 
the other two mechanisms, acquired immunity and selection, result in negative 
relationships between mortality risks in childhood and adulthood. 
In summary, a large number of studies have suggested that undernutrition and infections 
in utero and infections contracted in the immediate post-birth period are related to worse 
health and increased mortality in adulthood. The most consistent associations between 
early life conditions and adult health have been found for the following outcomes: height, 
cardiovascular diseases (e.g., CHD, hypertension, and stroke), and respiratory diseases. 
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In general, the main limitations of these studies are that they often rely on retrospective 
self-reports of childhood conditions (which may be subject to recall bias) and self-
reporting of adult health outcomes.  
 
Environmental Conditions and the Disease Environment 
Environmental conditions such as temperature and rainfall can exert strong influences on 
the disease environment. For example, the incidence of waterborne infectious diseases 
affecting the gastrointestinal tract is correlated with flooding and warmer temperatures 
(Doblhammer 2004). Higher temperatures can shorten pathogens’ incubation periods, 
contributing to the spread of foodborne diseases. Diarrheal disease, a major cause of 
morbidity and mortality among children, was historically referred to as the “summer 
complaint” (Preston and Nelson 1974). The incidence of other gastrointestinal diseases 
such as cholera, dysentery, and typhoid also peaks in summer. Temperature and rainfall 
levels can also affect the proliferation and range of disease vectors like mosquitoes, flies, 
and rodents. Malaria is particularly sensitive to climate conditions since temperature 
affects both parasite and vector development, while rainfall influences mosquito breeding 
sites and survival (Craig et al. 1999; Craig et al. 2004). As a result, climate data is 
commonly used to predict malaria epidemics.  
If environmental conditions increase the incidence of infectious and parasitic diseases, 
the synergy between infections and the absorption of nutrients provides an additional 
pathway through which environmental conditions affect child nutrition and health. Mata 
(1992) documented the striking effects of repeated infections (predominantly from 
diarrhea) on weight gain in children. Environmental conditions and their associated 
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effects on infectious disease burdens are likely to be particularly relevant for this 
analysis, which considers samples of older individuals born prior to 1960. For example, 
refrigeration is still not widespread in India: as of 2002, only 3.8% of rural households 
and 30.0% of urban households reported having a refrigerator (Sharma and Haub 2008). 
Several recent studies have examined the effects of environmental conditions on child 
outcomes (mainly height and infant mortality) in developing countries. While these 
studies generally find that rainfall and temperature conditions are significantly associated 
with child outcomes, the direction of the effect varies depending on the outcome and 
context. Few of these studies discuss specific mechanisms connecting climate conditions 
and health outcomes, although the most commonly mentioned are nutrition, infectious 
disease prevalence, income shocks, and epidemiological pathways in general. Thai and 
Myrskylä (2012) suggest that rainfall shocks may affect health by increasing labor 
demand and consequently decreasing breastfeeding. Using data from the Vietnam 
Demographic Health Survey, they find support for this hypothesis – excess rainfall in the 
birth year decreased the proportion breastfed for more than 12 months and for more than 
18 months by 11%  and 9%, respectively, among children aged 12-36 months (Ibid.). 
 
Rainfall and Temperature Studies 
Skoufias and Vinha (2011) examined the effects of weather shocks (deviations from 
long-run averages) on height-for-age among children aged 12-47 months surveyed in 
2000 in rural Mexico. They found that positive (higher) rainfall shocks in 1999 and 
negative (lower) temperature shocks in 1998 were significantly associated with lower 
height-for-age in most regions; negative (lower) rainfall shocks were significantly 
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associated with taller height-for-age in some areas; but positive (higher) temperature 
shocks were not significantly associated with height-for-age (Ibid.). Hoddinott and 
Kinsey (2001) examined the effects of the 1994-1995 drought on changes in height 
among children aged 12-60 months in rural Zimbabwe. They specify the “drought 
cohort” as children who were aged 12-24 months in 1995-1996, since failed rains in the 
1994-1995 agricultural year were expected to result in food shortages during the 
subsequent 12 months. Compared to the older children in this sample, the drought cohort 
experienced growth faltering on the order of 1.5-2 cm, with no evidence of catch-up 
growth, and the impact was greatest for children in poor households (Ibid.). While the 
main focus of Bhalotra’s (2010) study was on the effect of income shocks on infant 
mortality, the author also included rainfall shocks (deviations from state-level means) as 
a predictor.29 A one standard deviation increase in rainfall was associated with a 0.004 
decline in infant mortality risk among children born between 1961-1999 whose mothers 
were surveyed in the National Family Health Survey of India (NFHS-2) (Ibid.).  
One historical study of the associations between rainfall and temperature and overall 
mortality rates in England in 1665-1834 found evidence of temperature effects but no 
evidence of rainfall effects on mortality during this period (Lee 1981). Cold winters 
(December-May) and hot summers (June-November) were associated with increases in 
mortality. The results suggest that increasing winter temperatures by 1° Celsius and 
lowering summer temperatures by 1° Celsius would reduce annual mortality by roughly 
2% and 4% respectively, resulting in an increase in period life expectancy of 
                                                           
29
 This study used rainfall data from indiastat.com, which requires a membership fee to access the data. 
Their rainfall data appear to pertain mainly to the post-1950 period and may only be available at the state 
level, which would not be useful to my analyses.  
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approximately 2 years (Ibid.). Lee (1981) suggests that these associations may be due to 
mortality from respiratory tract diseases (e.g., pneumonia, bronchitis, influenza) among 
the elderly in winter months and mortality from digestive tract diseases among infants 
and children in summer months.  
I know of only one study which examines the effect of rainfall on later life health 
outcomes. Maccini and Yang (2009) used the Indonesian Family Life Surveys (IFLS) and 
data from rainfall stations to examine the association between birth year rainfall and adult 
outcomes among Indonesian men and women born between 1953-1974. Among women, 
higher levels of rainfall in the birth year were significantly and positively associated with 
self-rated health, height, schooling, and socioeconomic status in adulthood; however, no 
significant effects are observed for men (Ibid.). 
 
Season of Birth Patterns in Health and Mortality 
While there is general agreement regarding the importance of early life conditions, data 
capturing these conditions have often been scarce. As a result, many scholars have 
focused on the effects of month or season of birth as a proxy or “indicator for 
environmental factors that are linked to seasons of the year” (Doblhammer and Vaupel 
2001: 2934). Relative to birthweight, month of birth is regarded as being less susceptible 
to selection biases and to influence by socioeconomic factors. In addition, while 
birthweight captures only prenatal influences, month or season of birth serves as an 
indicator of seasonal influences operating during pregnancy and the first year of life. In 
general, studies have found that longevity is highest for those born between September 
and December and lowest for those born between March and June (Doblhammer  and 
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Vaupel 2001; Doblhammer 2004; Gavrilov and Gavrilova 2011) for countries located in 
the Northern Hemisphere, although the peaks and troughs vary from study to study.  
Using Swedish parish data from 1766-1894, Bengtsson and Lindstrom (2003) found 
strong season of birth influences on the association between infectious disease load in the 
first year and mortality at ages 55-80. The associations between infant mortality and older 
age mortality were stronger for individuals born in the winter and summer than those 
born in spring and autumn. The authors note that historically in Sweden, infectious 
diseases peaked in the winter and summer months, with respiratory diseases and 
smallpox being particularly important in winter months and water- and airborne 
infectious diseases being highly prevalent in the summer months (Ibid.). Based on more 
recent data, Doblhammer (2004)’s comprehensive study found distinctive patterns in life 
expectancy at age 50 by season of birth in Australia, Austria, Denmark, and the United 
States. The data were based on individuals aged 50 and above who died between 1988-
1996 in Austria, between 1993-1997 in Australia, between 1968-1998 in Denmark, and 
between 1989-1997 in the United States. In Austria and Denmark, located in the Northern 
Hemisphere, individuals born between September and December had the highest life 
expectancy at age 50, while those born between March and June had the lowest life 
expectancy at age 50. In the U.S., those born between September and November had the 
highest life expectancy at age 50, and those born between April and July had the lowest 
life expectancy at age 50. This pattern is mirrored in Australia, located in the Southern 
Hemisphere, where those born between March and June had the highest life expectancy 
at age 50 and those born between September and December had the lowest life 
expectancy at age 50. Differences in adult lifespan between those born in October-
 121 
 
December and April-June were statistically significant and ranged from 0.3 to 0.6 years 
in Denmark, Austria, and Australia (Ibid.).  
For regions located somewhat closer to the equator (e.g., Hawaii and Queensland, 
Australia), temperature appears to influence longevity. In these areas, mean age at death 
is highest for months coinciding with lower temperatures (January-April in Hawaii and 
May-June in Queensland) (Doblhammer 2004). Season of birth patterns by cause of death 
were also identified in Austria and the United States. Compared to those born in October-
December, those born in April-June in Austria were significantly more likely to die at 
younger ages from ischemic heart disease, cerebrovascular disease, diabetes, certain 
cancers (stomach cancer and the residual group of “Other neoplasms”), chronic 
respiratory diseases, pneumonia and influenza, and injuries (Doblhammer and Vaupel 
2001). In the U.S., those born in September-November died later from several cancers 
(breast, prostate, lung, colorectal, stomach, pancreatic, liver, and the residual group of 
“Other neoplasms”), circulatory diseases, diabetes, chronic respiratory diseases, 
pneumonia, influenza, and injuries compared to those born in April- June (Doblhammer 
2004). In Doblhammer (2004)’s analyses, the hypothesis that these patterns were related 
to food availability and infectious disease exposures experienced early in life and which 
differ by season of birth received the strongest support. For example, autumn months 
generally coincide with the harvest season, so individuals born in autumn and early 
winter were likely to have experienced the most favorable nutrition conditions during the 
third trimester (the period of peak growth) and directly after birth (Ibid.). 
These findings for the U.S. are consistent with those of Costa and Lahey (2005) and 
Gavrilov and Gavrilova (2011). Using historical data on white male Union Army recruits 
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who survived to 1900, Costa and Lahey (2005) found that individuals born in the second 
and third quarters of the year experienced elevated mortality rates between ages 60-79 
compared to those born in the fourth quarter. They ruled out differences in household 
wealth, father’s occupation, and mortality selection as explanations for these patterns and 
suggested that maternal diet and early life exposures to infectious diseases were the likely 
drivers of these patterns (Ibid.). Gavrilov and Gavrilova (2011) examined month of birth 
patterns among validated centenarians born in the U.S. in 1880-1895. Compared to their 
shorter-lived siblings and spouses, centenarians were more likely to be born in 
September-November and less likely to be born in March, May, and July (Ibid.).   
Two recent studies of season of birth effects on health in developing countries focused on 
Puerto Rico and India. McEniry and Palloni (2010) examined the effects of seasonal 
exposures to poor nutrition and infectious diseases during late gestation in a sample of 
older Puerto Ricans. In this study, season of birth effects were hypothesized to derive 
from seasonal variation in parental employment and exposure to infectious and parasitic 
diseases during the hurricane season. Controlling for childhood socioeconomic 
conditions, childhood health conditions, and adult risk factors, individuals born in rural 
areas during high exposure periods were at greater risk of developing heart disease 
(Ibid.). Lokshin and Radyakin (2012) examined the relationship between month of birth 
and child height in India using the NFHS.30 They found that children born in May, June, 
and July (during the monsoon months) had lower anthropometric scores (height-for-age 
z-scores) compared to children born during November, December, and January (Ibid.). 
                                                           
30
 They also examine but do not present rainfall coefficients from models controlling for both month of 
birth and district-level rainfall (taken from the same data source used in this analysis). They note that the 
month of  birth coefficients remain largely unchanged after controlling for rainfall and that prenatal rainfall 
does not predict height-for-age, but they do not describe the direction of effects of rainfall at the month of 
birth or postnatal rainfall (1-2 months after birth) on height-for-age.  
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To the best of my knowledge, however, no studies have examined the effects of being 
born during the monsoon season on later life health outcomes in India.  
Studies in developed countries have found month and season of birth patterns in adult 
mortality, while studies in developing countries have documented month and season of 
birth patterns on height among children and cardiovascular disease among adults. The 
main criticisms of such studies are that month or season of birth is not free of 
socioeconomic influences (e.g., those in certain occupations or social classes are more 
likely to have births in certain seasons than others). However, Doblhammer (2004) 
concluded that the month-of-birth patterns in longevity observed in developed countries 
were not due to differences in the seasonal distribution of births by parental 
socioeconomic status or age at entry into school, seasonality of death, or differential 
infant survival. Finally, as with many of previous studies discussed above, reliance on 
self-reported morbidity in adulthood may be an issue. 
Studying season of birth effects in developing countries is particularly appropriate given 
that these effects are expected to be strongest in populations with greater susceptibility to 
seasonal cycles in disease prevalence and food availability and with higher disease loads 
(e.g., prior to mortality transitions) (Becker and Weng 1998; Costa and Lahey 2005; 
Crimmins and Finch 2006). This is supported by Doblhammer and Vaupel (2001) and 
Doblhammer (2004), who found that in developed countries, differences in adult lifespan 
by month of birth were significantly smaller in more recent cohorts that had experienced 
substantial improvements in maternal and infant mortality relative to older cohorts. 
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Data from the Annual Reports of the Public Health Commissioner of India (1937) 
indicate that the prevalence of and mortality from several diseases were highly seasonal 
in the first half of the 20th century. For example, in 1931-1935, cholera deaths peaked 
between July and October, which makes since given that these months coincide with the 
monsoon season and cholera is a waterborne disease (Figure 3.1). It is also notable that 
in two of the years, 1932 and 1933, cholera mortality was much lower and did not exhibit 
pronounced seasonal variation. In contrast, plague deaths in 1923-1935 peaked between 
February and May, during what are considered the winter and summer seasons (Figure 
3.2). Plague mortality during this time period appears to have been lowest between June 
and November, during the monsoon season. Smallpox cases also peaked between 
February and May in 1931-1935, with 1931 and 1932 being somewhat more favorable 
years in terms of lower smallpox incidence (Figure 3.3). These figures of seasonality in 
disease prevalence and mortality from the 1920s-1930s provide a snapshot of disease 
conditions to which individuals in the analytical sample would have been exposed.31  
 
Hypotheses 
In the first part of the analysis, I examine associations between season of birth and adult 
health in six developing and newly industrialized countries. Prior studies, mostly 
conducted in developed countries, suggest that individuals born between September and 
December have a mortality advantage relative to individuals born in the other months of 
the year. It is likely that this pattern also holds for morbidity. The standard 
meteorological definitions for autumn are September-November in the Northern 
Hemisphere and March-May in the Southern Hemisphere, which I employ in this analysis 
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 Respondents  in the India sample were born between 1913 and 1957. 
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(see Table 3.1 for the season of birth classifications in each of the six countries).32 Thus, 
I hypothesize that chronic disease prevalence will be lower among those born in 
September-November in the Northern Hemisphere (China, Ghana, Mexico, Russia) and 
among those born in March-May in the Southern Hemisphere (South Africa) compared to 
individuals born in the remaining months. Specifically, I test for an autumn-born health 
advantage by comparing those born in autumn to those born in all other months.33 The 
India Meteorological Department (Attri and Tyagi 2010) designates the seasons in India 
as: winter (January-February), summer (March-May), monsoon (June-September), and 
post-monsoon (October-December). One previous study (Lokshin and Radyakin 2012) 
has examined the effect of being born during monsoon months on height-for-age among 
children. In this study, I examine the association between adult health outcomes and 
being born in the monsoon season versus being born in all other months. It is 
indeterminate which direction the effect will be in since higher levels of rainfall may 
promote the transmission of water- and vector-borne diseases like cholera and malaria, 
but temperatures are highest during the summer months, when the incidence and 
mortality from diseases such as smallpox and plague peak.  
In the second part of the analysis, I examine the impact of pre- and postnatal 
environmental conditions (rainfall and temperature) on adult health in India. While 
environmental conditions are hypothesized to be important influences on early life 
disease environment and nutritional conditions, relatively few direct tests of their 
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 I also test the robustness of the results to defining autumn as October-December in the Northern 
Hemisphere and April-June in the Southern Hemisphere following Doblhammer (2004). 
33
 In addition, Appendix Tables A3.5-A3.10 present results comparing those born in autumn to those born 
in the winter, spring, and summer seasons separately in China, Ghana, Mexico, Russia, and South Africa 
and those born in the monsoon season to those born in the winter, summer, and post-monsoon seasons in 
India. 
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importance for later life health outcomes have been performed. In addition, many prior 
studies of the effects of early life conditions on adult health focus on the long-term 
impacts of large, one-time shocks (e.g., pandemics, famines, droughts). I am interested in 
testing whether routinely-experienced environmental conditions affect adult health 
outcomes. The expected direction of the association between rainfall and adult health 
outcomes is indeterminate: more rain can be beneficial or deleterious in its effects. On the 
one hand, it is very important to have sufficient rain for crops, which affects both fetal 
and infant nutrition. On the other hand, too much rain can be deleterious for crops, cause 
flooding, and contribute to the spread of water- and vector-borne diseases. However, I 
hypothesize that rainfall shocks during the monsoon will be associated with worse health. 
Excess rain (above the 90th percentile) may lead to flooding, poor harvests, and greater 
spread of infectious and parasitic diseases, while insufficient rain (below the 10th 
percentile) may result in failed harvests. I hypothesize that higher temperatures will be 
unfavorable for health because they may contribute to food spoilage and expand the 
range of disease vectors. I also hypothesize that particularly high temperatures in the 
summer will be associated with worse health, potentially by promoting diarrheal diseases 
through food spoilage and by providing ideal conditions for mosquitoes, which transmit 
malaria and dengue. These hypotheses are summarized in Table 3.2. 
Based on the existing literature (summarized above), studies have found the most 
consistent associations between early life exposures and height, cardiovascular diseases, 
respiratory diseases, disability, and mortality. Thus, out of the outcomes considered in 
this analysis, I expect the associations between season of birth and adult health and 
between early life environmental exposures and adult health to be strongest for: height; 
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blood pressure, hypertension, angina, and stroke (all risk factors for or types of 
cardiovascular disease); and chronic lung disease (a respiratory disease).  
 
Data and Methods 
Data 
The WHO Study on Global Ageing and Adult Health (known as SAGE) is the primary 
data source for this study. SAGE is a longitudinal survey modeled after the HRS, the 
English Longitudinal Study of Ageing, and the World Health Survey, with waves 2 and 3 
to be fielded in the coming years.34 The first wave was fielded in 2007-2010 in six 
countries: India, China, Ghana, Mexico, Russia, and South Africa. The samples are 
nationally representative of the population aged 50+ in each country, although they also 
include younger adults aged 18-49 (Kowal et al. 2012). The total number of respondents 
aged 50+ in each survey were: 13,367 (China), 4,724 (Ghana), 7,150 (India), 2,315 
(Mexico), 3,933 (Russia), and 3,840 (South Africa). The following number were dropped 
due to missing information on month of birth: 623 (China), 3,540 (Ghana), 5,196 (India), 
9 (Mexico), 64 (Russia), and 569 (South Africa). Next, 6,769 (China), 346 (Ghana), 578 
(India), 1,369 (Mexico), 1,609 (Russia), and 1,940 (South Africa) cases were dropped 
due to missing information on the other key variables of interest (i.e., respondents in the 
final sample were not missing information on any of the adult health outcomes, state, 
education, father’s education, and father’s occupation). The final sample sizes for each 
country were as follows: 5,975 (China), 838 (Ghana), 1,376 (India), 937 (Mexico), 2,260 
                                                           
34
 While the analyses in the present study examine the association between season of birth and adult health 
at a point in time, the longitudinal design of this study allows for the possibility of looking at the 
relationship between season of birth and changes in health status over time once data from subsequent 
waves become available. 
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(Russia), and 1,331 (South Africa). For India, an additional subsample was used: 
individuals who were not missing information on rainfall and temperature near the time 
of birth and who had always lived in their current district of residence (N=1,044). 
This dataset has many strengths for the present analysis: it includes information on 
respondents’ geographic location and month of birth, which are rare and essential to this 
study; it collects measured as well as self-reported health indicators; and it is very recent, 
allowing me to assess the current state of health and aging in developing countries. In 
addition to collecting information on respondents’ sociodemographic characteristics, 
SAGE also collects information on self-reported chronic conditions, functional 
limitations, anthropometrics, performance tests, and biomarkers. The questionnaires were 
designed to be fielded consistently across the six survey countries.  
The second dataset used in this analysis is the Climate Research Unit (CRU) TS2.1 
dataset, which is publicly available through the Indian Meteorological Department (IMD) 
and collected by the Tyndall Centre for Climate Change Research, School of 
Environmental Sciences, University of East Anglia. This dataset contains monthly 
temperature and rainfall measures from rainfall stations in selected districts in 35 Indian 
states and union territories from 1901-2002. While variation in climate conditions within 
districts may remain, districts are a much finer unit of analysis than other larger 
administrative divisions (e.g., states). District-wise data are produced from interpolations 
based on 0.5 degree latitude-longitude climate grids (Mitchell and Jones 2005). These 
data are linked to the SAGE India sample by matching on month, year, state, and district 
of birth. The sample for these analyses consists of 1,044 respondents from six states and 
118 districts who are considered non-movers. 
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Health Outcomes 
A set of measured and self-reported health outcomes are the main outcomes of interest in 
these analyses. Respondents are coded as falling into either the “normal” or “high-risk” 
category for the measured health outcomes (see Table 3.3 for the measures and high-risk 
cutpoints used in this study). Most of the high-risk cutpoints are taken from the 
recommendations of the World Health Organization (WHO), National Institutes of 
Health, or previously published studies. There is some evidence that the associations 
between biomarkers and health outcomes may differ across populations. For example, 
WHO Asia Pacific (WHO 2000), Misra et al. (2006), and Mohan et al. (2007) suggest 
that Asian populations may have lower cutpoints for body mass index (BMI) and waist 
circumference because they may have less skeletal muscle mass and greater abdominal 
obesity and visceral fat at lower BMIs. Although the WHO has not issued standard 
cutpoints for specific Asian populations (e.g., WHO 2004; WHO 2013), WHO Asia 
Pacific (WHO 2000) and several epidemiological studies proposed alternate thresholds 
based on examinations of cutpoints that best identify cardiovascular risk factors. I test the 
sensitivity of these results for the India sample to two alternate cutpoints for BMI (≥23.0 
kg/m2 and ≥25.0 kg/m2) and waist circumference (≥ 90 cm for males, ≥ 80 cm for females 
and ≥ 87 cm for males, ≥ 82 cm for females) from epidemiologic studies conducted using 
data on Asian Indian adult populations (Misra et al. 2006), and Mohan et al. 2007).  
The blood pressure and pulse rate measures are based on the average of three measures 
taken.35 For systolic and diastolic blood pressure, individuals were coded as falling into 
the high-risk categories if they met the high-risk cutpoints or if they reported taking 
                                                           
35
 This was true for respondents in all of the SAGE countries except for Mexico, where blood pressure and 
pulse rate measures were based on the average of two measures taken per individual.  
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antihypertensive medication within the past two weeks. A third blood pressure measure 
(referred to as overall blood pressure) was created, with respondents falling in the high-
risk category if they met the high-risk cutpoints for both systolic and diastolic blood 
pressure (also adjusted for hypertensive medication usage in the past two weeks). For 
height, I consider two outcome measures: whether the respondents fell below the 10th or 
25th height percentiles, where the thresholds are specific to each sex and country. These 
thresholds are based on all SAGE respondents aged 50+ for whom height measurements 
were taken. Tables A3.1-A3.4 show the percentages of adults in each sample who fall 
into the normal and high-risk categories for these health outcomes.  
Questions eliciting information on chronic diseases are in the form of: “Have you ever 
been diagnosed with” or “Have you ever been told by a health professional that you have 
had” a particular condition. These conditions are: hypertension, diabetes, angina, stroke, 
chronic lung disease, arthritis, and asthma. The reporting of chronic conditions and other 
health measures is dependent on respondents’ interactions with health care professionals 
and health knowledge and the level of health system infrastructure within each country. 
However, the collection of measured health outcomes allows for the examination of the 
relationship between early life conditions and health outcomes which are not dependent 
on individuals’ interactions with the health care system. Tables A3.1-A3.4 show the 
percentages of adults in each sample who report having been diagnosed with each of 
these chronic conditions. 
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Explanatory Variables 
The main social and demographic variables considered are age, sex, region of residence, 
father’s education, father’s occupation, and respondent’s education (see Tables A3.1-
A3.4 for the summary statistics for each of the samples). Region, father’s education, and 
respondent’s education are coded on a country-specific basis. Father’s occupation is 
coded as a binary variable (agricultural vs. non-agricultural) capturing those who are 
classified as Skilled Agricultural and Fishery Workers based on the current version of the 
International Standard Classification of Occupations (ISCO-88).36 
 
 Season of Birth 
The first predictor variable of interest is season of birth. Based on the existing literature, 
the autumn-born are hypothesized to have a health advantage relative to those born in 
other seasons. I use a binary variable that defines an autumn births as occurring in 
September-November and all other births as occurring in December-August in the 
Northern Hemisphere countries (China, Ghana, Mexico, and Russia) and autumn births as 
occurring in March-May and all other births as occurring in June-February in the 
                                                           
36
 Ideally, we would like to be able to determine whether the respondent’s father was a farmer since the 
mechanisms through which these early life exposures are hypothesized to act (e.g., seasonal variation in 
food availability and disease prevalence, effects of rainfall and temperature on nutrition and disease 
transmission) may be most relevant for respondents from farming backgrounds and/or rural areas. 
However, this is difficult to ascertain since occupations are classified according to skill level and 
specialization rather than industrial sector under the ISCO-88 classification (Elias and Birch 1994). 
Farmers may be classified in three major groups (1 - Legislators, Senior Managers, and Officials, 6 - 
Skilled Agricultural and Fishery Workers, and 9 - Elementary Occupations) under the ISCO-88. Most 
farmers classified under major group 1 are not the type we are thinking of, since they would be managing 
very large farms. This leaves us with major groups 6 and 9, with most skilled market-oriented farmers and 
agricultural workers and subsistence agricultural occupations falling within major group 6 and unskilled 
farmhands falling within major group 9 (Ganzeboom and Treiman 1996). However, major group 9 is a 
highly heterogeneous group, including domestic cleaners, food vendors, and mining and construction 
laborers in addition to unskilled farmhands. Since it is not possible to separately identify unskilled 
farmhands from other occupations within major group 9 in all of the SAGE countries, the present study 
defines agricultural father’s occupation  as major group 6 alone for the sake of maintaining comparability 
across countries.    
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Southern Hemisphere countries (South Africa). Tables A3.5-A3.10 show additional 
results using a four-category season of birth variable (defined as shown in Table 3.1). In 
India, the distinction is between births occurring in June-September (the monsoon 
season) and all other births occurring in October-May. While parents may be aware that 
certain seasons provide more or less favorable conditions for infants, month of birth is 
plausibly exogenous. In the full models, I test whether the effects of season of birth are 
robust to the inclusion of controls for father’s education and father’s occupation.   
 
 Temperature and Rainfall Conditions 
The two main measures of climate conditions in India are constructed from monthly 
rainfall (in meters) and monthly minimum temperature (in °Celsius) measures capturing 
both pre- and post-birth conditions. I create three variables capturing climate conditions 
during the 9-month gestational period (total rainfall and average minimum temperatures 
observed during the first, second, and third trimesters) and three variables capturing 
conditions during a 9-month post-birth period (total rainfall and average minimum 
temperatures observed during the first 1-3, 4-6, and 7-9 months after birth). Respondents 
are assumed to have been born at the end of the month. For example, a respondent born 
in May 1930 would be linked to rainfall and temperature conditions observed in May 
1930, April 1930, and March 1930 in the third trimester; February 1930, January 1930, 
and December 1929 in the second trimester, and November 1929, October 1929, and 
September 1929 in the first trimester. For the post-birth period, the climate conditions for 
this respondent would correspond to June 1930, July 1930, and August 1930 in the first 
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1-3 months; September 1930, October 1930, and November 1930 in the first 4-6 months, 
and December 1930, January 1931, and February 1931 in the first 7-9 months. 
In supplementary analyses, I also examine the effects of rainfall and temperature shocks 
in the monsoon and summer seasons and rainfall and temperature conditions through the 
first 60 months after birth to test whether climate conditions are particularly important 
during the weaning period. I define an excess rainfall or temperature shock as occurring 
when rainfall or temperature in a given month and district is ≥90th percentile of rainfall or 
temperature observed in that month and district between 1901-2002. I define an 
insufficient rainfall shock as occurring when rainfall in a given month and district is ≤10th 
percentile of rainfall observed in that month and district between 1901-2002. I focus on 
whether rainfall shocks during the monsoon season and temperature shocks during the 
summer matter for adult health.  
To capture rainfall and temperature conditions occurring during the first 60 months after 
birth, I create five variables capturing total rainfall and average minimum temperature 
during the first 1-12, 13-24, 25-36, 37-48, and 49-60 months after birth. I also consider 
whether rainfall and temperature shocks in each of these 12 month periods are associated 
with adult morbidity. 
There is substantial temporal and spatial variation in India’s climate, allowing for the 
examination of the effects of experiencing a wide range of temperature and rainfall 
conditions. Figures 3.4-3.7 provide an illustration of this variability, considering climate 
conditions in 1907-1957 in the two most populous districts in the states of Rajasthan and 
West Bengal: Jaipur and North 24 Parganas. Rajasthan has a tropical desert climate. 
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Rainfall in Jaipur generally peaks in June-September, coinciding with the monsoon 
season, but the timing and magnitude of the peak vary considerably from year to year. 
During this time period, monthly rainfall ranged from 0 to 0.518 meters. In contrast, West 
Bengal is more coastal and has a more moderate climate. North 24 Parganas receives 
much more rainfall spread over a greater number of months, and the month of peak 
rainfall occurs slightly later than in Jaipur. Monthly rainfall in this district ranged from 0 
to 0.704 meters in 1907-1957. The range in minimum temperatures is much wider in 
Jaipur, ranging from 5.6-29.7 °Celsius over this period, compared to 12.2-27.6 °Celsius 
in North 24 Parganas. Temperatures peak in May-September in Jaipur, with higher 
temperatures observed closer to May, whereas the level of peak temperatures is fairly 
stable over a greater number of months in North 24 Parganas. 
 
Methods 
In the first set of analyses, I estimate logistic regression models using season of birth 
(autumn vs. all other or monsoon vs. all other) to predict adult health outcomes in each of 
the six SAGE countries. In these models, being born in the autumn or during the 
monsoon season is specified as the reference category. In the second set of analyses, 
which focus on India, I consider the gestational and post-birth periods separately. First, I 
estimate logistic regression models using rainfall or temperature conditions in the three 
trimesters to predict adult health outcomes. Next, I estimate logistic regression models 
using rainfall or temperature conditions in the first 1-3, 4-6, and 7-9 months after birth to 
predict adult health outcomes. The dependent variables in these models are the set of the 
measured health outcomes and self-reported chronic conditions described above. 
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All models are estimated using sample weights to account for the complex survey design 
and include controls for age and sex. I specify five models: Model 1 (M1) includes 
controls for sex and 5-year age group. Model 2 (M2) adds region, Model 3 (M3) adds 
father’s education, Model 4 (M4) adds father’s occupation, and Model 5 (M5) adds 
respondent’s education. In this chapter, I focus on and present results from Model 1, 
referred to as the basic model, and Model 5, referred to as the full model. 
 
Results 
I. Season of Birth and Adult Morbidity in Six Countries37 
Results from these models are summarized in Table 3.4 and detailed in the following 
text. The main hypothesis tested in these models is whether being born during the autumn 
or monsoon seasons confers a health advantage relative to being born in all other seasons. 
 
South Africa 
South Africa is the only one of the six SAGE countries located in the Southern 
Hemisphere, with its seasons proceeding from summer to spring during the calendar year. 
Table 3.5 Part A presents odds ratios from logistic regression models predicting 
measured health outcomes using autumn as the reference category. Individuals born in 
the autumn appear to be healthiest (the odds ratios for those born in the other seasons 
exceed one for all measured health outcomes). Compared to the autumn-born, those born 
in other seasons have significantly higher odds of falling below the 10th height percentile 
(OR=1.96, M1). These findings are robust to the inclusion of controls including province, 
                                                           
37
 Significant differences refer to significance levels of p<0.05. Borderline significance refers to 
significance levels of p<0.10. 
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education, and father’s education and occupation (M1 vs. M5). When the autumn-born 
are compared to those born in each of the other three seasons separately (Table A3.5 
Part A), we see that in addition to having higher odds of falling below the 10th percentile, 
the summer-born have significantly higher odds of having a high-risk pulse rate and the 
winter-born have significantly higher odds of falling below the 25th height percentile 
compared to the autumn-born in the basic models. The odds ratios reach borderline 
significance for high-risk waist-to-hip ratio (spring vs. autumn).  
For self-reported chronic conditions, we do not observe strong season of birth effects 
(Table 3.5 Part B). Those born in all other seasons have higher odds of reporting 
diabetes, arthritis, and asthma but lower odds of reporting hypertension, angina, stroke, 
and chronic lung disease compared to the autumn-born. The results are highly similar for 
the basic and the full models. In the full models considering a more detailed season of 
birth variable (Table A3.5 Part B), the results for hypertension, angina, and stroke reach 
borderline significance, with the spring-born being less likely to report hypertension and 
angina and the winter-born being less likely to report stroke compared to the autumn-
born. The odds ratios for season of birth do not attain significance in the basic models or 
for the other health outcomes.  
Thus, in South Africa, the results for the measured health outcomes provide weak support 
for a health advantage for the autumn-born relative to those born in other seasons, while 
the results for self-reported chronic conditions are mixed.  
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Ghana 
In Ghana, there is some evidence to support a health advantage among the autumn-born 
for most of the measured health outcomes (Table 3.6 Part A). In general, the odds ratios 
for the other seasons exceed one, with the exceptions of waist-to-hip ratio, pulse rate, and 
height. Those born in all other seasons have significantly higher odds of having high-risk 
diastolic blood pressure (OR=1.46, M1), although this result reaches only borderline 
significance in the full model. Odds ratios for the other measured health outcomes are 
mostly similar in the basic and the full models with the exception of pulse rate and 
height, which are less than one in the basic models but exceed one in the full models. 
Consideration of the more detailed season categorization (Table A3.6 Part A) indicates 
that the finding for diastolic blood pressure is mainly due to a health advantage of the 
autumn-born relative to the summer-born.  
Season of birth is not a significant predictor of any self-reported chronic conditions in 
Ghana (Table 3.6 Part B). Relative to those born in all other seasons, the autumn-born 
experience a health advantage for hypertension (basic and full models) and asthma (full 
model only) but a health disadvantage for diabetes, stroke, angina, and asthma. Results 
from models comparing the autumn-born to those born in each of the other three seasons 
separately indicate that the summer-born have significantly lower odds of reporting 
diabetes than the autumn-born (Table A3.6 Part B). 
In Ghana, there appears to be weak support for a health advantage for the autumn-born 
relative to those born in other seasons for the measured health outcomes. However, there 
is no support for an autumn-born health advantage for self-reported chronic conditions. 
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Russia  
In Russia, the autumn-born experience a health advantage relative to those born in other 
seasons for diastolic blood pressure, pulse rate, and height (Table 3.7 Part A). Compared 
to the autumn-born, those born in other seasons are more likely to fall below the 25th 
height percentile (OR=1.56, M1), but the results reach only borderline significance in 
both the basic and full models. In contrast, those born in other seasons appear to 
experience a health advantage relative to the autumn-born for obesity, waist 
circumference (significant at p<0.10), waist-to-hip ratio, systolic blood pressure (basic 
model only), and overall blood pressure. Results from models using a detailed season of 
birth categorization indicate that the autumn-born are less likely to fall below the 25th 
height percentile relative to the winter-born and are more likely to have high-risk waist 
circumference relative to the winter- and summer-born (all odds ratios significant at 
p<0.05 in both the basic and full models) (Table A3.7 Part A).  
The results for self-reported chronic conditions provide stronger support for an autumn-
born health advantage in Russia (Table 3.7 Part B). Compared to the autumn-born, those 
born in other seasons have higher odds of having diabetes (OR=1.84, M1), angina 
(OR=1.81, M1), and stroke (OR=3.32, M1). For diabetes and angina, the odds ratios are 
significant in both the basic and the full models. For stroke, the odds ratio is borderline 
significant in the basic model and significant in the full model. These results are 
supported by models comparing the autumn-born to those born in each of the other three 
seasons separately, where the odds ratios for those born in the other seasons all exceed 
one (Table A3.7 Part B). Compared to the autumn-born, the spring-born have 
significantly higher odds of diabetes and stroke and the summer-born have significantly 
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higher odds of stroke. Those born in other seasons also have higher odds of having 
hypertension and chronic lung disease relative to the autumn-born, although these results 
do not reach significance in the main models. However, those born in other seasons have 
higher odds of having arthritis and asthma than the autumn-born, although these 
differences are not significant.  
In Russia, the autumn-born experience a health advantage for measured health outcomes 
such as blood pressure and height but not for waist circumference relative to those born 
in all other seasons. An autumn-born health advantage is observed for diabetes, angina, 
and stroke among the self-reported chronic conditions.  
 
Mexico 
In Mexico, the results for measured health outcomes generally support the existence of a 
health advantage for the autumn-born (Table 3.8 Part A). With the exceptions of waist-
to-hip ratio (basic model only), systolic blood pressure, and pulse rate, the autumn-born 
experience a health advantage relative to those born in all other seasons. Compared to the 
autumn-born, those born in other seasons are significantly more likely to fall below the 
25th height percentile (OR=2.53, M1; the odds ratio reaches borderline significance in the 
full model) and more likely to have high-risk waist circumference (the odds ratio reaches 
borderline significance only in the full model). Results from models considering the more 
detailed season of birth variable are similar to those from the main models (Table A3.8 
Part A). Compared to the autumn-born, the winter-born are more likely to fall below the 
10th and 25th height percentiles and the summer-born are more likely to fall below the 25th 
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height percentile (results significant at the 10% level in both the basic and full models in 
nearly all cases). 
In terms of self-reported chronic conditions, however, the picture is more mixed (Table 
3.8 Part B). The autumn-born appear to be better off in terms of hypertension and 
chronic lung disease but not diabetes, stroke, or arthritis. Compared to the autumn-born, 
those born in all other seasons have significantly higher odds of reporting chronic lung 
disease (OR=6.87, M1) in both the basic and full models. However, they have 
significantly lower odds of reporting diabetes (OR=0.41, M1) in both the basic and full 
models and lower odds of reporting stroke (borderline significant in the full model only). 
These findings are supported by results from models comparing the autumn-born to those 
born in each of the other three seasons separately (Table A3.8 Part B). Both the spring- 
and particularly the summer-born have higher odds of reporting chronic lung disease than 
the autumn-born (significant for the summer-born in both the basic and full models and 
borderline significant in the full model for the spring-born). These models indicate that 
those born in each of the other seasons have lower odds of reporting diabetes than the 
autumn-born (all odds ratios are significant in the full models and significant at the 5% 
and 10% levels for summer and winter, respectively, in the basic model).  
In Mexico, the results for the measured health outcomes generally support a health 
advantage for the autumn-born relative to those born in other seasons, but the results for 
self-reported chronic conditions are mixed.  
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China 
In China, the autumn-born appear to be the most unhealthy in terms of measured health 
outcomes (Table 3.9 Part A). With the exception of waist-to-hip ratio, the odds ratios are 
less than one for all other measured health outcomes. Compared to the autumn-born, 
those born in all other seasons have significantly lower odds of having high-risk systolic 
blood pressure (OR=0.80, M1) and overall blood pressure (OR=0.83, M1) in the basic 
and full models. They also have lower odds of being obese, having high-risk waist 
circumference, and having high-risk diastolic blood pressure than the autumn-born 
(results are borderline significant in the basic and full models). Results from models 
comparing the autumn-born to those born in each of the other three seasons separately are 
similar to the main models (Table 3A.9 Part A). Although the winter- and summer-born 
are also better off than the autumn-born for many of the measured health outcomes, the 
spring-born in particular experience a strong health advantage for obesity, systolic blood 
pressure, diastolic blood pressure, and overall blood pressure relative to the autumn-born 
(significant in all basic and full models).  
Results from models for self-reported chronic conditions are mixed but also tend to 
indicate a health disadvantage for the autumn-born (Table 3.9 Part B). Relative to the 
autumn-born, those born in all other seasons are significantly less likely to report having 
hypertension (OR=0.89, M1; the odds ratio is borderline significant in the full model) and 
less likely to report having diabetes, angina, or asthma. However, those born in other 
seasons are more likely to report having stroke, chronic lung disease, or arthritis 
compared to the autumn-born. Results from models using a more detailed season of birth 
categorization are consistent with those from the main models (Table A3.9 Part B). 
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Compared to the autumn-born, the spring-born have significantly lower odds of reporting 
hypertension in the basic and full models, and the winter-born have borderline 
significantly lower odds of reporting hypertension in the basic and full models.   
In China, I find no support for an autumn-born health advantage for either measured or 
self-reported adult health outcomes. It is unclear why the season of birth pattern may be 
different in China, but looking across different cohorts, provinces, and urban/rural status 
may help to shed light on these results. 
 
 India 
In India, individuals born during the monsoon appear to be healthiest in terms of 
measured health outcomes compared to those born in all other seasons (Table 3.10 Part 
A). The odds ratios for those born in the other seasons exceed one for almost all 
measured health outcomes. The exceptions are obesity defined using the lowest alternate 
cutpoint (≥23 kg/m2) and high-risk waist circumference defined using both of the 
alternate cutpoints, although these differences are not significant. Compared to those born 
during the monsoon, those born in all other seasons are significantly more likely to meet 
the high-risk cutpoints for both systolic and diastolic blood pressure (OR=1.59, M1) in 
both the basic and full models. They are also more likely to have high-risk systolic blood 
pressure (borderline significant in the basic model), high-risk diastolic blood pressure 
(borderline significant in the basic and full models), and high-risk pulse rate (borderline 
significant in the basic and full models). Models comparing those born in the monsoon 
season to those born in the winter, summer, and post-monsoon seasons separately 
indicate that this disadvantage is mostly concentrated among individuals born in the 
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summer and, to a lesser extent, in the winter (Table A3.10 Part A). Compared to those 
born during the monsoon season, those born in summer have significantly higher odds of 
having high-risk overall blood pressure (significant in the basic model borderline 
significant in the full model) and high-risk pulse rate (significant in both the basic and 
full models). They also have higher odds of having high-risk systolic blood pressure and 
diastolic blood pressure (borderline significant in the basic models). The winter-born also 
have higher odds of having high-risk overall blood pressure (significant at the 10% level 
in the basic model and at the 5% level in the full model).  
 For the self-reported chronic conditions, the results are more mixed, although there is 
general support for a health advantage for individuals born during the monsoon season 
(Table 3.10 Part B). Compared to those born during the monsoon, those born in all other 
seasons have higher odds of reporting hypertension, angina (full model only), stroke 
(OR=3.38, M1; significant in the basic model only), chronic lung disease (OR=2.35, M1; 
significant in the basic model and borderline significant in the full model), and asthma 
(borderline significant in the full model only). However, they have lower odds of 
reporting angina (basic model only), diabetes (OR=0.58, M1; significant in the basic and 
full models), and arthritis. Models using a more detailed categorization for season of birth 
indicate that the summer-born are particularly disadvantaged in terms of chronic lung 
disease (significant in the basic and full models) (Table 3.10 Part B). The winter-born 
have higher odds of reporting stroke (significant at the 5% level in the basic model and at 
the 10% level in the full model) and lower odds of reporting diabetes relative to those 
born during the monsoon season (significant in the basic and full models). Those born 
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during the post-monsoon season have lower odds of reporting diabetes relative to those 
born during the monsoon season (significant only in the full model).  
Thus, in India, those born during the monsoon appear to experience a health advantage 
for measured health outcomes and for some of the self-reported chronic conditions, 
particularly compared to those born during the summer.  One potential explanation for 
the health advantage of those born during the monsoon season is that those born during 
the winter and summer seasons would have been exposed to the highest temperatures of 
the year and monsoon conditions shortly after birth. During the 1920s-1930s in India, 
cholera deaths peaked in the monsoon season, while plague deaths and smallpox cases 
clustered in the winter and summer months (Figures 3.1-3.3; Public Health 
Commissioner of India 1937). 
 
II. Pre- and Postnatal Climate Conditions and Adult Morbidity in India 
I now discuss results from models using climate conditions in an 18-month window 
around birth to predict measured and self-reported health outcomes in India. The main 
hypotheses being tested in these models is whether more rainfall and higher temperatures 
during the gestational and post-birth periods are associated with adult morbidity. Models 
are estimated separately for the gestational and post-birth periods. I present results from 
models based on the sample of individuals with complete data on all predictor variables 
of interest and who report always having lived in their current place of residence to 
ensure that the climate conditions correspond to those experienced by the respondents 
around the time of birth. In the summary of the results, I focus on the health outcomes 
hypothesized to most strongly connected to early life conditions (e.g., height, risk factors 
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for or types of cardiovascular disease, and respiratory disease) although all of the health 
outcomes are included in the results tables. 
 
A. Rainfall Conditions and Adult Morbidity in India 
Results from these models are summarized in Table 3.11 and detailed in the following 
text. The main hypothesis being tested in these models is whether higher levels of rainfall 
in an 18-month window around birth are associated with adult morbidity in India. 
  
Gestation 
Barker’s fetal origins hypothesis is the main theory regarding the effects of exposures 
experienced in utero and later life health outcomes. According to this theory, the main 
pathway connecting early life exposures and adult health is nutrition (although it has also 
been used in studies considering the long-term impacts of in utero exposure to the 
influenza pandemic), and the outcomes we would expect to be most strongly affected by 
adverse conditions during gestation are cardiovascular disease and height.   
More rainfall during each of the three trimesters increases the odds that an individual falls 
below the 10th and 25th height percentiles (Table 3.12 Part A). For falling below the 10th 
height percentile, the odds ratios for rainfall in the second trimester are borderline 
significant in the basic and full models, and the odds ratio for rainfall in the third 
trimester is borderline significant in the basic model. For falling below the 25th height 
percentile, the odds ratios for rainfall in the second trimester are significant at the 5% 
level in the basic model and at the 10% level in the full model, and the odds ratio for 
rainfall in the third trimester is significant at the 5% level in the basic model. 
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Among the measured health outcomes, obesity, waist circumference, waist-to-hip ratio, 
and blood pressure are risk factors for cardiovascular disease.  In general, higher amounts 
of rainfall during gestation appear to be favorable for these adult health outcomes (e.g., 
the odds ratios are less than one), although the results are sensitive to the high-risk 
cutpoints used for obesity and waist circumference. More rain in the third trimester is 
only a significant predictor of obesity (in both the basic and full models) when it is 
defined as ≥BMI of 25 kg/m2. More rain in the first and third trimesters has the strongest 
association with high-risk waist circumference using the lowest cutpoint for waist 
circumference (specification c in Table 3.12 Part A). Finally, higher amounts of rainfall 
in the third trimester are associated with significantly lower odds of having high-risk 
systolic, diastolic, and overall blood pressure in the full models (the odds ratios are 
borderline significant in the basic models for diastolic and overall blood pressure).   
Among the self-reported chronic conditions, hypertension, diabetes, angina, and stroke 
are risk factors for or types of cardiovascular disease. There is no clear pattern of 
advantage or disadvantage associated with higher rainfall levels for these health 
outcomes (Table 3.12 Part B). Significant associations are observed only for rainfall in 
the third trimester and hypertension in the full model and rainfall in the first trimester and 
diabetes in the full model, where higher rainfall levels are associated with lower odds of 
reporting these conditions.  
 
 Post-Birth 
 In the post-birth period, infectious diseases (and the synergy between infection and 
nutrition) are considered to be the most important early life exposures associated with 
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later life health outcomes. Thus, we may expect to see the strongest influences on height, 
a measure of childhood disease and nutritional conditions; chronic lung disease, which 
may be related to early respiratory infections; and the risk factors for and types of 
cardiovascular disease discussed above, which may result from chronic inflammation due 
to childhood infections.  
Higher levels of rainfall in the post-birth period are generally unfavorable for the 
measured health outcomes (Table 3.12 Part A). Higher levels of rainfall during the first 
1-3 months after birth are associated with significantly increased odds of falling below 
the 25th height percentile in the basic model (OR=1.70, M1), and higher levels of rainfall 
during the first 7-9 months after birth are associated with significantly increased odds of 
falling below the 25th height percentile in the basic and full models (OR=2.01, M1). 
Among the measured health outcomes that pertain to cardiovascular disease, the most 
consistent associations are observed for blood pressure and waist-to-hip ratio. Higher 
levels of rainfall during the first 1-3 months after birth (significant in the basic model 
only) and the first 7-9 months after birth (significant in the basic model, borderline 
significant in the full model) are associated with higher odds of having high-risk waist-to-
hip ratio. Higher levels of rainfall during the first 4-6 months after birth are significantly 
associated with higher odds of having high-risk systolic, diastolic, and overall blood 
pressure in the basic models (odds ratios are borderline significant for diastolic and 
overall blood pressure in the full models). Rainfall during the post-birth period is only 
significantly associated with obesity defined as a BMI ≥30 kg/m2 and is not significantly 
associated with any of the three waist circumference measures. 
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Among the self-reported chronic conditions, we may expect to see stronger associations 
between rainfall and chronic lung disease, hypertension, diabetes, angina, and stroke. 
Similar to the case for rainfall during the gestational period, we do not observe strong 
associations between rainfall during the post-birth period and self-reported chronic 
conditions (Table 3.12 Part B). The odds ratios for these health outcomes are not 
consistently less than or greater than one. The only significant association is observed 
between rainfall in the first 7-9 months after birth and angina in the basic model 
(OR=0.24, M1).   
I also estimate models which include both season of birth and rainfall conditions as 
predictors of adult health outcomes (results not shown). In these models, season of birth 
is generally not a significant of measured health outcomes, and the associations between 
rainfall and adult morbidity are largely robust to the inclusion of season of birth as a 
predictor variable.  
  
B. Temperature Conditions and Adult Morbidity in India 
Results from models examining the associations between minimum temperature 
conditions in an 18-month window around birth and adult morbidity are summarized in 
Table 3.13 and detailed in the following text. The main hypothesis being tested in these 
models is whether higher temperatures during the gestational and post-birth periods are 
associated with adult morbidity in India. 
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Gestation 
Similar to the hypotheses for rainfall, we may expect temperatures in gestation to be most 
strongly related to cardiovascular disease and height. Among the measured health 
outcomes, the most consistent associations are observed for height and, to a lesser extent, 
blood pressure (Table 3.14 Part A). Higher temperatures during gestation are uniformly 
unfavorable for height (odds ratios for temperatures in all trimesters exceed one in both 
the basic and full models). Higher temperatures during the first and third trimesters are 
associated with significantly higher odds of falling below the 10th height percentile in the 
basic models (significant at the 10% level in the full model for temperature in the first 
trimester and at the 5% level in the full model for temperature in the third trimester). 
Higher temperatures during the first and third trimesters are associated with significantly 
higher odds of falling below the 25th height percentile in the basic models only. For blood 
pressure, there is some evidence that higher temperatures during the first trimester may 
be unfavorable for systolic and overall blood pressure (significant at the 5% level in the 
basic models only), but results are mixed for higher temperatures during the other 
trimesters and for diastolic blood pressure. Temperatures during gestation do not appear 
to be associated with waist-to-hip ratio or any of the measures of obesity or waist 
circumference.  
Among the self-reported chronic conditions, there is weak support for the influence of 
temperature during gestation and conditions related to cardiovascular disease (Table 3.14 
Part B). The odds ratios for temperature in all three trimesters exceed one for angina and 
stroke, although the odds ratios are only significant for first trimester temperature and 
stroke (significant in the basic model and borderline significant in the full model). The 
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results are more mixed for hypertension and diabetes, although higher temperatures 
during the first trimester are associated with significantly higher odds of reporting 
hypertension in the basic model only.   
 
Post-Birth 
In the post-birth period, we are most interested in the associations between temperature 
and height, chronic lung disease, and risk factors for and types of cardiovascular disease.  
As was the case with temperatures during gestation, temperatures during the post-birth 
period are most strongly associated with height and blood pressure among the measured 
health outcomes (Table 3.14 Part A).  For these outcomes, the odds ratio for 
temperatures during all of the three post-birth periods exceed one. Higher temperatures 
during the first 7-9 months after birth are significantly associated with falling below the 
10th (OR=1.14, M1) and 25th (OR=1.11, M1) height percentiles in both the basic and full 
models. The odds ratio for temperature during the first 1-3 months after birth is 
borderline significant for falling below the 25th height percentile in the basic model only 
(OR=1.08, M1). For blood pressure, most, but not all, of the odds ratios for temperatures 
in the three post-birth periods are greater than one. Higher temperatures during the first 4-
6 months after birth are associated with significantly higher odds of having high-risk 
overall blood pressure in the basic and full models (OR=1.05, M1). The odds ratios for 
temperature during the first 4-6 months after birth are significant and borderline 
significant in the basic models for systolic and diastolic blood pressure, respectively. 
Temperatures during the post-birth period do not appear to be associated with waist-to-
hip ratio or any of the measures of obesity or waist circumference. 
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For the self-reported chronic conditions, it is unclear whether higher temperatures in the 
post-birth period are favorable or unfavorable for adult morbidity (Table 3.14 Part B). 
Temperature in any of the post-birth periods is not a significant of hypertension, diabetes, 
or angina, and there is no clear pattern to the odds ratios. However, higher temperatures 
in all three post-birth do appear to be associated with higher odds of reporting stroke. The 
results are significant for temperature in the first 4-6 months after birth in both the basic 
and full models (OR=1.16, M1) and borderline significant for temperature in the first 1-3 
and 7-9 months after birth in the basic models. In contrast, higher temperatures appear to 
be associated with lower odds of reporting chronic lung disease. The odds ratios are 
significant for temperature in the first 7-9 months after birth (OR=0.83, M1) in both the 
basic and full models and borderline significant for temperature in the first 1-3 months 
after birth in the basic model only. 
I also estimate models which include both season of birth and temperature conditions as 
predictors of adult morbidity (results not shown). In these models, season of birth is 
generally not a significant predictor of measured health outcomes, and the associations 
between temperature and adult morbidity are largely robust to the inclusion of season of 
birth as a predictor variable.  
 
III. Climate Conditions in the First Five Years After Birth and Shocks in Pre- and 
Postnatal Climate Conditions and Adult Morbidity in India 
I conducted a number of supplementary analyses examining whether climate conditions 
up to 60 months after birth are associated with adult health outcomes, and whether 
additional insights can be gleaned from investigating the impacts of pre- and postnatal 
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climate shocks on adult morbidity. This resulted in a very large set of results, in which 
the most consistent associations were generally observed for height and blood pressure 
measure. Instead of detailing all of these results, I discuss three cases that are best 
motivated by the theories and existing literature on early life exposures on adult health.  
 
a. Rainfall Shocks During Gestation 
During the gestational period, insufficient rain during the monsoon months is associated 
with worse adult health outcomes for all three blood pressure measures.38 Insufficient 
rain is defined as when a given month fell during the monsoon season and when rainfall 
during that month fell below the 10th percentile observed for that particular month and 
district over the period 1901-2002. The predictor variable of interest here is the fraction 
of each trimester for which monsoon rains were abnormally low (e.g., a failed monsoon), 
with possible values ranging from 0-1 in increments of 1/3.  
Insufficient monsoon rains during all three trimesters are associated with higher odds of 
falling in the high-risk categories for systolic, diastolic, and overall blood pressure. The 
odds ratios are significant at the 5% level for all trimesters in the basic models except for 
insufficient monsoon rains during the first trimester, which is significant at the 10% level. 
The odds ratios are at least borderline significant for nearly all trimesters in the full 
models. The strongest effects are observed for insufficient monsoon rains during the third 
trimester. Experiencing one month of insufficient monsoon rains during the third 
trimester is significantly associated with two- to three-fold increases in the odds of 
having high-risk blood pressure (systolic: OR=3.04, M1; diastolic: OR=2.01, M1; 
                                                           
38
 Insufficient monsoon rains do not display consistent associations with other health outcomes.  
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overall: OR=2.84, M1). Given that failed monsoon rains are likely to have a substantial 
negative impact on the harvest and that the third trimester is considered by many to be the 
period of peak growth, these results are consistent with the Barker hypothesis that 
adverse nutritional conditions in utero may be related to an increased risk of 
cardiovascular disease in adulthood.  
 
b. Rainfall Shocks in the First Five Years After Birth 
Excess rain during the post-birth period is associated with worse adult health outcomes 
for height and diastolic blood pressure.39 Excess rain experienced during the 1st year (1-
12 months) and 3rd year (24-36 months) after birth is associated with worse adult health 
outcomes for diastolic blood pressure and height, respectively.40 Each model uses five 
12-month measures of excess rain to predict adult health outcomes, where the other 
controls in the basic and full models are as described above. Excess rain is defined as the 
fraction of each 12-month period when rainfall exceeded the 90th percentile of rainfall 
observed for the particular month and district over the period 1901-2002 (thus, the 
possible values range from 0-1 in increments of 1/12).  
Excess rain during the 1st year is significantly associated with high-risk diastolic blood 
pressure in both the basic and full models. Experiencing rainfall above the 90th percentile 
in one month during the 1st year is associated a 29% increase in the odds of having high-
risk diastolic blood pressure in the basic model (M1). Excess rain during the 3rd year is 
associated with higher odds of falling below the 10th (odds ratios are significant in the 
basic and full models) and 25th (odds ratios are borderline significant in the basic and full 
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 Excess rain during the post-birth does not display consistent associations with other health outcomes.  
40
 Odds ratios for the other 12-month periods are not significant. 
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models) height percentiles. Experiencing rainfall above the 90th percentile in one month 
during the 3rd year is associated with a 39% increase in the odds of falling below the 10th 
height percentile in the basic model (M1). These results are highly similar to results from 
models that use total rainfall (rather than rainfall shocks) in each of the five 12-month 
periods to predict height and blood pressure in adulthood.41  
While data on the duration of breastfeeding are scarce for the period when individuals in 
this sample were born, the earliest available estimates for India from the 1940s and 1950s 
suggest that breastfeeding lasted for approximately 2 years (see the Discussion section 
below for more detail). The associations between excess rainfall shocks in the 3rd year 
and height suggest that environmental conditions may take on increased importance 
during the weaning or immediate post-weaning period. 
 
c. Temperature Shocks in the First Five Years After Birth 
The third case considers the impact of exceptionally hot summers during the first 60 
months after birth. In this case, a temperature shock is defined as occurring when the 
minimum temperature in a particular month and district exceeded the 90th percentile for 
minimum temperature observed for that month and district over the period 1901-2002. 
The predictor variable of interest here is the fraction of the summer months in a given 
year that were abnormally hot, with possible values ranging from 0-1 in increments of 
                                                           
41
 These models indicate that higher levels of rainfall in the first year are associated with higher odds of 
having high-risk diastolic blood pressure and that higher levels of rainfall in the first 25-36 months after 
birth are associated with higher odds of falling below the 10th and 25th height percentiles (results are at least 
borderline significant in all basic and full models). 
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1/3. Exceptionally hot summers in the 1st year (1-12 months) and 2nd year (13-24 months) 
after birth are associated with higher odds of falling below the lowest height percentiles.42 
Exceptionally hot summers in the 2nd year after birth are associated with significantly 
higher odds of falling below the 10th height percentile in both the basic and full models. 
Exceptionally hot summers in the 1st year and 2nd year after birth are associated with 
higher odds of falling below the 25th height percentile (significant at the 5% and 10% 
levels only in the full models, respectively). Based on the existing literature, two 
pathways that are likely to connect high summer temperature shocks in first 24 months 
after birth and adult height are: (1) the contribution of higher summer temperatures to 
food spoilage and increased infections during the weaning period (e.g., diarrheal 
diseases) and (2) the contribution of higher summer temperatures to ideal conditions for 
the transmission of vector-borne diseases (e.g., malaria, dengue, and other mosquito-
borne diseases).  
 
Discussion  
Researchers have become increasingly interested in the impacts of early life conditions 
on later life morbidity, socioeconomic outcomes, and mortality, motivated in part by 
growing importance of chronic disease as a major cause of morbidity and mortality 
worldwide. In general, studies have found support for long-term negative health 
consequences of pre- and postnatal exposure to infectious diseases, including the 1918 
influenza pandemic. Findings from studies examining the effects of prenatal exposure to 
famines are mixed, with some studies finding no long-term impacts and others 
                                                           
42
 For height, odds  ratios for the other 12-month periods are not significant. Excess summer temperatures 
during the post-birth period do not display consistent associations with other health outcomes. 
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documenting adverse impacts on adult morbidity and mortality. The main pathways 
theorized to connect these early life conditions and later life health outcomes are 
physiological changes that occur in response to unfavorable nutritional conditions in 
utero (developmental plasticity) and physiological scarring and chronic inflammation due 
to infectious diseases (Barker 1995; Elo and Preston 1992; Finch and Crimmins 2004). 
Among the outcomes hypothesized to be most strongly linked to early life exposures, the 
most consistent associations have been observed between early life conditions and later 
life height, cardiovascular disease, respiratory disease, and mortality.  
Data on early life exposures are often scarce, leading some researchers to focus on season 
of birth as a proxy for environmental exposures that influence early life nutrition and 
exposure to infectious diseases. Several studies have documented season of birth patterns 
in developed countries indicating a longevity advantage for those born in the autumn 
relative to those born in all other seasons. To the best of my knowledge, however, no 
studies have systematically examined whether these season of birth patterns exist in 
developing countries.  
In this chapter, I examined whether season of birth is associated with adult morbidity in 
six developing and newly industrialized countries: India, China, Ghana, Mexico, Russia, 
and South Africa. I also tested whether environmental exposures (rainfall and 
temperature) experienced around the time of birth have a direct influence on adult 
morbidity in India. Climate exposures are hypothesized to have strong effects on the 
infectious disease environment and nutrition early in life, particularly in developing 
countries.  
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Season of Birth and Adult Morbidity 
Studies in developed countries (e.g., Doblhammer and Vaupel 2001, Doblhammer 2004, 
and Gavrilov and Gavrilova 2011) have documented an autumn-born longevity 
advantage. The health advantage of the autumn-born is hypothesized to be related to the 
harvest season and the availability of food, as maternal nutrition during the third trimester 
is generally expected to be better for those born in the autumn and early winter compared 
to those born in spring and early summer (Doblhammer 2004). In addition, the incidence 
of infectious disease varies seasonally. 
In this chapter, I consider whether season of birth patterns in adult morbidity exist in 
developing countries. The findings from these analyses (summarized in Table 3.4) are 
inconclusive. I do not find evidence of strong season of birth patterns in adult morbidity 
in the six countries considered in these analyses. In these models, the coefficients rarely 
reach statistical significance and at times the effects are not in the expected direction. 
This may be related to limited power due to small sample sizes, the consideration of 
different adult health outcomes compared to earlier studies (e.g., morbidity versus 
mortality), or different processes operating in developing versus developed countries. 
Compared to the United States and other Western European countries for which an 
autumn-born longevity advantage has been documented, the countries considered in this 
chapter may have very different climates and seasonal patterns in disease incidence and 
agricultural production. It is possible that future studies may be able to further explore 
whether season of birth patterns exist in developing countries. 
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Pre- and Postnatal Rainfall and Temperature Conditions and Adult Morbidity 
In the second set of analyses, I examine whether rainfall and temperature conditions 
during the pre- and post-birth periods affect adult health outcomes in India. These results 
are summarized in Tables 3.11 and 3.13 for rainfall and temperature, respectively. I find 
that rainfall and temperature conditions around the time of birth are most strongly 
associated with adult height and blood pressure, two of the outcomes we would expect to 
be most related to early life exposures. Height is a measure of disease and nutritional 
conditions in childhood, and high blood pressure is a risk factor for cardiovascular 
disease. The results are more consistent for measured health outcomes than for self-
reported chronic conditions. Supplementary cases provide support for the importance of 
environmental conditions influencing nutrition in utero and influencing the disease 
environment during the weaning period. 
 
Rainfall 
During the gestational period, higher amounts of rainfall appear to be somewhat 
beneficial for blood pressure but deleterious for height. The most consistent associations 
are observed between rainfall during the third trimester and adult morbidity. Although 
higher amounts of rainfall during gestation are associated with lower odds of high-risk 
blood pressure in the main models, supplementary analyses indicate that exposure to 
failed monsoon rains during gestation is associated with higher odds of high-risk blood 
pressure. Similarly, the effects are strongest for failed monsoon rains experienced during 
the third trimester, the period of peak fetal growth. Failed monsoon rains are likely to 
have a substantial negative impact on agricultural production. In 2002, for example, the 
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drought caused by failed monsoon rains resulted in a 7.2% contraction in the agricultural 
sector and a 2% decline in GDP growth (“Monsoon Blues” 2009). The finding that failed 
monsoon rains during gestation are associated with adverse later life outcomes for blood 
pressure is consistent with the hypothesis that adverse nutritional conditions in utero are 
related to an increased risk of cardiovascular disease in adulthood (Barker 1995). 
 During the post-birth period, higher levels of rainfall are consistently associated with 
worse health outcomes for height, blood pressure, and waist-to-hip ratio. One possible 
mechanism that may be operating here is that higher levels of rainfall contribute to 
greater infectious and parasitic disease exposure in early life, which in turn lead to greater 
adult morbidity through scarring and chronic inflammation. This possibility is supported 
by supplementary analyses examining the importance of climate conditions during an 
extended post-birth window, discussed below.  
 
 Temperature 
 With very few exceptions, higher temperatures around the time of birth are 
associated with worse adult health outcomes. During gestation, higher temperatures are 
associated with higher odds of having high-risk blood pressure and higher odds of falling 
below the lowest height percentiles. These associations are generally most consistent for 
conditions experienced during the first and third trimesters. It is possible that higher 
temperatures during gestation may influence maternal stress, infection, and nutrition.  
During the post-birth period, higher temperatures are also associated with higher odds of 
having high-risk blood pressure and higher odds of falling below the lowest height 
percentiles. These associations are stronger in the later two post-birth periods (4-6 and 7-
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9 months after birth) than in the earliest post-birth period. The most likely explanation for 
these associations are the contribution of higher temperatures to diarrheal disease and 
other gastrointestinal infections through food spoilage and to the spread of vector-borne 
diseases. 
 
 Temperature and Rainfall Shocks During the First Five Years After Birth 
I also examine whether temperature and rainfall conditions during the first 60 months 
after birth are associated with adult health outcomes. I find that abnormally high levels of 
rainfall during the third year and abnormally high summer temperatures during the 
second year after birth are associated with significantly higher odds of falling below the 
lowest height percentiles. These findings provide suggestive evidence of the increased 
importance of environmental conditions during the weaning period. 
Estimates of the duration of breastfeeding in India, especially for the period prior to the 
1960s, are scarce. According to Visaria, Visaria, and Jain (1995), even at present, few 
surveys in India have collected information on breastfeeding. However, the majority of 
the literature indicates that up until very recently, breastfeeding in India was considered 
to be universal and quite lengthy in duration, typically lasting up until the next pregnancy 
(Jain and Adlakha 1982; Nath, Land, and Singh 1994; Visaria 2004; Visaria, Visaria, and 
Jain 1995). The earliest period estimates suggest that the average duration of 
breastfeeding was approximately two years. Based on observation of a village in 
Karnataka, Caldwell, Reddy, and Caldwell (1982) state that “in the 1940s, only women 
who had no milk or were very sick failed to breastfeed for two years, and many did so for 
three to five years” (694). Other estimates from 1958 and 1959, the first based on patients 
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in a birth control clinic in Bombay and the second on 11 villages in Punjab, placed the 
mean duration of lactation at 21 and 19.8 months, respectively (Peters et al. 1958; Potter 
et al. 1965). One study from 1957-1969 found the average duration of breastfeeding to be 
28 months (Rao and Mathen 1970).  
Given that the average duration of breastfeeding has tended to decline over time in 
developing countries, estimates from more recent periods may serve as lower bounds. 
From their review of data from six studies covering both rural and urban areas in several 
regions of India conducted during the 1960s and 1970s, Jain and Adlakha (1982) 
concluded that the average duration of breastfeeding during the 1970s was 20-22 months. 
Estimates of the average duration of breastfeeding from the six studies ranged from 19.6-
30.3 months (Ibid.). A 1967 study based in rural Uttar Pradesh estimated the average 
duration of breastfeeding to be 22.6 months (Visaria, Visaria, and Jain 1995). Estimates 
from 1981-1982 suggest that breastfeeding lasted 21.8 and 22.9 months in urban and 
rural areas of Rajasthan, respectively, and 23.8 and 28.6 months in urban and rural areas 
of Orissa, respectively (Ibid.). 
More recently, data from a 1992 survey indicated that children in rural West Bengal and 
an urban slum in Calcutta were breastfed for 12-15 and 20-23 months, respectively (Sen 
and Biswas 1993). Even through the late 1990s, the duration of breastfeeding seems to 
have been quite long. Visaria (2004) estimated the median duration of breastfeeding to be 
25.4 months. Although urban women had shorter durations of breastfeeding than rural 
women, on average the median duration of breastfeeding among urban women was still 
in excess of 21 months. Data from the National Family Health Survey 1998-9 indicate 
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that for the six states included in this analysis, estimates of the duration of breastfeeding 
ranged from 20 months in Karnataka to 36 months in Assam (Ibid.). 
Since breastfeeding is combined with the introduction of solid foods and other 
supplements as the child ages, ideally we would like to have estimates of the average 
duration of exclusive breastfeeding. According to Visaria (1988), “Women continue to 
feed their children for up to 24-36 months, and do not introduce supplementary foods 
very systematically,” although supplementary milk (diluted with water) may be 
introduced around 6 months (86). A study in 1982 of low-income women in Hyderabad 
found that the total duration of lactation was 21.4 months, but exclusive breastfeeding 
lasted for 8.9 months (Prema and Ravindranath 1982).  
Overall, these studies suggest that breastfeeding may have lasted for roughly 2 years for 
the individuals in my sample. With regards to the findings from my analyses, it is striking 
that rainfall and temperature conditions in the weaning or post-weaning period (in the 
second and third years after birth) show strong associations with height, a marker of 
infectious disease and nutritional conditions during childhood. The associations observed 
between rainfall and temperature conditions during the 4-6 month and 7-9 month post-
birth periods and blood pressure and height in adulthood may reflect the end of exclusive 
breastfeeding, the introduction of weaning foods, and waning protection from maternal 
antibodies, all of which would result in increased susceptibility to infectious and parasitic 
diseases in childhood. For example, Motarjemi et al. (1993) noted the relationship 
between higher ambient temperatures and the contamination of weaning foods, which in 
turn are strongly associated with diarrheal disease and malnutrition among children. In 
addition, based on longitudinal studies conducted in Matlab, Bangladesh, Black et al. 
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(1982) found that 41% of samples of food fed to children of weaning age and 50% of 
drinking water specimens contained E. coli. The proportion of children’s food samples 
containing E. coli was strongly associated with incidence of diarrheal disease, and higher 
E. coli levels were related to cooked foods stored at higher temperatures (Ibid.).  
 
Robustness of the Results 
In general, results summarized above are robust to the inclusion of controls for district of 
residence, education, and father’s occupation and education (all models control for age 
and sex). Additional analyses indicate that the findings are also robust to controlling for 
race in South Africa and religion in each of the six countries. For countries located in the 
Northern Hemisphere, autumn is defined as occurring from September-November. 
Results from models in which autumn is defined as occurring from October-December 
are highly similar to those presented here.  
Although I also explored whether interactions between father’s occupation and season of 
birth and interactions between father’s occupation and climate conditions around the time 
of birth are significant predictors of adult morbidity, the results from these models did not 
show a clear pattern. In addition, these interactions rarely reached statistical significance. 
 
Limitations 
There are a number of important limitations to this study. First, I necessarily rely on the 
accuracy of respondents’ reporting of their month and year of birth, and age misreporting 
may be an issue for these samples. In addition, the proportions of the total samples who 
report their month of birth vary by country and may result in a select sample (e.g., a 
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lower fraction of women than men report their month of birth in India and Ghana). 
However, it is unlikely that nonresponse to the month of birth question varies 
systematically by month of birth (e.g., individuals born in June should not be any less 
likely to report their month of birth than individuals born in December). Measurement 
error in month of birth is thus expected to be mean zero; generally, this should result in 
attenuation bias and the estimates may be considered conservative (Stefanski and Carroll 
1985).  
In addition, it is uncertain how and to what extent these patterns may be influenced by 
selective survival to age 50.43 For example, if we expect certain seasons to be particularly 
unfavorable for infant survival and survival to age 50, we may expect that individuals 
who were born in those seasons and who survive to age 50 may be particularly hardy. In 
contrast, if being born in certain seasons is health-promoting, the group of individuals 
who were born in those seasons and who survive to age 50 may be more heterogeneous in 
terms of frailty. However, given that being born in autumn is considered to be most 
favorable for early and later life health outcomes, we would expect the group of autumn-
born survivors to be more heterogeneous than the hardier survivors born in other seasons 
and that any health advantage for the autumn-born should be muted at older ages. 
However, I still observe a consistent health advantage in adult morbidity for the autumn-
born in most countries. It is also possible that there may be countervailing effects which 
cancel out on average (e.g., if both acquired immunity and scarring are operating), 
resulting in null findings.  
                                                           
43
 The month of birth distributions for the six analytical samples in the season of birth models are shown in 
Figure A3.1. 
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Finally, data limitations result in fairly small sample sizes for some countries (e.g., 
Ghana, Mexico). Although many of the associations are in the hypothesized direction, 
they do not always reach significance. It may be the case that there is insufficient power 
to detect more robust relationships between the predictor variables of interest and health 
outcomes.  
 
Conclusion 
In this chapter, I examined the associations between early life conditions, captured by 
season of birth and climate conditions experienced around the time of birth, and both 
measured and self-reported adult health outcomes. In the first part of the analysis, I do 
not find strong season of birth patterns in adult morbidity in the six developing and newly 
industrialized countries considered in this chapter (China, Ghana, India, Mexico, Russia, 
and South Africa).  
In the second part of the analysis, I find evidence that both pre- and postnatal rainfall and 
temperature conditions are associated with adult morbidity in India. The most consistent 
associations are observed for height and blood pressure, two adult health outcomes we 
would expect to be most strongly related to early life exposures based on the existing 
literature. While more rainfall is associated with both beneficial and deleterious adult 
health outcomes, higher temperatures are nearly always associated with worse adult 
health outcomes. Furthermore, supplementary analyses examining rainfall and 
temperature shocks and extending the post-birth observation window through 5 years 
support the importance of nutritional conditions during gestation and infectious disease 
exposure during the weaning period.  
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Tables 
Table 3.1. Four-Category Season of Birth Classifications 
 
China, Ghana, 
Mexico, Russia South Africa India 
January Winter Summer Winter February 
March 
Spring Autumn Summer April 
May 
June 
Summer Winter Monsoon July August 
September 
Autumn Spring October 
Post Monsoon November 
December Winter Summer 
 
 
Table 3.2. Hypotheses for the Associations Between Season of Birth and Environmental 
Exposures and Adult Health 
Variable of Interest Expected Association with Adult Health 
Season of Birth (China, Ghana, India, Mexico, Russia, South Africa) 
Autumn vs. All other Better 
Monsoon vs. All other Indeterminate 
 
 
Environmental Exposures (India)  
I. Rainfall 
   a. Higher levels 
   b. Shocks 
       ≥ 90th percentile during monsoon 
       ≤ 10th percentile during monsoon 
 
Indeterminate 
 
Worse 
Worse 
II. Minimum temperature  
   a. Higher levels 
   b. Shocks 
       ≥ 90th percentile during summer 
 
Worse 
 
Worse 
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Table 3.3. Measured Health Outcomes and High-Risk Cutpoints 
Measure High-Risk Cutpoint Source 
Body mass index (BMI)44 a. BMI ≥ 30 kg/m2 1 
      India 
 
b. BMI ≥ 25 kg/m2 
c. BMI ≥ 23 kg/m2 
2 
3 
Waist circumference a. > 102 cm (M), > 88 cm (F) 4 
      India 
 
b. ≥ 90 cm (M), ≥ 80 cm (F) 
c. ≥ 87 cm (M), ≥ 82 cm (F) 
2 
3 
Waist-to-hip ratio > 0.90 (M), > 0.85 (F) 5 
Systolic blood pressure25 > 140 mm Hg 6 
Diastolic blood pressure45 > 90 mm Hg 6 
Blood pressure25 > 140 mm Hg systolic and > 90 mm Hg diastolic 6 
Pulse rate25 ≥ 90 beats/min 5 
Height, ≤10th percentile China: ≤ 1.555 m (M), 1.46 m (F) 
Ghana: ≤ 1.55 m (M), ≤ 1.49 m (F) 
India: ≤ 1.545 m (M), ≤ 1.418 m (F) 
Mexico: ≤ 1.568 m (M), ≤ 1.426 m (F) 
Russia: ≤ 1.62 m (M), ≤ 1.52 m (F) 
South Africa: ≤ 1.56 m (M), ≤ 1.49 m (F) 
 
Height, ≤25th percentile China: ≤ 1.6 (M) m (M), ≤ 1.5 m (F) 
Ghana: ≤ 1.61 m (M), ≤ 1.533 m (F) 
India: ≤ 1.587 m (M), ≤ 1.461 m (F) 
Mexico: ≤ 1.593 m (M), ≤ 1.443 m (F) 
Russia: ≤ 1.68 m (M), ≤ 1.55 m (F) 
South Africa: ≤ 1.5 m (M), ≤ 1.44 m (F) 
 
 Sources: (1) WHO (2013); (2) WHO (2000) and Misra et al. (2006); (3) Mohan et al. (2007); (4) NHLBI;      
(5) Seeman et al. (2008); (6) Crimmins et al. (2005). 
  
                                                           
44
 Calculated from respondents’ measured height and weight. 
45
 Calculated from the average of three measurements taken. 
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Table 3.4. Summary of Results from Logistic Regression Models Using Season of Birth (Autumn vs. All other or Monsoon vs. All 
other) to Predict Measured Health Outcomes (Part A) and Self-Reported Chronic Conditions (Part B), Males and Females Aged 50+, 
India (2007-2008) 
Part A: Measured Health Outcomes  
 
 
High-Risk Height 
 Obese Waist Circ. WHR 
Systolic 
BP 
Diastolic 
BP BP Pulse 
≤10th 
Percentile 
≤25th 
Percentile 
South Africa 
 
        
Ghana          
Russia          
Mexico          
China          
India          
          
Part B: Self-Reported Chronic Conditions       
 
Hypertension Diabetes Angina Stroke CLD Arthritis Asthma   
South Africa 
 
        
Ghana 
 
        
Russia 
 
        
Mexico 
 
        
China 
 
        
India 
 
        
Notes: WHR refers to waist-to-hip ratio, BP refers to blood pressure, CLD refers to chronic lung disease. Shaded boxes refer to support for a health advantage for 
those born in the autumn or monsoon seasons relative to those born in all other seasons (OR>1) and check marks indicate that these associations are significant at 
p<0.05 in the basic models (M1). Crossed out boxes indicate that models were not run for a particular health outcome due to very low incidence of the health 
outcome in that sample.  
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Table 3.5. Odds Ratios and 95% Confidence Intervals from Logistic Regression Models 
Predicting Measured Health Outcomes (Part A) and Self-Reported Chronic Conditions 
(Part B), Males and Females Aged 50+, South Africa (2007-2008) 
Part A Season of Birth (ref=Autumn) N 
  Part B Season of Birth (ref=Autumn) N 
Obese (BMI ≥ 30 kg/m2)   Hypertension 
 
M1 1.22 [0.85,1.75] 1,331   M1 0.85 [0.57,1.25] 1,331 
M5 1.18 [0.83,1.70] 1,331   M5 0.80 [0.54,1.18] 1,331 
High-Risk Waist Circumference   Diabetes 
 
M1 1.02 [0.68,1.52] 1,331   M1 1.39 [0.69,2.78] 1,331 
M5 1.06 [0.72,1.55] 1,331   M5 1.22 [0.60,2.51] 1,331 
High-Risk Waist-to-Hip Ratio   Angina 
  
M1 1.32 [0.90,1.93] 1,331   M1 0.76 [0.31,1.85] 1,331 
M5 1.29 [0.88,1.90] 1,331   M5 0.72 [0.32,1.63] 1,331 
High-Risk Systolic Blood Pressure   Stroke 
 
M1 1.06 [0.66,1.72] 1,331   M1 0.88 [0.36,2.19] 1,331 
M5 1.03 [0.63,1.68] 1,331   M5 0.65 [0.28,1.51] 1,331 
High-Risk Diastolic Blood Pressure   Chronic Lung Disease 
 
M1 1.25 [0.81,1.93] 1,331   M1 0.94 [0.26,3.36] 1,331 
M5 1.17 [0.77,1.79] 1,331   M5 0.92 [0.23,3.62] 1,331 
High-Risk Blood Pressure 
 
  Arthritis 
 
M1 1.31 [0.85,2.02] 1,331   M1 1.38 [0.87,2.18] 1,331 
M5 1.28 [0.83,1.98] 1,331   M5 1.18 [0.71,1.95] 1,331 
High-Risk Pulse Rate   Asthma 
 
M1 1.47 [0.89,2.42] 1,331   M1 1.10 [0.45,2.68] 1,331 
M5 1.48 [0.88,2.49] 1,331   M5 1.05 [0.43,2.56] 1,331 
Height, ≤ 10th Percentile   
    
M1 1.96* [1.06,3.61] 1,331   
    
M5 2.16* [1.14,4.09] 1,331   
    
Height, ≤ 25th Percentile   
    
M1 1.34 [0.88,2.03] 1,331   
    
M5 1.25 [0.82,1.90] 1,331   
    
 + p <0.10, * p < 0.05, ** p < 0.01, *** p < 0.001  
Notes: Model 1 includes controls for age and sex. Model 5 adds controls for region, father’s 
education, father’s occupation, and respondent’s education. See Table 3.3 for the high-risk cutpoints.  
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Table 3.6. Odds Ratios and 95% Confidence Intervals from Logistic Regression Models 
Predicting Measured Health Outcomes (Part A) and Self-Reported Chronic Conditions 
(Part B), Males and Females Aged 50+, Ghana (2007-2008) 
Part A Season of Birth (ref=Autumn) N 
  Part B Season of Birth (ref=Autumn) N 
Obese (BMI ≥ 30 kg/m2) 
 
  Hypertension 
 
M1 1.44 [0.80,2.62] 838   M1 1.21 [0.77,1.91] 838 
M5 1.25 [0.68,2.29] 838   M5 1.05 [0.64,1.75] 838 
High-Risk Waist Circumference   Diabetes 
 
 
M1 1.20 [0.74,1.96] 838   M1 0.79 [0.34,1.80] 838 
M5 1.01 [0.63,1.61] 838   M5 0.70 [0.33,1.49] 838 
High-Risk Waist-to-Hip Ratio   Angina 
 
M1 0.85 [0.58,1.26] 838   M1 0.47 [0.14,1.61] 838 
M5 0.79 [0.52,1.20] 838   M5 0.47 [0.14,1.55] 838 
High-Risk Systolic Blood Pressure   Stroke 
 
 
M1 1.19 [0.84,1.69] 838   M1 0.97 [0.30,3.08] 838 
M5 1.09 [0.75,1.57] 838   M5 0.91 [0.28,2.94] 838 
High-Risk Diastolic Blood Pressure   Chronic Lung Disease 
 
M1 1.46* [1.06,2.01] 838   M1 
 
 
 
M5 1.38+ [0.99,1.92] 838   M5 
 
 
 
High-Risk Blood Pressure   Arthritis 
 
 
M1 1.26 [0.90,1.76] 838   M1 0.86 [0.54,1.37] 838 
M5 1.16 [0.82,1.64] 838   M5 0.84 [0.52,1.35] 838 
High-Risk Pulse Rate 
 
  Asthma 
 
 
M1 0.97 [0.55,1.72] 838   M1 0.95 [0.38,2.40] 838 
M5 1.06 [0.60,1.86] 838   M5 1.14 [0.42,3.10] 838 
Height, ≤ 10th Percentile 
 
  
  
 
 
M1 0.98 [0.46,2.09] 838   
  
 
 
M5 1.09 [0.53,2.26] 838   
  
 
 
Height, ≤ 25th Percentile 
 
  
  
 
 
M1 0.99 [0.66,1.49] 838   
  
 
 
M5 1.02 [0.68,1.52] 838   
  
 
 
 + p <0.10, * p < 0.05, ** p < 0.01, *** p < 0.001  
 Notes: Model 1 includes controls for age and sex. Model 5 adds controls for region, father’s 
education, father’s occupation, and respondent’s education. See Table 3.3 for the high-risk 
cutpoints. Chronic lung disease is omitted due to very low incidence of this condition in this sample.   
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Table 3.7. Odds Ratios and 95% Confidence Intervals from Logistic Regression Models 
Predicting Measured Health Outcomes (Part A) and Self-Reported Chronic Conditions 
(Part B), Males and Females Aged 50+, Russia (2007-2010) 
Part A Season of Birth (ref=Autumn) N 
  Part B Season of Birth (ref=Autumn) N 
Obese (BMI ≥ 30 kg/m2)   Hypertension 
 
M1 0.89 [0.45,1.74] 2,260   M1 1.14 [0.57,2.26] 2,260 
M5 0.98 [0.55,1.78] 2,260   M5 1.24 [0.64,2.41] 2,260 
High-Risk Waist Circumference   Diabetes 
  
M1 0.56+ [0.31,1.01] 2,260   M1 1.84** [1.25,2.70] 2,260 
M5 0.56+ [0.30,1.03] 2,260   M5 2.06** [1.27,3.36] 2,260 
High-Risk Waist-to-Hip Ratio   Angina 
  
M1 0.78 [0.40,1.55] 2,260   M1 1.81* [1.08,3.03] 2,260 
M5 0.78 [0.38,1.60] 2,260   M5 1.89* [1.16,3.09] 2,260 
High-Risk Systolic Blood Pressure   Stroke 
  
M1 0.99 [0.61,1.62] 2,260   M1 3.32+ [0.95,11.56] 2,260 
M5 1.01 [0.65,1.57] 2,260   M5 3.53* [1.18,10.58] 2,260 
High-Risk Diastolic Blood Pressure   Chronic Lung Disease 
 
M1 1.08 [0.74,1.58] 2,260   M1 1.13 [0.49,2.59] 2,260 
M5 1.16 [0.80,1.67] 2,260   M5 1.22 [0.68,2.19] 2,260 
High-Risk Blood Pressure   Arthritis 
  
M1 0.82 [0.49,1.37] 2,260   M1 0.96 [0.55,1.68] 2,260 
M5 0.86 [0.53,1.39] 2,260   M5 0.93 [0.52,1.67] 2,260 
High-Risk Pulse Rate   Asthma 
  
M1 1.18 [0.44,3.16] 2,260   M1 0.52 [0.13,2.10] 2,260 
M5 1.37 [0.55,3.43] 2,260   M5 0.78 [0.32,1.87] 2,260 
Height, ≤ 10th Percentile   
    
M1 1.17 [0.50,2.71] 2,260   
    
M5 1.12 [0.54,2.31] 2,260   
    
Height, ≤ 25th Percentile   
    
M1 1.56+ [0.94,2.59] 2,260   
    
M5 1.53+ [0.96,2.45] 2,260   
    
+ p <0.10, * p < 0.05, ** p < 0.01, *** p < 0.001  
Notes: Model 1 includes controls for age and sex. Model 5 adds controls for region, father’s education, 
father’s occupation, and respondent’s education. See Table 3.3 for the high-risk cutpoints.   
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Table 3.8. Odds Ratios and 95% Confidence Intervals from Logistic Regression Models 
Predicting Measured Health Outcomes (Part A) and Self-Reported Chronic Conditions 
(Part B), Males and Females Aged 50+, Mexico (2009-2010) 
Part A Season of Birth (ref=Autumn) N 
 Part B Season of Birth (ref=Autumn) N 
Obese (BMI ≥ 30 kg/m2)  Hypertension 
  
M1 1.73 [0.73,4.12] 937  M1 1.29 [0.54,3.07] 937 
M5 1.71 [0.86,3.39] 937  M5 1.37 [0.73,2.57] 937 
High-Risk Waist Circumference  Diabetes 
  
M1 1.55 [0.68,3.52] 937  M1 0.41* [0.18,0.94] 937 
M5 1.67+ [0.93,2.99] 937  M5 0.23*** [0.10,0.55] 937 
High-Risk Waist-to-Hip Ratio  Angina 
  
M1 0.90 [0.41,2.00] 937  M1 
   
M5 1.10 [0.49,2.51] 937  M5 
   
High-Risk Systolic Blood Pressure  Stroke 
  
M1 0.57 [0.22,1.43] 937  M1 0.59 [0.16,2.21] 937 
M5 0.80 [0.36,1.74] 937  M5 0.43+ [0.17,1.06] 937 
High-Risk Diastolic Blood Pressure  Chronic Lung Disease 
 
M1 1.22 [0.52,2.85] 937  M1 6.87** [1.79,26.45] 937 
M5 1.33 [0.72,2.45] 937  M5 8.37* [1.42,49.41] 937 
High-Risk Blood Pressure 
 
 Arthritis 
  
M1 1.40 [0.62,3.17] 937  M1 0.51 [0.17,1.52] 937 
M5 1.59 [0.88,2.88] 937  M5 0.66 [0.31,1.42] 937 
High-Risk Pulse Rate 
 
 Asthma 
  
M1 0.99 [0.19,5.17] 937  M1 
   
M5 0.87 [0.29,2.57] 937  M5 
   
Height, ≤ 10th Percentile 
 
 
 
   
M1 2.01 [0.70,5.83] 937  
 
   
M5 2.47 [0.57,10.71] 937  
 
   
Height, ≤ 25th Percentile 
 
 
 
   
M1 2.53* [1.07,5.98] 937  
 
   
M5 2.39+ [0.89,6.37] 937  
 
   
+ p <0.10, * p < 0.05, ** p < 0.01, *** p < 0.001  
Notes: Model 1 includes controls for age and sex. Model 5 adds controls for region, father’s education, 
father’s occupation, and respondent’s education. See Table 3.3 for the high-risk cutpoints. Angina and 
asthma are omitted due to very low incidence of these conditions in this sample.    
  
 173 
 
Table 3.9. Odds Ratios and 95% Confidence Intervals from Logistic Regression Models 
Predicting Measured Health Outcomes (Part A) and Self-Reported Chronic Conditions 
(Part B), Males and Females Aged 50+, China (2007-2010) 
Part A Season of Birth (ref=Autumn) N 
 Part B Season of Birth (ref=Autumn) N 
Obese (BMI ≥ 30 kg/m2)  Hypertension 
 
M1 0.80+ [0.62,1.04] 5,975  M1 0.89* [0.80,1.00] 5,975 
M5 0.79+ [0.60,1.04] 5,975  M5 0.90+ [0.80,1.00] 5,975 
High-Risk Waist Circumference  Diabetes 
  
M1 0.87+ [0.74,1.02] 5,975  M1 0.90 [0.70,1.15] 5,975 
M5 0.86+ [0.74,1.01] 5,975  M5 0.90 [0.70,1.15] 5,975 
High-Risk Waist-to-Hip Ratio  Angina 
  
M1 1.13 [0.96,1.34] 5,975  M1 0.94 [0.77,1.16] 5,975 
M5 1.14 [0.96,1.35] 5,975  M5 0.93 [0.77,1.13] 5,975 
High-Risk Systolic Blood Pressure  Stroke 
  
M1 0.80** [0.70,0.92] 5,975  M1 1.10 [0.72,1.67] 5,975 
M5 0.79** [0.69,0.91] 5,975  M5 1.09 [0.71,1.66] 5,975 
High-Risk Diastolic Blood Pressure  Chronic Lung Disease 
 
M1 0.90+ [0.82,1.00] 5,975  M1 1.19 [0.93,1.51] 5,975 
M5 0.92+ [0.84,1.01] 5,975  M5 1.18 [0.93,1.51] 5,975 
High-Risk Blood Pressure 
 
 Arthritis 
  
M1 0.83*** [0.75,0.92] 5,975  M1 1.03 [0.85,1.25] 5,975 
M5 0.84** [0.76,0.93] 5,975  M5 1.04 [0.86,1.26] 5,975 
High-Risk Pulse Rate 
 
 Asthma 
  
M1 0.93 [0.75,1.17] 5,975  M1 0.77 [0.48,1.25] 5,975 
M5 0.94 [0.75,1.18] 5,975  M5 0.74 [0.46,1.18] 5,975 
Height, ≤ 10th Percentile 
 
 
 
   
M1 0.88 [0.69,1.13] 5,975  
 
   
M5 0.89 [0.69,1.14] 5,975  
 
   
Height, ≤ 25th Percentile 
 
 
 
   
M1 0.96 [0.81,1.13] 5,975  
 
   
M5 0.95 [0.81,1.13] 5,975  
 
   
+ p <0.10, * p < 0.05, ** p < 0.01, *** p < 0.001  
Notes: Model 1 includes controls for age and sex. Model 5 adds controls for region, father’s education, 
father’s occupation, and respondent’s education. See Table 3.3 for the high-risk cutpoints.  
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Table 3.10. Odds Ratios and 95% Confidence Intervals from Logistic Regression Models 
Predicting Measured Health Outcomes (Part A) and Self-Reported Chronic Conditions 
(Part B), Males and Females Aged 50+, India (2007-2008) 
Part A Season of Birth  (ref=Monsoon) N 
 
 
Part B Season of Birth  (ref=Monsoon) N 
Obese (BMI ≥ 30 kg/m2)  
 
Hypertension 
 
M1 1.09 [0.48,2.50] 1,376  
 
M1 1.24 [0.83,1.84] 1,376 
M5 1.21 [0.51,2.85] 1,376  
 
M5 1.14 [0.80,1.63] 1,376 
Obese (BMI ≥ 25 kg/m2)  
 
Diabetes 
  
M1 1.06 [0.70,1.62] 1,376  
 
M1 0.58* [0.35,0.96] 1,376 
M5 1.04 [0.66,1.66] 1,376  
 
M5 0.49* [0.28,0.85] 1,376 
Obese (BMI ≥ 23 kg/m2)  
 
Angina 
  
M1 0.92 [0.64,1.33] 1,376  
 
M1 0.96 [0.55,1.65] 1,376 
M5 0.88 [0.61,1.28] 1,376  
 
M5 1.12 [0.66,1.92] 1,376 
High-Risk Waist Circumferencea  
 
Stroke 
  
M1 1.16 [0.68,2.00] 1,376  
 
M1 3.38* [1.07,10.67] 1,376 
M5 1.27 [0.76,2.14] 1,376  
 
M5 2.96 [0.80,10.91] 1,376 
High-Risk Waist Circumferenceb  
 
Chronic Lung Disease 
 
M1 0.90 [0.59,1.37] 1,376  
 
M1 2.35+ [0.90,6.14] 1,376 
M5 0.87 [0.57,1.31] 1,376  
 
M5 2.35* [1.02,5.42] 1,376 
High-Risk Waist Circumferencec  
 
Arthritis 
  
M1 0.95 [0.62,1.44] 1,376  
 
M1 0.82 [0.53,1.27] 1,376 
M5 0.97 [0.63,1.49] 1,376  
 
M5 0.73 [0.47,1.11] 1,376 
High-Risk Waist-to-Hip Ratio  
 
Asthma 
  
M1 1.10 [0.73,1.67] 1,376  
 
M1 1.48 [0.75,2.90] 1,376 
M5 1.02 [0.68,1.52] 1,376  
 
M5 1.74+ [0.92,3.32] 1,376 
High-Risk Systolic Blood Pressure  
 
 
   
M1 1.41+ [1.00,1.99] 1,376  
 
 
   
M5 1.28 [0.92,1.78] 1,376  
 
 
   
High-Risk Diastolic Blood Pressure  
 
 
   
M1 1.42+ [0.95,2.11] 1,376  
 
 
   
M5 1.39+ [0.96,2.00] 1,376  
 
 
   
High-Risk Blood Pressure  
 
 
   
M1 1.59* [1.11,2.30] 1,376  
 
 
   
M5 1.47* [1.04,2.10] 1,376  
 
 
   
High-Risk Pulse Rate 
 
 
 
 
   
M1 1.55+ [0.98,2.45] 1,376  
 
 
   
M5 1.57+ [0.99,2.47] 1,376  
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Height, ≤ 10th Percentile 
 
 
 
 
   
M1 1.41 [0.76,2.60] 1,376  
 
 
   
M5 1.36 [0.75,2.47] 1,376  
 
 
   
Height, ≤ 25th Percentile 
 
 
 
 
   
M1 1.13 [0.75,1.72] 1,376  
 
 
   
M5 1.08 [0.72,1.61] 1,376  
 
 
   
+ p <0.10, * p < 0.05, ** p < 0.01, *** p < 0.001  
Notes: Model 1 includes controls for age and sex. Model 5 adds controls for region, father’s education, 
father’s occupation, and respondent’s education. See Table 3.3 for the high-risk cutpoints.  
a
 > 102 cm (males), > 88 cm (females) 
b
 ≥ 90 cm (males), ≥ 80 cm (females) 
c
 ≥ 87 cm (males), ≥ 82 cm (females) 
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Table 3.11. Summary of Results from Logistic Regression Models Using Rainfall in Gestation (Part A) and the Post-Birth Period 
(Part B) to Predict Measured Health Outcomes and Self-Reported Chronic Conditions, Males and Females Aged 50+, India (2007-
2008) 
Part A: Gestational Period          
 Measured Health Outcomes  Self-Reported Chronic Conditions 
  High-Risk Height       
 Obese WC WHR SBP DBP BP ≤10th ≤25th  Hypertension Diabetes Angina Stroke  
1st  
Trim. ()              
2nd  
Trim.       (X) (X)       
3rd  
Trim.     () () (X) X       
               
Part B: Post-Birth Period           
 Measured Health Outcomes    Self-Reported Health Outcomes 
 
 High-Risk Height       
 
Obese WC WHR SBP DBP BP ≤10th ≤25th  Hypertension Diabetes Angina Stroke CLD 
1-3  
Months   X     X       
4-6  
Months    X X X       (X)  
7-9  
Months   X     X       
Notes: WC refers to waist circumference, WHR refers to waist-to-hip ratio, SBP refers to systolic blood pressure, DBP refers to diastolic blood pressure, BP 
refers to overall blood pressure, and CLD refers to chronic lung disease. Height measures refer to falling below the 10th and 25th height percentiles. ’s indicate 
that higher levels of rainfall are associated with a significant health advantage (OR<1) and X’s indicate that higher levels of rainfall are associated with a 
significant health disadvantage (OR>1) for a particular health outcome. Parentheses indicate that the odds ratios are significant at p<0.10, otherwise ’s and X’s 
indicate that odds ratios are significant at p<0.05 in the basic models (M1). For obesity and waist circumference, this table summarizes results from models using 
the standard cutpoints. 
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Table 3.12. Odds Ratios from Logistic Regression Models Using Total Rainfall (m) to Predict Measured Health Outcomes (Part A) 
and Self-Reported Chronic Conditions (Part B), Males and Females Aged 50+, India (2007-2008) 
Part A: Measured Health Outcomes 
  
 
     
 
Gestation 
  
 
 
Post-Birth 
 
 
1st Trimester 2nd  Trimester 3rd  Trimester N 
 
 
 
1-3 Months 4-6 Months 7-9 Months N 
Obese (BMI ≥30 kg/m2) 
   
 Obese (BMI ≥30 kg/m2) 
  
M1 0.22+ 0.45 0.52 1044 
 
 M1 1.46 0.20* 0.64 1044 
M5 0.25 0.44 0.55 1044 
 
 M5 1.55 0.22* 0.68 1044 
Obese (BMI ≥25 kg/m2) 
   
 Obese (BMI ≥25 kg/m2) 
  
M1 0.70 1.01 0.44* 1044 
 
 M1 1.02 0.95 0.88 1044 
M5 0.66 1.04 0.41* 1044 
 
 M5 1.01 1.03 0.92 1044 
Obese (BMI ≥23 kg/m2) 
   
 Obese (BMI ≥23 kg/m2) 
  
M1 1.02 1.01 0.91 1044 
 
 M1 1.19 0.98 1.04 1044 
M5 1.15 1.02 0.97 1044 
 
 M5 1.23 1.11 1.05 1044 
High-Risk Waist Circumferencea 
  
 High-Risk Waist Circumferencea 
 
M1 0.59 0.77 0.57 1044 
 
 M1 1.12 0.69 0.68 1044 
M5 0.64 0.71 0.54 1044 
 
 M5 0.97 0.85 0.62 1044 
High-Risk Waist Circumferenceb 
  
 High-Risk Waist Circumferenceb 
 
M1 0.44* 1.18 0.52+ 1044 
 
 M1 1.16 0.58+ 1.19 1044 
M5 0.51+ 1.27 0.58 1044 
 
 M5 1.41 0.72 1.59 1044 
High-Risk Waist Circumferencec 
  
 High-Risk Waist Circumferencec 
 
M1 0.48* 1.2 0.49* 1044 
 
 M1 1.00 0.72 1.18 1044 
M5 0.51* 1.24 0.47* 1044 
 
 M5 1.05 0.92 1.42 1044 
High-Risk Waist-to-Hip Ratio 
  
 High-Risk Waist-to-Hip Ratio 
 
M1 0.85 1.40 0.94 1044 
 
 M1 1.82* 0.81 2.68* 1044 
M5 0.56 1.23 0.65 1044 
 
 M5 1.66 0.75 2.36+ 1044 
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High-Risk Systolic Blood Pressure 
  
 High-Risk Systolic Blood Pressure 
 
M1 1.25 1.21 0.66 1044 
 
 M1 1.20 1.55* 1.44 1044 
M5 0.86 0.94 0.46* 1044 
 
 M5 1.00 1.49 1.04 1044 
High-Risk Diastolic Blood Pressure 
  
 High-Risk Diastolic Blood Pressure 
 
M1 1.23 1.19 0.57+ 1044 
 
 M1 0.91 1.66* 1.33 1044 
M5 0.83 1.05 0.39* 1044 
 
 M5 0.73 1.60+ 1.08 1044 
High-Risk Blood Pressure 
  
 High-Risk Blood Pressure 
 
M1 1.11 1.28 0.49+ 1044 
 
 M1 0.91 1.70* 1.25 1044 
M5 0.76 1.02 0.34* 1044 
 
 M5 0.77 1.68+ 0.94 1044 
High-Risk Pulse Rate 
  
 High-Risk Pulse Rate 
  
M1 1.26 0.61 1.00 1044 
 
 M1 0.75 1.29 0.46+ 1044 
M5 1.37 0.73 1.13 1044 
 
 M5 0.90 1.28 0.63 1044 
Height, ≤10th Percentile 
   
 Height, ≤10th Percentile 
  
M1 1.38 2.18+ 1.72+ 1044 
 
 M1 1.18 1.06 1.99 1044 
M5 1.12 2.82+ 1.44 1044 
 
 M5 0.94 0.86 1.89 1044 
Height, ≤25th Percentile 
   
 Height, ≤25th Percentile 
 
M1 1.70 1.69+ 1.75* 1044 
 
 M1 1.70* 1.16 2.01* 1044 
M5 1.43 2.04* 1.55 1044 
 
 M5 1.61 1.00 2.19* 1044 
      
 
     
Part B: Self-Reported Chronic Conditions 
  
 
     
 
Gestation 
  
 
 
Post-Birth 
 
 
1st Trimester 2nd Trimester 3rd Trimester N 
 
 
 
1-3 Months 4-6 Months 7-9 Months N 
Hypertension 
   
 Hypertension 
  
M1 1.07 1.54 0.68 1044 
 
 M1 0.98 1.17 1.60 1044 
M5 0.54 1.12 0.37* 1044 
 
 M5 0.59 0.92 0.82 1044 
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Diabetes 
    
 Diabetes 
   
M1 0.61 0.90 0.89 1044 
 
 M1 1.32 0.77 0.93 1044 
M5 0.28* 0.68 0.52 1044 
 
 M5 0.77 0.57 0.49 1044 
Angina 
    
 Angina 
  
M1 0.58 0.51 0.69 1044 
 
 M1 0.59 0.59 0.24* 1044 
M5 0.87 0.74 0.80 1044 
 
 M5 0.43 0.74 0.27+ 1044 
Stroke 
    
 Stroke 
   
M1 1.23 1.96 0.18 1044 
 
 M1 0.60 2.28+ 1.62 1044 
M5 0.37 1.66 0.03+ 1044 
 
 M5 0.42 2.00 1.10 1044 
Chronic Lung Disease 
  
 Chronic Lung Disease 
 
M1 0.50 0.50 0.05+ 1044 
 
 M1 0.77 1.54 0.45 1044 
M5 0.43 0.46 0.05* 1044 
 
 M5 1.00 1.77 0.73 1044 
Arthritis 
   
 Arthritis 
  
M1 1.71 0.54* 1.64 1044 
 
 M1 1.71+ 1.14 0.94 1044 
M5 1.00 0.55+ 1.31 1044 
 
 M5 1.45 0.80 0.85 1044 
Asthma 
   
 Asthma 
   
M1 0.25* 2.10 0.16* 1044 
 
 M1 0.60 0.55 1.41 1044 
M5 0.31+ 2.97+ 0.19+ 1044 
 
 M5 0.85 0.75 2.78 1044 
+ p <0.10, * p < 0.05, ** p < 0.01, *** p < 0.001  
Notes: Model 1 includes controls for age and sex. Model 5 adds controls for region, father’s education, father’s occupation, and respondent’s education. See 
Table 3.3 for the high-risk cutpoints. Models are based on a sample of non-movers who are not missing information on rainfall and temperature around the 
time of birth. 
a
 > 102 cm (males), > 88 cm (females) 
b
 ≥ 90 cm (males), ≥ 80 cm (females) 
c
 ≥ 87 cm (males), ≥ 82 cm (females) 
  
 180 
 
Table 3.13. Summary of Results from Logistic Regression Models Using Average Minimum Temperature in Gestation (Part A) and 
the Post-Birth Period (Part B) to Predict Measured Health Outcomes and Self-Reported Chronic Conditions, Males and Females Aged 
50+, India (2007-2008) 
Part A: Gestational Period          
 Measured Health Outcomes  Self-Reported Chronic Conditions 
  High-Risk Height       
 Obese WC WHR SBP DBP BP ≤10th ≤25th  Hypertension Diabetes Angina Stroke  
1st  
Trim.    X  X X X  X   X  
2nd  
Trim.      (X)         
3rd  
Trim.    (X)   X X       
               
Part B: Post-Birth Period           
 Measured Health Outcomes    Self-Reported Health Outcomes 
 
 High-Risk Height       
 
Obese WC WHR SBP DBP BP ≤10th ≤25th  Hypertension Diabetes Angina Stroke CLD 
1-3  
Months        (X)     (X) () 
4-6  
Months    X (X) X       X  
7-9  
Months       X X     (X)  
Notes: WC refers to waist circumference, WHR refers to waist-to-hip ratio, SBP refers to systolic blood pressure, DBP refers to diastolic blood pressure, BP 
refers to overall blood pressure, and CLD refers to chronic lung disease. Height measures refer to falling below the 10th and 25th height percentiles. ’s indicate 
that higher temperatures are associated with a significant health advantage (OR<1) and X’s indicate that higher temperatures are associated with a significant 
health disadvantage (OR>1) for a particular health outcome. Parentheses indicate that the odds ratios are significant at p<0.10, otherwise ’s and X’s indicate 
that odds ratios are significant at p<0.05 in the basic models (M1). For obesity and waist circumference, this table summarizes results from models using the 
standard cutpoints. 
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Table 3.14. Odds Ratios from Logistic Regression Models Using Average Minimum Temperature (°Celsius) to Predict Measured 
Health Outcomes (Part A) and Self-Reported Chronic Conditions (Part B), Males and Females Aged 50+, India (2007-2008) 
Part A: Measured Health Outcomes 
 
  
     
 
Gestation 
 
  
 
Post-Birth 
 
 
1st Trimester 2nd Trimester 3rd Trimester N   
 
1-3 Months 4-6 Months 7-9 Months N 
Obese (BMI ≥30 kg/m2) 
 
  Obese (BMI ≥30 kg/m2) 
 
M1 1.00 0.94 1.05 1044   M1 0.96 0.96 0.92 1044 
M5 1.10 0.94 1.12 1044   M5 0.96 0.98 0.92 1044 
Obese (BMI ≥25 kg/m2) 
 
  Obese (BMI ≥25 kg/m2) 
 
M1 1.06 0.99 1.06 1044   M1 1.01 1.01 1.01 1044 
M5 1.06 0.99 1.05 1044   M5 1.00 1.02 1.00 1044 
Obese (BMI ≥23 kg/m2) 
 
  Obese (BMI ≥23 kg/m2) 
 
M1 1.04 0.99 1.05 1044   M1 1.02 1.00 1.02 1044 
M5 1.02 0.99 1.02 1044   M5 1.02 1.00 1.02 1044 
High-Risk Waist Circumferencea 
 
  High-Risk Waist Circumferencea 
 
M1 1.03 0.98 1.07 1044   M1 0.93 0.99 0.93 1044 
M5 1.06 0.97 1.09 1044   M5 0.90 0.98 0.90 1044 
High-Risk Waist Circumferenceb 
 
  High-Risk Waist Circumferenceb 
 
M1 1.00 1.00 1.01 1044   M1 0.97 0.99 0.98 1044 
M5 1.04 1.00 1.05 1044   M5 1.01 1.00 1.02 1044 
High-Risk Waist Circumferencec 
 
  High-Risk Waist Circumferencec 
 
M1 1.02 0.98 1.01 1044   M1 0.95 1.01 0.95 1044 
M5 1.07 0.99 1.05 1044   M5 0.98 1.01 0.97 1044 
High-Risk Waist-to-Hip Ratio 
 
  High-Risk Waist-to-Hip Ratio 
 
M1 1.07 1.00 1.04 1044   M1 1.01 1.03 1.01 1044 
M5 1.04 0.99 1.02 1044   M5 0.99 1.03 0.98 1044 
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High-Risk Systolic Blood Pressure 
 
  High-Risk Systolic Blood Pressure 
 
M1 1.10** 0.97 1.07+ 1044   M1 1.04 1.04* 1.00 1044 
M5 1.05 0.96+ 1.02 1044   M5 1.02 1.03 0.98 1044 
High-Risk Diastolic Blood Pressure 
 
  High-Risk Diastolic Blood Pressure 
 
M1 1.06 0.97 1.02 1044   M1 1.02 1.04+ 1.00 1044 
M5 1.00 0.97 0.96 1044   M5 1.00 1.03 0.98 1044 
High-Risk Blood Pressure 
 
  High-Risk Blood Pressure 
 
M1 1.07* 0.96+ 1.03 1044   M1 1.02 1.05* 0.98 1044 
M5 1.03 0.96+ 0.99 1044   M5 1.00 1.04* 0.96 1044 
High-Risk Pulse Rate 
  
  High-Risk Pulse Rate 
 
M1 1.01 0.94+ 0.98 1044   M1 0.98 1.03 0.93 1044 
M5 1.02 0.95 0.98 1044   M5 0.99 1.03 0.95 1044 
Height, ≤10th Percentile 
 
  Height, ≤10th Percentile 
 
M1 1.16* 1.06 1.18* 1044   M1 1.09 1.01 1.14** 1044 
M5 1.15+ 1.07+ 1.15* 1044   M5 1.07 1.02 1.13* 1044 
Height, ≤25th Percentile 
 
  Height, ≤25th Percentile 
 
M1 1.12** 1.03 1.12** 1044   M1 1.08+ 1.01 1.11** 1044 
M5 1.08 1.04 1.07 1044   M5 1.07 1.02 1.11** 1044 
     
  
     
Part B: Self-Reported Chronic Conditions   
     
 
Gestation    
 
Post-Birth 
 
 
1st Trimester 2nd Trimester 3rd Trimester N   
 
1-3 Months 4-6 Months 7-9 Months N 
Hypertension 
  
  Hypertension 
  
M1 1.08* 1.00 1.06 1044   M1 1.01 1.03 1.01 1044 
M5 1.00 0.99 0.98 1044   M5 0.94 1.01 0.95 1044 
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Diabetes 
  
  Diabetes 
  
M1 1.05 0.98 1.07 1044   M1 1.05 0.99 1.02 1044 
M5 0.92 0.95 0.96 1044   M5 0.98 0.95 0.95 1044 
Angina 
  
  Angina 
  
M1 1.03 1.01 1.07 1044   M1 0.94 0.97 0.95 1044 
M5 1.01 1.03 1.02 1044   M5 0.94 0.98 0.97 1044 
Stroke 
  
  Stroke 
  
M1 1.32* 1.00 1.12 1044   M1 1.23+ 1.16** 1.20+ 1044 
M5 1.24+ 1.00 1.01 1044   M5 1.20 1.20** 1.18 1044 
Chronic Lung Disease 
 
  Chronic Lung Disease 
 
M1 0.99 0.90+ 0.94 1044   M1 0.90+ 1.04 0.83* 1044 
M5 1.02 0.89+ 0.98 1044   M5 0.90 1.03 0.82* 1044 
Arthritis 
  
  Arthritis 
  
M1 1.04 0.99 1.06 1044   M1 1.07 1.00 1.04 1044 
M5 0.99 0.98 1.01 1044   M5 1.03 0.99 1.01 1044 
Asthma 
  
  Asthma 
  
M1 1.00 0.98 0.97 1044   M1 0.94 1.02 0.95 1044 
M5 1.07 0.99 1.03 1044   M5 0.99 1.04 1.00 1044 
+ p <0.10, * p < 0.05, ** p < 0.01, *** p < 0.001 
a
 > 102 cm (males), > 88 cm (females) 
b
 ≥ 90 cm (males), ≥ 80 cm (females) 
c
 ≥ 87 cm (males), ≥ 82 cm (females) 
Notes: Model 1 includes controls for age and sex. 5 adds state, father’s education, father’s occupation, and respondent’s education. See Table 3.3 for the 
high-risk cutpoints. Models are based on a sample of non-movers who are not missing information on rainfall and temperature around the time of birth. 
 
 Figures 
Figure 3.1. Weekly Cholera Deaths, India, 1931
Source: Public Health Commissioner of India 
 
 
Figure 3.2. Reported Plague Deaths, Northern India
Source: Public Health Commissioner of India 
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Figure 3.3. Reported Smallpox Cases, India, 1930-1935 
 
Source: Public Health Commissioner of India (1937). 
 
Figure 3.4. Monthly Rainfall (m), Jaipur, Rajasthan, 1907-1957 
 
Source: India Water Portal (2012). 
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Figure 3.5. Monthly Rainfall (m), North 24 Parganas, 1907-1957 
 
Source: India Water Portal (2012). 
Figure 3.6. Monthly Minimum Temperature (°Celsius), Jaipur, Rajasthan, 1907-1957 
 
Source: India Water Portal (2012). 
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Figure 3.7. Monthly Minimum Temperature (°Celsius), North 24 Parganas, 1907-1957 
 
Source: India Water Portal (2012). 
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Appendix 
Chapter 1 
Table A1.1. Comparison of Population Attributable Fractions (%) from Indirect 
Estimation and Cox Regression Models, Black and White Males and Females Aged 50+ 
(Indirect Estimation) and Aged 50-84 at Baseline (Direct Estimation) 
 
Males 
 
 
Blacks 
 
Whites 
Difference 
(B-W) 
    
Indirect Estimation (2001) 26.64 21.76 4.89 
Direct Estimation (1997-2006) 
• 8-category smoking status (non-Hispanics)† 
• 8-category smoking status (including Hispanics)† 
• 3-category smoking status (non-Hispanics)‡ 
 
33.08 
32.32 
31.16 
 
29.43 
28.90 
29.08 
 
3.65 
3.42 
2.08 
    
Females 
 
 
Blacks 
 
Whites 
Difference 
(B-W) 
    
Indirect Estimation (2001) 13.31 15.35 -2.04 
Direct Estimation (1997-2006) 
• 8-category smoking status (non-Hispanics)† 
• 8-category smoking status (including Hispanics)† 
• 3-category smoking status (non-Hispanics)‡ 
 
22.41 
22.00 
21.48 
 
23.62 
22.85 
23.42 
 
-1.22 
-0.85 
-1.94 
    
†
 Categories: never smoker, former smoker quit 30+ years ago, former smoker quit 20-29 years ago, former 
smoker quit 10-19 years ago, former smoker quit 5-9 years ago, former smoker quit 0-4 years ago, current 
smoker <1 pack per day, current smoker 1+packs per day 
‡
 Categories: never smoker, former smoker, current smoker 
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Table A1.2. Final Sample Sizes and Number of Deaths, National Health Interview 
Survey, Respondents Aged 50-84 at Baseline, 1997-2003 
     
  Total Whites Blacks 
  
   
Non-Hispanic Males 
     Sample size 
 
 
27,164 
 
23,701 
 
3,463 
     Number of deaths 
 
4,831 4,082 749 
  
   
Males, including Hispanics 
     Sample size 
 
 
29,922 
 
26,411 
 
3,511 
     Number of deaths 
 
5,215 4,456 759 
     
     
Non-Hispanic Females 
     Sample size 
 
 
36,646 
 
31,156 
 
5,490 
     Number of deaths 
 
5,046 4,228 818 
  
   
Females, including Hispanics 
     Sample size 
 
 
40,528 
 
34,966 
 
5,562 
     Number of deaths 
 
5,427 4,603 824 
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Chapter 2  
Table A2.1. Life Expectancy at Birth, Difference with United States, and Ranking for 
Males and Females in 17 High-Income Countries, 2006-2008 
  
Males  Females 
Country Year e0 
Difference 
with U.S. Rank  e0 
Difference 
with U.S. Rank 
Switzerland 2007 79.33 3.69 1  84.09 3.31 4 
Japan 2008 79.31 3.67 2  86.04 5.26 1 
Australia 2006 79.17 3.53 3  83.79 3.01 6 
Sweden 2008 79.09 3.45 4  83.12 2.34 7 
Italy 2007 78.82 3.18 5  84.09 3.31 4 
Canada 2007 78.35 2.71 6  82.95 2.17 11 
Norway 2008 78.34 2.70 7  82.97 2.19 9 
Netherlands 2008 78.32 2.68 8  82.28 1.5 13 
Spain 2008 78.03 2.39 9  84.2 3.42 3 
United Kingdom 2008 77.63 1.99 10  81.74 0.96 15 
Austria 2008 77.62 1.98 11  82.97 2.19 9 
France 2008 77.62 1.98 11  84.39 3.61 2 
Germany 2006 76.93 1.29 13  82.27 1.49 14 
Finland 2008 76.32 0.68 14  83.01 2.23 8 
Portugal 2008 76.18 0.54 15  82.36 1.58 12 
Denmark 2006 75.91 0.27 16  80.52 -0.26 17 
United States 2007 75.64 
 
17  80.78 
 
16 
     
 
   Non-U.S. Average 
 
77.94 2.30 
 
 83.17 2.39 
 
Source: Human Mortality Database (2012)
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Table A2.2. Cause of Death Categories and Corresponding ICD-10 Codes47 
Category ICD-10 Codes Source 
   
1. Communicable and nutritional conditions 
a. HIV 
b. All other communicable and nutritional 
conditions,  
excluding HIV/AIDS 
 
1. A00-B99, D50-D53, D64.9, E00-E02, E40-E46, E50, E51-E64, G00-G04, 
H65-H66, J00-J06, J10-J18, J20-J22, N70-N73 
a. B20-B24 
b. A00-B99 (excluding B20-B24), D50-D53, D64.9, E00-E02, E40-E46, 
E50, E51-E64, G00-G04, H65-H66, J00-J06, J10-J18, J20-J22, N70-
N73 
GBD 
 
2. Noncommunicable diseases 
 
 
 
a. Malignant neoplasms 
i. Lung cancer 
ii. All other cancers,  
excluding lung cancer 
b. Other neoplasms 
c. Diabetes mellitus 
d. Endocrine disorders 
 
e. Neuropsychiatric disorders 
f. Sense organ diseases 
g. Cardiovascular disease 
h. Respiratory diseases 
i. Digestive diseases 
j. Genitourinary diseases 
2. C00-C97, D00-D48, D55-D64 (minus D64.9), D65-D89, E03-E07, E10-
E16, E20-E34, E65-E88, F01-F99, G06-G98, H00-H61, H68-H93, I00-
I99, J30-J98, K00-K14, K20-K92, N00-N64, N75-N98, L00-L98, M00-
M99, Q00-Q99 
a. C00-C97 
i. C33-C34 
ii. C00-C97 (excluding C33-C34) 
 
b. D00-D48 
c. E10-E14 
d. D55-D64 (minus D64.9), D65-D89, E03-E07, E15-E16, E20-E34, 
E65-E88 
e. F01-F99, G06-G98 
f. H00-H61, H68-H93 
g. I00-I99 
h. J30-J98 
i. K20-K92 
j. N00-N64, N75-N98 
GBD 
                                                          
47
 GBD indicates that cause-of-death groupings are specified per the Global Burden of Disease Study conventions, NVSR indicates that cause-of-death groupings 
are specified following the conventions of the U.S. National Vital Statistics Reports. 
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k. Skin diseases 
l. Musculoskeletal diseases 
m. Congenital anomalies 
n. Oral conditions 
 
k. L00-L98 
l. M00-M99 
m. Q00-Q99 
n. K00-K14 
3. Maternal conditions 
 
3. O00-O99 GBD 
4. Perinatal conditions 
 
4. P00-P96 GBD 
5. Unintentional injuries 
a. Transport injuries 
b. Nontransport injuries 
 
5. V01-X59,Y85-Y86 
a. V01-V99,Y85 
b. W00-X59,Y86 
NVSR 
 
6. Intentional injuries 
a. Suicide 
b. Homicide 
 
6. X60-Y09, Y87.0-Y87.1 
a. X60-X84,Y87.0 
b. X85-Y09, Y87.1 
NVSR 
 
7. Drug-related causes48  7. D52.1, D59.0, D59.2, D61.1, D64.2, E06.4, E16.0, E23.1, E24.2, E24.4, 
E27.3, E66.1, F10, F11.0-F11.5, F11.7-F11.9, F12.0-F12.5, F12.7-F12.9, 
F13.0-F13.5, F13.7-F13.9, F14.0-F14.5, F14.7-F14.9, F15.0-F15.5, 
F15.7-F15.9, F16.0-F16.5, F16.7-F16.9, F17.0, F17.3-F17.5, F17.7-F17.9, 
F18.0-F18.5,F18.7-F18.9, F19.0-F19.5, F19.7-F19.9, G21.1, G24.0, 
G25.1, G25.4, G25.6, G31.2, G44.4, G62.0, G62.1, G72.0, G72.1, I42.6, 
I95.2, J70.2–J70.4, K29.2, K70, K85.2, K85.3, K86.0, L10.5, L27.0-
L27.1, M10.2, M32.0, M80.4, M81.4, M83.5, M87.1, R50.2, R78.0, 
R78.1-R78.5, X40-X44, X45, X60-X64, X65, X85, Y10-Y14, Y15 
NVSR 
 
 
 
                                                          
48
 Composed of the “drug-induced causes” and “alcohol-induced causes” categories from the NVSR.  
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Table A2.3. Percentage Contribution of Causes of Death to the Difference in Years of Life Lost Between the U.S. and 15 OECD 
Countries, Males, 2006-200849 
 
Communicable 
Diseases  Intentional Injuries  
Noncommunicable 
Diseases  
Unintentional 
Injuries    
Country HIV 
All 
other  Suicide Homicide  CVD 
All 
other  Transport Nontransport  
Perinatal 
conditions  Residual 
Australia 3 3  4 23  9 14  15 11  11  7 
Austria 3 3  4 21  11 -1  17 18  13  12 
Canada 3 2  1 20  12 15  16 20  4  7 
Denmark 3 3  7 21  10 2  20 14  10  10 
Finland 4 3  -16 24  8 12  24 3  25  14 
France 2 2  0 22  9 11  17 18  16  1 
Germany 2 2  6 19  6 10  17 21  12  4 
Italy 1 2  11 16  7 13  9 17  12  11 
Japan 2 1  -7 16  4 15  21 17  20  9 
Netherlands 2 2  7 15  7 11  20 19  9  8 
Norway 3 4  1 19  11 16  18 8  16  4 
Portugal -6 0  14 23  11 7  19 28  17  -12 
Spain 1 1  10 18  7 9  16 15  12  10 
Sweden 2 2  2 15  8 16  19 13  17  5 
United  
Kingdom 
3 0  8 25  6 -3  26 17  8  9 
  
 
  
 
  
 
  
   
 
Mean 2 2  4 19  8 10  18 16  13  7 
 
 
 
                                                          
49
 Contributions sum to 100% across the rows of this table. The mean row corresponds to the data presented in Figure 2.9. 
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Table A2.4. Percentage Contribution of Causes of Death to the Difference in Years of Life Lost Between the U.S. and 15 OECD 
Countries, Females, 2006-200850 
 
Communicable 
Diseases  
Intentional 
Injuries  
Noncommunicable 
Diseases  
Unintentional 
Injuries     
Country HIV 
All 
other  Suicide Homicide  CVD 
All 
other  Transport 
Non- 
transport 
Perinatal 
conditions  
Maternal 
conditions  Residual 
Australia 4 4  1 9  9 23  17 11 14  2  6 
Austria 2 3  1 7  9 17  14 15 16  1  13 
Canada 3 4  -4 9  14 26  15 17 3  2  11 
Denmark 2 3  0 7  11 16  14 15 16  1  14 
Finland 3 4  -9 4  9 23  16 8 27  1  14 
France 3 4  -1 8  9 22  17 14 20  1  4 
Germany 2 3  2 7  6 21  16 16 17  1  9 
Italy 2 4  4 7  8 20  13 14 15  1  12 
Japan 3 1  -12 7  7 23  19 12 30  1  9 
Netherlands 2 3  1 7  7 14  19 17 17  1  12 
Norway 2 5  -5 7  9 22  16 10 22  1  10 
Portugal -2 3  5 8  10 19  15 19 22  2  1 
Spain 1 3  4 7  9 18  15 14 18  1  11 
Sweden 2 2  -4 6  10 25  17 13 23  1  4 
United 
Kingdom 
3 -1  3 11  9 6  24 16 13  2  13 
  
 
  
 
  
 
  
    
 
Mean 2 3  -1 7  9 20  16 14 19  1  9 
 
 
                                                          
50
 Contributions sum to 100% across the rows of this table. The mean row corresponds to the data presented in Figure 2.10. 
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Chapter 3 
Table A3.1. Summary Statistics, Distribution (%) or Mean (SE), Males and Females 
Aged 50+, South Africa (2007-2008) and Ghana (2007-2008) SAGE Wave 1 
 South Africa    Ghana 
 Males Females Total    Males Females Total 
 568 763 1,331    581 257 838 
 (40%) (60%)     (69%) (31%)  
Sociodemographic Characteristics   Sociodemographic Characteristics 
Season of Birth      Season of Birth    
   Summer 25.5 22.4 23.7      Winter 24.6 23.6 24.3 
   Autumn 22.3 23.7 23.1      Spring 24.9 29.0 26.2 
   Winter 28.4 28.3 28.4      Summer 28.2 26.6 27.7 
   Spring 23.8 25.6 24.8      Autumn 22.3 20.8 21.9 
Age Group      Age Group    
   50-54 29.6 33.4 31.8      50-54 26.7 32.5 28.5 
   55-59 24.3 16.5 19.6      55-59 25.7 30.5 27.2 
   60-64 17.5 15.0 16.0      60-64 16.4 14.1 15.7 
   65-69 14.3 14.9 14.7      65-69 13.9 10.0 12.7 
   70-74 6.1 11.1 9.0      70-74 9.1 5.7 8.1 
   75-79 3.6 6.4 5.3      75-79 5.9 3.3 5.1 
   80-84 2.8 1.4 2.0      80-84 1.9 2.8 2.2 
   85+ 1.9 1.3 1.5      85+ 0.5 1.2 0.7 
Ethnic Background        
   African/Black 69.8 67.2 68.2       
   White 13.3 13.7 13.5       
   Coloured 12.6 14.5 13.8       
   Other 4.3 4.6 4.5       
Religion      Religion    
   Christianity 86.7 90.9 89.2      Christianity 89.9 95.9 91.7 
   Other 13.3 9.1 10.8      Islam 4.4 2.9 3.9 
         Other 5.8 1.2 4.4 
Province      Region    
   Eastern 13.0 11.6 12.1      Ashanti 23.7 14.4 20.8 
   Free State 8.2 7.6 7.8      Brong-Ahafo  7.4 6.6 7.1 
   Gauteng 31.9 27.4 29.2      Central 7.2 7.9 7.4 
   KwaZulu-Natal 11.8 18.0 15.5      Eastern 15.4 11.3 14.1 
   Limpopo 6.4 5.2 5.7      Greater Accra 22.5 38.3 27.3 
   Mpumalanga 7.3 6.6 6.9      Northern 0.7 0.0 0.5 
   North-West 8.3 8.3 8.3      Upper East 0.8 0.0 0.6 
   Northern Cape 2.9 2.9 2.9      Upper West 0.5 0.3 0.5 
   Western Cape 10.3 12.4 11.6      Volta 11.8 14.5 12.6 
         Western 10.1 6.7 9.1 
Education      Education    
   Less than  
   primary 29.1 31.2 30.4 
     Less than  
   primary 5.9 13.2 8.1 
   Primary  26.6 29.3 28.2      Primary  19.1 27.1 21.5 
   Secondary  18.6 21.5 20.3      Secondary  13.5 8.8 12.0 
   High school + 25.6 18.1 21.1      High school 48.4 39.5 45.6 
         College + 13.2 11.5 12.7 
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Father's Education     Father's Education   
   No formal  
   education 38.4 37.0 37.5 
     No formal  
   education 71.9 49.6 65.1 
   Less than  
   primary 24.3 21.8 22.8 
     Less than  
   primary 8.4 7.3 8.0 
   Primary  19.6 19.5 19.5      Primary  4.8 11.6 6.9 
   Secondary + 17.6 21.8 20.1      Secondary  3.0 4.0 3.3 
         High School + 11.9 27.6 16.7 
Father’s Occupation    Father’s Occupation  
   Non-agricultural 78.8 79.1 79.0      Non-agricultural 30.6 51.0 36.9 
   Agricultural  21.2 20.9 21.0      Agricultural  69.4 49.0 63.1 
    
Measured Health Outcomes   Measured Health Outcomes 
Body Mass Index    
  
Body Mass Index    
   Underweight 4.3 1.9 2.8      Underweight 13.3 5.0 10.7 
   Normal 28.8 17.1 21.9      Normal 57.1 35.0 50.3 
   Overweight 29.2 30.2 29.8      Overweight 20.9 29.0 23.4 
   Obese I 24.9 22.9 23.7      Obese I 6.5 12.7 8.4 
   Obese II/III 12.8 27.9 21.8      Obese II/III 2.2 18.3 7.1 
High-Risk Waist Circumference    High-Risk Waist Circumference  
   Normal 75.1 34.5 50.9      Normal 91.8 40.0 75.9 
   High-risk 24.9 65.6 49.1      High-risk 8.2 60.0 24.1 
High-Risk Hip-to-Waist Ratio    High-Risk Hip-to-Waist Ratio  
   Normal 40.3 25.6 31.6      Normal 34.1 13.6 27.8 
   High-risk 59.7 74.4 68.5      High-risk 65.9 86.4 72.2 
High-Risk Systolic Blood Pressure    High-Risk Systolic Blood Pressure  
   Normal 38.3 31.3 34.2      Normal 55.5 48.8 53.5 
   High-risk 61.7 68.7 65.9      High-risk 44.5 51.2 46.6 
High-Risk Diastolic Blood Pressure    High-Risk Diastolic Blood Pressure  
   Normal 30.1 23.6 26.3      Normal 42.2 40.7 41.8 
   High-risk 69.9 76.4 73.8      High-risk 57.8 59.3 58.2 
 High-Risk Blood Pressure     High-Risk Blood Pressure  
   Normal 44.4 36.1 39.5      Normal 57.4 53.3 56.1 
   High-risk 55.6 63.9 60.5      High-risk 42.7 46.7 43.9 
High-Risk Pulse Rate     High-Risk Pulse Rate   
   Normal 85.7 83.9 84.7      Normal 87.6 91.8 88.9 
   High-risk 14.3 16.1 15.4      High-risk 12.4 8.2 11.1 
Height      Height    
   Mean (SE) 1.646 
(0.007) 
1.578 
(0.007) 
1.605 
(0.006) 
     Mean (SE) 1.671 
(0.004) 
1.592 
(0.006) 
1.647 
(0.004) 
   ≤10th percentile         ≤10th percentile   
      No 95.5 94.1 94.6         No 94.5 95.6 94.9 
      Yes 4.5 5.9 5.4         Yes 5.5 4.4 5.1 
   ≤25th percentile         ≤25th percentile   
      No 82.3 75.5 78.3         No 81.6 83.7 82.2 
      Yes 17.7 24.5 21.7         Yes 18.4 16.3 17.8 
 
    
 
  
Chronic Conditions     Chronic Conditions   
Hypertension    
  
Hypertension    
   No 72.0 65.2 68.0      No 82.7 67.8 78.1 
   Yes 28.0 34.8 32.1      Yes 17.3 32.2 21.9 
Diabetes      Diabetes    
   No 92.6 86.9 89.2      No 94.7 93.0 94.2 
   Yes 7.4 13.1 10.8      Yes 5.3 7.0 5.8 
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Angina      Angina    
   No 96.0 95.0 95.4      No 98.2 95.6 97.4 
   Yes 4.0 5.0 4.6      Yes 1.8 4.4 2.6 
Stroke      Stroke    
   No 96.3 96.5 96.4      No 97.2 98.2 97.5 
   Yes 3.7 3.5 3.6      Yes 2.8 1.8 2.5 
Chronic Lung Disease     Chronic Lung Disease   
   No 98.4 96.5 97.3      No 99.4 100.0 99.6 
   Yes 1.7 3.5 2.7      Yes 0.6 0.0 0.4 
Arthritis      Arthritis    
   No 83.9 72.9 77.3      No 89.3 82.4 87.2 
   Yes 16.1 27.1 22.7      Yes 10.8 17.6 12.9 
Asthma      Asthma    
   No 94.4 96.3 95.5      No 96.2 96.8 96.4 
   Yes 5.6 3.7 4.5      Yes 3.8 3.2 3.6 
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Table A3.2. Summary Statistics, Distribution (%) or Mean (SE), Males and Females 
Aged 50+, Russia (2007-2010) and Mexico (2009-2010) SAGE Wave 1 
 Russia    Mexico 
 Males Females Total    Males Females Total 
 765 1,495 2,260    397 540 937 
 (42%) (58%)     (50%) (50%)  
Sociodemographic Characteristics    Sociodemographic Characteristics  
Season of Birth      Season of Birth    
   Summer 28.9 26.9 27.7      Summer 13.1 20.7 16.9 
   Autumn 25.2 21.8 23.2      Autumn 28.9 22.5 25.8 
   Winter 17.1 25.5 22.0      Winter 19.1 21.6 20.3 
   Spring 28.9 25.7 27.1      Spring 38.9 35.2 37.1 
Age Group      Age Group    
   50-54 22.4 26.5 24.8      50-54 31.6 17.8 24.7 
   55-59 25.7 21.2 23.1      55-59 29.9 30.3 30.1 
   60-64 16.0 12.0 13.6      60-64 12.6 15.8 14.2 
   65-69 17.6 11.5 14.1      65-69 9.2 12.0 10.6 
   70-74 9.3 10.9 10.2      70-74 5.1 6.9 6.0 
   75-79 4.9 11.3 8.6      75-79 6.9 12.4 9.6 
   80-84 1.7 3.8 2.9      80-84 1.7 4.0 2.8 
   85+ 2.5 2.8 2.7      85+ 2.9 0.9 1.9 
Religion       Religion    
   None 27.9 13.2 19.3      Catholic 95.0 95.3 95.1 
   Christianity 68.2 80.6 75.4      Other 5.1 4.7 4.9 
   Islam 3.4 5.4 4.6       
   Other 0.6 0.8 0.7       
Federal District      Region    
   Central 30.6 27.8 29.0      Center-North 11.2 5.7 8.4 
   Far Eastern 7.3 5.1 6.0      Center-South 34.2 27.5 30.9 
   North Caucasian 4.1 4.5 4.3      East 3.3 5.8 4.6 
   Northwestern 23.8 20.9 22.1      Northeast 9.0 17.3 13.1 
   Siberian 5.8 7.3 6.7      Northwest 20.1 16.9 18.5 
   Southern 2.1 2.4 2.3      Southeast 6.2 3.2 4.7 
   Ural 5.7 6.7 6.3      Southwest 10.8 8.4 9.6 
   Volga 20.6 25.4 23.4      West 5.3 15.2 10.2 
Education      Education    
   Primary or less 
   Secondary 
4.9 
10.3 
7.1 
14.6 
6.2 
12.8 
     Less than  
   primary 35.3 42.5 38.9 
   High school 61.3 59.6 60.3      Primary  34.3 28.4 31.3 
   College + 23.5 18.7 20.7      Secondary  10.8 17.4 14.1 
         High school 3.3 4.9 4.1 
         College + 16.4 6.8 11.6 
Father's Education     Father's Education  
   No formal  
   education 9.8 10.8 10.4 
     No formal  
   education 42.7 42.2 42.5 
   Less than  
   primary 9.5 11.0 10.4 
     Less than  
   primary 26.9 32.7 29.8 
   Primary  21.2 18.4 19.6      Primary  14.7 16.0 15.3 
   Secondary  17.6 18.8 18.3      Secondary + 15.7 9.1 12.4 
   High school 31.5 30.2 30.7       
   College + 10.4 10.8 10.6       
Father’s Occupation    Father’s Occupation   
   Non-agricultural 95.8 94.8 95.2      Non-agricultural 75.6 71.2 73.4 
   Agricultural 4.2 5.2 4.8      Agricultural 24.4 28.8 26.6 
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Measured Health Outcomes    Measured Health Outcomes  
Body Mass Index      Body Mass Index    
   Underweight 1.5 1.3 1.4      Underweight 0.0 0.8 0.4 
   Normal 28.3 21.3 24.2      Normal 18.6 25.0 21.8 
   Overweight 43.2 37.7 40.0      Overweight 54.1 40.3 47.3 
   Obese I 23.0 24.1 23.6      Obese I 24.8 25.2 25.0 
   Obese II/III 3.9 15.8 10.8      Obese II/III 2.5 8.6 5.5 
High-Risk Waist Circumference    High-Risk Waist Circumference  
   Normal 76.3 41.9 56.4      Normal 61.0 39.1 50.1 
   High-risk 23.7 58.1 43.6      High-risk 39.0 60.9 49.9 
High-Risk Hip-to-Waist Ratio    High-Risk Hip-to-Waist Ratio  
   Normal 33.8 43.3 39.3      Normal 3.6 27.9 15.7 
   High-risk 66.3 56.7 60.7      High-risk 96.4 72.1 84.3 
High-Risk Systolic Blood Pressure    High-Risk Systolic Blood Pressure  
   Normal 51.1 39.3 44.3      Normal 51.5 40.5 46.0 
   High-risk 48.9 60.7 55.7      High-risk 48.5 59.5 54.0 
High-Risk Diastolic Blood Pressure    High-Risk Diastolic Blood Pressure  
   Normal 46.7 40.9 43.3      Normal 72.5 62.8 67.6 
   High-risk 53.3 59.1 56.7      High-risk 27.6 37.2 32.4 
 High-Risk Blood Pressure     High-Risk Blood Pressure  
   Normal 58.7 44.9 50.7      Normal 72.7 65.7 69.2 
   High-risk 41.3 55.1 49.3      High-risk 27.3 34.3 30.8 
High-Risk Pulse Rate    High-Risk Pulse Rate  
   Normal 91.5 91.4 91.4      Normal 91.3 95.1 93.2 
   High-risk 8.5 8.6 8.6      High-risk 8.7 4.9 6.8 
Height      Height    
   Mean (SE) 1.717 
(0.006) 
1.597 
(0.005) 
1.648 
(0.004) 
     Mean (SE) 1.650 
(0.010) 
1.511 
(0.007) 
1.581 
(0.010) 
   ≤10th percentile         ≤10th percentile    
      No 93.2 91.0 91.9         No 93.4 94.8 94.1 
      Yes 6.8 9.0 8.1         Yes 6.6 5.2 5.9 
   ≤25th percentile         ≤25th percentile    
      No 72.8 74.6 73.8         No 82.8 88.6 85.7 
      Yes 27.2 25.4 26.2         Yes 17.2 11.4 14.3 
Chronic Conditions     Chronic Conditions   
Hypertension      Hypertension    
   No 57.2 42.4 48.6      No 77.5 63.5 70.5 
   Yes 42.8 57.6 51.4      Yes 22.5 36.5 29.5 
Diabetes      Diabetes    
   No 94.9 91.5 93.0      No 81.4 81.2 81.3 
   Yes 5.1 8.5 7.0      Yes 18.6 18.8 18.7 
Angina      Angina    
   No 67.3 67.2 67.2      No 97.4 95.4 96.4 
   Yes 32.7 32.9 32.8      Yes 2.6 4.7 3.6 
Stroke      Stroke    
   No 92.6 96.4 94.8      No 96.0 95.2 95.6 
   Yes 7.4 3.6 5.2      Yes 4.0 4.8 4.4 
Chronic Lung Disease    Chronic Lung Disease  
   No 84.6 86.3 85.6      No 97.5 96.9 97.2 
   Yes 15.4 13.7 14.4      Yes 2.5 3.1 2.8 
Arthritis      Arthritis    
   No 79.7 72.1 75.3      No 97.6 88.1 92.9 
   Yes 20.3 27.9 24.7      Yes 2.4 11.9 7.1 
Asthma      Asthma    
   No 97.2 92.9 94.7      No 98.9 98.8 98.9 
   Yes 2.8 7.1 5.3      Yes 1.1 1.2 1.1 
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Table A3.3. Summary Statistics, Distribution (%) or Mean (SE), Males and Females 
Aged 50+, China (2007-2010)  
  China  
 Males Females Total 
 3,202 2,773 5,975 
 (57%) (44%)  
Sociodemographic Characteristics  
Season of Birth    
   Winter 24.5 25.7 25.0 
   Spring 23.8 21.4 22.7 
   Summer 25.3 25.8 25.5 
   Autumn 26.4 27.2 26.7 
Age Group    
   50-54 26.6 29.4 27.8 
   55-59 26.5 27.7 27.0 
   60-64 18.7 19.3 18.9 
   65-69 13.8 12.7 13.3 
   70-74 7.8 7.2 7.6 
   75-79 4.5 2.8 3.8 
   80-84 1.7 0.8 1.3 
   85+ 0.4 0.2 0.3 
Religion    
   None 96.9 91.5 94.6 
   Buddhism or Chinese Traditional 2.4 5.7 3.9 
   All other 0.6 2.8 1.6 
Province    
   Guangdong 21.1 16.4 19.0 
   Hubei 14.6 15.4 14.9 
   Jilin 2.7 3.1 2.9 
   Shaanxi 11.4 8.2 10.0 
   Shandong 27.8 32.6 29.9 
   Shanghai 4.9 5.4 5.1 
   Yunnan 8.8 9.7 9.2 
   Zhejiang 8.8 9.3 9.0 
Education    
   Less than primary 22.2 29.5 25.4 
   Primary 28.9 25.3 27.4 
   Secondary 26.8 25.2 26.1 
   High school + 22.0 19.9 21.1 
Father's Education  
   No formal education 60.4 56.5 58.7 
   Less than primary 17.0 15.2 16.2 
   Primary  10.3 13.3 11.6 
   Secondary  6.1 7.8 6.8 
   High school + 6.2 7.2 6.6 
Father’s Occupation  
   Non-agricultural 27.7 32.4 29.7 
   Agricultural  72.3 67.7 70.3 
 
 
Measured Health Outcomes  
Body Mass Index    
   Underweight 3.5 2.7 3.1 
   Normal 65.0 55.1 60.7 
   Overweight 27.5 33.5 30.1 
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   Obese I 2.9 7.4 4.8 
   Obese II/III 1.2 1.3 1.2 
High-Risk Waist Circumference  
   Normal 96.9 62.8 82.1 
   High-risk 3.1 37.2 17.9 
High-Risk Hip-to-Waist Ratio  
   Normal 53.7 35.1 45.6 
   High-risk 46.3 64.9 54.4 
High-Risk Systolic Blood Pressure  
   Normal 47.7 44.9 46.5 
   High-risk 52.3 55.1 53.5 
High-Risk Diastolic Blood Pressure  
   Normal 58.8 61.7 60.1 
   High-risk 41.2 38.3 39.9 
High-Risk Blood Pressure  
   Normal 65.3 65.7 65.5 
   High-risk 34.7 34.3 34.5 
High-Risk Pulse Rate  
   Normal 89.2 90.8 89.9 
   High-risk 10.8 9.2 10.1 
Height    
   Mean (SE) 1.649 
(0.002) 
1.556 
(0.002) 
1.609 
(0.002) 
   ≤10th percentile   
      No 92.3 94.5 93.2 
      Yes 7.8 5.5 6.8 
   ≤25th percentile   
      No 79.3 83.4 81.1 
      Yes 20.7 16.6 18.9 
 
  
Chronic Conditions   
Hypertension    
   No 77.7 72.4 75.4 
   Yes 22.3 27.6 24.6 
Diabetes    
   No 95.0 92.9 94.1 
   Yes 5.0 7.1 6.0 
Angina    
   No 94.6 90.8 92.9 
   Yes 5.4 9.2 7.1 
Stroke    
   No 96.8 98.0 97.3 
   Yes 3.2 2.0 2.7 
Chronic Lung Disease   
   No 90.7 94.7 92.4 
   Yes 9.3 5.3 7.6 
Arthritis    
   No 81.8 73.7 78.3 
   Yes 18.2 26.3 21.7 
Asthma    
   No 98.2 98.7 98.4 
   Yes 1.8 1.3 1.6 
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Table A3.4. Summary Statistics, Distribution (%) or Mean (SE), Males and Females 
Aged 50+, India (2007-2008) SAGE Wave 1 
 Season of Birth Sample  Climate Conditions Sample51 
 Males Females Total  Males Females Total 
 1,071 305 1,376  854 190 1,044 
 (84%) (16%)   (87%) (13%)  
Sociodemographic Characteristics      
Season of Birth        
   Winter 19.6 19.5 19.6  19.9 19.0 19.8 
   Summer 23.3 31.0 24.6  22.9 32.3 24.1 
   Monsoon 41.0 31.8 39.5  41.0 33.1 40.0 
   Post Monsoon 16.1 17.8 16.4  16.2 15.6 16.1 
Age Group        
   50-54 25.5 31.8 26.5  25.7 32.1 26.5 
   55-59 29.8 25.3 29.1  30.9 30.1 30.8 
   60-64 12.3 15.9 12.9  11.2 13.3 11.5 
   65-69 13.9 12.4 13.6  13.5 13.0 13.5 
   70-74 13.5 10.2 13.0  13.7 10.8 13.3 
   75-79 3.0 2.6 2.9  3.1 0.3 2.7 
   80-84 1.4 1.9 1.5  1.3 0.4 1.1 
   85+ 0.7 0.0 0.6  0.7 0.0 0.6 
Religion        
   Hinduism 89.3 90.3 89.5  88.5 88.6 88.5 
   Islam 5.8 5.9 5.9  6.5 7.7 6.7 
   Other 4.8 3.8 4.7  5.0 3.7 4.8 
State        
   Assam 2.1 2.8 2.3  2.1 2.2 2.1 
   Karnataka 13.3 26.8 15.5  10.6 19.7 11.9 
   Maharashtra 27.6 27.1 27.5  24.8 20.8 24.2 
   Rajasthan 9.5 5.0 8.8  9.7 4.7 9.1 
   Uttar Pradesh 25.3 6.9 22.3  28.8 8.1 26.0 
   West Bengal 22.2 31.5 23.7  24.1 44.6 26.8 
Always Lived in Current Region     
   Yes 80.2 93.8 86.8  100.0 100.0 100.0 
   No 19.8 6.2 13.2  0.0 0.0 0.0 
Education        
   Less than primary 8.6 17.2 10.0  8.8 16.5 9.9 
   Primary 17.6 33.4 20.2  17.0 33.7 19.2 
   Secondary 24.2 15.4 22.7  23.4 15.0 22.2 
   High school 28.5 18.2 26.8  30.0 15.3 28.0 
   College + 21.1 15.8 20.2  20.8 19.6 20.7 
Father's Education        
   No formal education 41.1 16.8 37.1  42.4 13.4 38.5 
   Less than primary 19.1 16.2 18.7  18.2 13.8 17.6 
   Primary completion 21.7 24.7 22.2  22.0 25.5 22.4 
   Secondary completion 8.4 16.1 9.7  8.3 16.5 9.4 
   High school + 9.6 26.3 12.4  9.1 30.9 12.0 
Father’s Occupation        
   Non-agricultural  52.2 71.8 55.4  49.5 69.4 52.2 
   Agricultural 47.8 28.2 44.6  50.5 30.6 47.8 
                                                           
51
 Respondents who are non-missing on all predictor variables (including rainfall and temperature around 
the time of birth) and who have always lived in their current place of residence. 
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Measured Health Outcomes      
Body Mass Index        
   Underweight 27.0 14.4 25.0  28.2 18.2 26.8 
   Normal 58.8 47.6 56.9  58.5 44.0 56.6 
   Overweight 11.4 26.9 14.0  10.7 26.6 12.8 
   Obese I 2.0 9.6 3.3  2.0 9.2 3.0 
   Obese II/III 0.8 1.5 0.9  0.6 2.1 0.8 
Obese (BMI≥ 30 kg/m2)       
   Normal 97.2 88.9 95.8  97.4 88.7 96.3 
   High-risk 2.8 11.1 4.2  2.6 11.3 3.7 
Obese (BMI≥ 25 kg/m2)        
   Normal 85.8 62.0 81.9  86.7 62.1 83.4 
   High-risk 14.2 38.0 18.1  13.3 37.9 16.6 
Obese (BMI≥ 23 kg/m2)        
   Normal 73.0 46.3 68.6  74.1 47.5 70.5 
   High-risk 27.0 53.7 31.4  25.9 52.5 29.5 
High-Risk Waist Circumferencea     
   Normal 95.4 43.0 86.8  96.4 49.1 90.0 
   High-risk 4.6 57.1 13.2  3.6 50.9 10.0 
High-Risk Waist Circumferenceb      
   Normal 70.6 24.9 63.1  71.4 30.3 65.9 
   High-risk 29.4 75.1 36.9  28.6 69.7 34.1 
High-Risk Waist Circumferencec      
   Normal 58.9 27.0 53.6  59.7 32.1 56.0 
   High-risk 41.2 73.0 46.4  40.3 68.0 44.0 
High-Risk Hip-to-Waist Ratio      
   Normal 20.1 10.2 18.5  20.7 9.4 19.1 
   High-risk 79.9 89.8 81.5  79.4 90.7 80.9 
High-Risk Systolic Blood Pressure      
   Normal 74.1 60.8 71.9  74.6 58.1 72.4 
   High-risk 25.9 39.2 28.1  25.4 41.9 27.6 
High-Risk Diastolic Blood Pressure      
   Normal 69.2 59.7 67.6  69.8 60.2 68.5 
   High-risk 30.8 40.3 32.4  30.2 39.8 31.5 
 High-Risk Blood Pressure      
   Normal 78.0 67.1 76.2  78.3 66.2 76.6 
   High-risk 22.0 32.9 23.8  21.7 33.8 23.4 
High-Risk Pulse Rate        
   Normal 82.6 81.3 82.4  82.6 78.6 82.1 
   High-risk 17.4 18.7 17.6  17.4 21.4 17.9 
Height (m)        
   Mean (SE) 1.650 
(0.004) 
1.515 
(0.005) 
1.628 
(0.005) 
 1.651 
(0.004) 
1.515 
(0.007) 
1.633 
(0.005) 
   ≤10th percentile        
      No 92.7 92.5 92.7  93.4 94.4 93.5 
      Yes 7.3 7.5 7.4  6.6 5.6 6.5 
   ≤25th percentile        
      No 80.5 82.9 80.9  81.1 83.5 81.5 
      Yes 19.5 17.1 19.1  18.9 16.5 18.6 
 
     
Chronic Conditions      
Hypertension        
   No 79.6 68.9 77.9  80.0 65.3 78.0 
   Yes 20.4 31.1 22.1  20.0 34.7 22.0 
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Diabetes        
   No 86.5 86.9 86.6  87.6 88.5 87.7 
   Yes 13.5 13.1 13.4  12.4 11.5 12.3 
Angina        
   No 89.8 95.8 90.8  89.1 95.6 90.0 
   Yes 10.2 4.2 9.2  10.9 4.4 10.0 
Stroke        
   No 97.6 99.7 98.0  97.7 100.0 98.0 
   Yes 2.4 0.3 2.0  2.3 0.0 2.0 
Chronic Lung Disease      
   No 94.0 97.8 94.6  93.6 96.8 94.1 
   Yes 6.0 2.2 5.4  6.4 3.2 5.9 
Arthritis        
   No 88.0 70.7 85.2  88.2 66.2 85.3 
   Yes 12.0 29.3 14.8  11.8 33.8 14.7 
Asthma        
   No 94.8 92.0 94.3  94.8 90.2 94.2 
   Yes 5.2 8.0 5.7  5.2 9.8 5.8 
a
 > 102 cm (males), > 88 cm (females) 
b
 ≥ 90 cm (males), ≥ 80 cm (females) 
c
 ≥ 87 cm (males), ≥ 82 cm (females) 
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Table A3.5. Odds Ratios from Logistic Regression Models Predicting Measured Health 
Outcomes (Part A) and Self-Reported Chronic Conditions (Part B), Males and Females 
Aged 50+, South Africa (2007-2008) 
Part A: Measured Health Outcomes  
 
 
  
 
Summer  Autumn  Winter  Spring N 
Obese (BMI ≥ 30 kg/m2)  
 
 
  
M1 1.23  1.00  1.17  1.27 1331 
M5 1.24  1.00  1.13  1.19 1331 
High-Risk Waist Circumference  
  
M1 1.33  1.00  1.06  0.76 1331 
M5 1.34  1.00  1.13  0.77 1331 
High-Risk Waist-to-Hip Ratio  
 
 
  
M1 1.07  1.00  1.35  1.61+ 1331 
M5 1.08  1.00  1.31  1.56+ 1331 
High-Risk Systolic Blood Pressure  
 
 
  
M1 1.33  1.00  0.96  0.97 1331 
M5 1.25  1.00  0.94  0.94 1331 
High-Risk Diastolic Blood Pressure  
  
M1 1.23  1.00  1.10  1.50 1331 
M5 1.10  1.00  1.06  1.44 1331 
High-Risk Blood Pressure  
 
 
  
M1 1.53  1.00  1.21  1.23 1331 
M5 1.44  1.00  1.21  1.22 1331 
High-Risk Pulse Rate  
 
 
  
M1 2.09*  1.00  1.39  1.02 1331 
M5 2.05*  1.00  1.41  1.03 1331 
Height, ≤10th Percentile  
 
 
  
M1 2.25*  1.00  1.76  1.93 1331 
M5 2.29*  1.00  1.90+  2.35* 1331 
Height, ≤25th Percentile  
 
 
  
M1 1.03  1.00  1.76*  1.19 1331 
M5 0.98  1.00  1.66+  1.07 1331 
  
 
 
 
 
 
  
Part B: Self-Reported Chronic Conditions 
  
 
Summer  Autumn  Winter  Spring N 
Hypertension  
 
 
  
M1 1.01  1.00  0.88  0.68 1331 
M5 0.94  1.00  0.85  0.61+ 1331 
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Diabetes  
 
 
 
 
  
M1 1.45  1.00  1.62  1.09 1331 
M5 1.26  1.00  1.48  0.91 1331 
Angina  
 
 
 
 
  
M1 0.98  1.00  0.91  0.41 1331 
M5 0.81  1.00  0.90  0.42+ 1331 
Stroke  
 
 
 
 
  
M1 1.52  1.00  0.50  0.76 1331 
M5 1.20  1.00  0.36+  0.56 1331 
Chronic Lung Disease  
 
 
  
M1 0.64  1.00  0.89  1.26 1331 
M5 0.58  1.00  1.05  1.17 1331 
Arthritis  
 
 
 
 
  
M1 1.17  1.00  1.47  1.46 1331 
M5 0.98  1.00  1.35  1.17 1331 
Asthma  
 
 
 
 
  
M1 0.78  1.00  1.34  1.14 1331 
M5 0.78  1.00  1.16  1.18 1331 
+ p <0.10, * p < 0.05, ** p < 0.01, *** p < 0.001 
Notes: Model 1 includes controls for age and sex. Model 5 adds region, father’s education, father’s 
occupation, and respondent’s education. See Table 3.3 for the high-risk cutpoints. 
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Table A3.6. Odds Ratios from Logistic Regression Models Predicting Measured Health 
Outcomes (Part A) and Self-Reported Chronic Conditions (Part B), Males and Females 
Aged 50+, Ghana (2007-2008) 
Part A: Measured Health Outcomes  
  
 
Winter  Spring  Summer  Autumn N 
Obese (BMI ≥ 30 kg/m2)  
 
 
  
M1 1.12  1.86+  1.36  1.00 838 
M5 1.12  1.49  1.15  1.00 838 
High-Risk Waist Circumference  
 
 
  
M1 1.28  1.13  1.21  1.00 838 
M5 1.20  0.84  1.00  1.00 838 
High-Risk Waist-to-Hip Ratio  
 
 
  
M1 0.79  0.81  0.96  1.00 838 
M5 0.74  0.74  0.89  1.00 838 
High-Risk Systolic Blood Pressure  
  
M1 1.20  1.22  1.17  1.00 838 
M5 1.12  1.10  1.05  1.00 838 
High-Risk Diastolic Blood Pressure  
 
 
  
M1 1.36  1.41  1.60*  1.00 838 
M5 1.30  1.29  1.53+  1.00 838 
High-Risk Blood Pressure  
 
 
  
M1 1.23  1.35  1.21  1.00 838 
M5 1.18  1.22  1.09  1.00 838 
High-Risk Pulse Rate  
 
 
  
M1 0.61  1.26  1.05  1.00 838 
M5 0.63  1.39  1.18  1.00 838 
Height, ≤10th Percentile  
 
 
  
M1 0.91  1.30  0.80  1.00 838 
M5 1.03  1.42  0.89  1.00 838 
Height, ≤25th Percentile  
 
 
  
M1 1.10  1.05  0.86  1.00 838 
M5 1.11  1.11  0.88  1.00 838 
  
 
 
 
 
 
  
Part B: Self-Reported Chronic Conditions  
  
 
Winter  Spring  Summer  Autumn N 
Hypertension  
 
 
  
M1 1.36  1.13  1.17  1.00 838 
M5 1.31  0.90  1.00  1.00 838 
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Diabetes  
 
 
  
M1 0.48  1.66  0.35*  1.00 838 
M5 0.42  1.60  0.30*  1.00 838 
Angina  
 
 
  
M1 0.43  0.42  0.54  1.00 838 
M5 0.41  0.48  0.51  1.00 838 
Stroke  
 
 
 
 
  
M1 1.20  1.08  0.71  1.00 838 
M5 1.13  1.17  0.61  1.00 838 
Chronic Lung Disease  
 
 
  
M1 
 
 
 
 
 
 
  
M5 
 
 
 
 
 
 
  
Arthritis  
 
 
 
 
  
M1 0.91  0.74  0.92  1.00 838 
M5 0.87  0.72  0.91  1.00 838 
Asthma  
 
 
 
 
  
M1 1.47  1.14  0.32  1.00 838 
M5 1.75  1.49  0.36  1.00 838 
+ p <0.10, * p < 0.05, ** p < 0.01, *** p < 0.001 
Notes: Model 1 includes controls for age and sex. Model 5 adds region, father’s education, father’s 
occupation, and respondent’s education. See Table 3.3 for the high-risk cutpoints. Chronic lung 
disease is omitted due to very low incidence of this condition in this sample.   
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Table A3.7. Odds Ratios from Logistic Regression Models Predicting Measured Health 
Outcomes (Part A) and Self-Reported Chronic Conditions (Part B), Males and Females 
Aged 50+, Russia (2007-2010) 
Part A: Measured Health Outcomes  
  
  Winter  Spring  Summer  Autumn N 
Obese (BMI ≥ 30 kg/m2)  
 
 
  
M1 0.83  1.22  0.66  1.00 2260 
M5 0.95  1.28  0.73  1.00 2260 
High-Risk Waist Circumference  
  M1 0.44*  0.86  0.47*  1.00 2260 
M5 0.43*  0.85  0.46*  1.00 2260 
High-Risk Waist-to-Hip Ratio  
  M1 0.67  1.09  0.67  1.00 2260 
M5 0.63  1.12  0.68  1.00 2260 
High-Risk Systolic Blood Pressure  
  M1 0.99  1.07  0.91  1.00 2260 
M5 1.00  1.12  0.91  1.00 2260 
High-Risk Diastolic Blood Pressure  
  M1 1.28  1.16  0.80  1.00 2260 
M5 1.45  1.22  0.82  1.00 2260 
High-Risk Blood Pressure  
  M1 0.87  0.88  0.69  1.00 2260 
M5 0.92  0.92  0.71  1.00 2260 
High-Risk Pulse Rate  
 
 
  M1 0.74  1.66  1.32  1.00 2260 
M5 0.77  1.78  1.89  1.00 2260 
Height, ≤10th Percentile  
 
 
  M1 1.21  1.25  1.02  1.00 2260 
M5 1.12  1.22  1.01  1.00 2260 
Height, ≤25th Percentile  
 
 
  M1 2.06*  1.39  1.18  1.00 2260 
M5 2.01*  1.43  1.14  1.00 2260 
  
 
 
 
 
 
 
  
Part B: Self-Reported Chronic Conditions  
  
 
Winter  Spring  Summer  Autumn N 
Hypertension  
 
 
  M1 0.94  1.14  1.48  1.00 2260 
M5 1.02  1.22  1.65  1.00 2260 
Diabetes  
 
 
  M1 1.44  2.81***  1.39  1.00 2260 
M5 1.63  3.02***  1.52  1.00 2260 
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Angina  
 
 
  M1 1.57  1.59  2.48**  1.00 2260 
M5 1.69  1.54  2.72**  1.00 2260 
Stroke  
 
 
  M1 2.76  5.16**  1.95  1.00 2260 
M5 2.92  5.41***  2.20  1.00 2260 
Chronic Lung Disease  
 
 
  M1 0.93  0.74  1.92  1.00 2260 
M5 0.97  0.78  2.34*  1.00 2260 
Arthritis  
 
 
 
 
  M1 0.79  1.10  1.05  1.00 2260 
M5 0.77  1.08  1.01  1.00 2260 
Asthma  
 
 
 
 
  M1 0.34+  0.20*  1.06  1.00 2260 
M5 0.50  0.29+  1.77  1.00 2260 
+ p <0.10, * p < 0.05, ** p < 0.01, *** p < 0.001 
Notes: Model 1 includes controls for age and sex. Model 5 adds region, father’s education, 
father’s occupation, and respondent’s education. See Table 3.3 for the high-risk cutpoints.  
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Table A3.8. Odds Ratios from Logistic Regression Models Predicting Measured Health 
Outcomes (Part A) and Self-Reported Chronic Conditions (Part B), Males and Females 
Aged 50+, Mexico (2009-2010) 
Part A: Measured Health Outcomes  
  
 
Winter  Spring  Summer  Autumn N 
Obese (BMI ≥ 30 kg/m2)  
 
 
  
M1 1.84  1.44  2.06  1.00 937 
M5 1.74  1.45  1.89  1.00 937 
High-Risk Waist Circumference  
  
M1 1.54  1.51  1.60  1.00 937 
M5 1.45  1.81  1.76  1.00 937 
High-Risk Waist-to-Hip Ratio  
  
M1 0.75  0.99  0.97  1.00 937 
M5 0.90  1.68  1.07  1.00 937 
High-Risk Systolic Blood Pressure  
  
M1 0.47  0.48  0.81  1.00 937 
M5 0.50  0.72  1.28  1.00 937 
High-Risk Diastolic Blood Pressure  
  
M1 1.18  1.12  1.37  1.00 937 
M5 1.19  1.35  1.43  1.00 937 
High-Risk Blood Pressure  
  
M1 1.31  1.39  1.50  1.00 937 
M5 1.37  1.60  1.78  1.00 937 
High-Risk Pulse Rate  
  
M1 1.79  0.43  1.08  1.00 937 
M5 1.79  0.23  0.93  1.00 937 
Height, ≤10th Percentile  
  
M1 3.57+  1.33  1.84  1.00 937 
M5 3.89+  1.60  2.21  1.00 937 
Height, ≤25th Percentile  
  
M1 2.43+  2.28  2.91+  1.00 937 
M5 2.58  1.81  2.77+  1.00 937 
  
 
 
 
 
 
  
Part B: Self-Reported Chronic Conditions 
 
 
Winter  Spring  Summer  Autumn N 
Hypertension  
 
 
  
M1 1.52  1.66  0.87  1.00 937 
M5 1.60  1.70  1.02  1.00 937 
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Diabetes  
 
 
  
M1 0.42+  0.64  0.22**  1.00 937 
M5 0.33*  0.25**  0.15***  1.00 937 
Angina  
 
 
  
M1 
 
 
 
 
 
 
  
M5 
 
 
 
 
 
 
  
Stroke  
 
 
  
M1 0.79  0.57  0.44  1.00 937 
M5 0.58  0.35  0.36  1.00 937 
Chronic Lung Disease  
 
 
  
M1 2.47  3.34  13.64***  1.00 937 
M5 2.42  5.67+  15.72**  1.00 937 
Arthritis  
 
 
  
M1 0.84  0.26*  0.53  1.00 937 
M5 0.99  0.33+  0.63  1.00 937 
Asthma  
 
 
  
M1 
 
 
 
 
 
 
  
M5 
 
 
 
 
 
 
  
+ p <0.10, * p < 0.05, ** p < 0.01, *** p < 0.001 
Notes: Model 1 includes controls for age and sex. Model 5 adds region, father’s 
education, father’s occupation, and respondent’s education. See Table 3.3 for the high-
risk cutpoints. Angina and asthma are omitted due to very low incidence of these 
conditions in this sample.   
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Table A3.9. Odds Ratios from Logistic Regression Models Predicting Measured Health 
Outcomes (Part A) and Self-Reported Chronic Conditions (Part B), Males and Females 
Aged 50+, China (2007-2010) 
Part A: Measured Health Outcomes  
  
 
Winter  Spring  Summer  Autumn N 
Obese (BMI ≥ 30 kg/m2)  
  
M1 0.71+  0.65**  1.03  1.00 5975 
M5 0.70+  0.66**  0.99  1.00 5975 
High-Risk Waist Circumference  
  
M1 0.91  0.80  0.89  1.00 5975 
M5 0.92  0.82  0.85  1.00 5975 
High-Risk Waist-to-Hip Ratio  
  
M1 1.16  1.10  1.14  1.00 5975 
M5 1.19  1.10  1.13  1.00 5975 
High-Risk Systolic Blood Pressure  
  
M1 0.86  0.76**  0.78*  1.00 5975 
M5 0.83+  0.77**  0.77*  1.00 5975 
High-Risk Diastolic Blood Pressure  
  
M1 0.89  0.86*  0.95  1.00 5975 
M5 0.91  0.88*  0.97  1.00 5975 
High-Risk Blood Pressure  
  
M1 0.83*  0.80**  0.87+  1.00 5975 
M5 0.83*  0.81**  0.87  1.00 5975 
High-Risk Pulse Rate  
  
M1 0.90  0.94  0.96  1.00 5975 
M5 0.90  0.94  0.98  1.00 5975 
Height, ≤10th Percentile  
  
M1 0.81  0.90  0.93  1.00 5975 
M5 0.82  0.88  0.97  1.00 5975 
Height, ≤25th Percentile  
  
M1 0.89  0.94  1.05  1.00 5975 
M5 0.88  0.91  1.07  1.00 5975 
  
 
 
 
 
 
  
Part B: Self-Reported Chronic Conditions 
 
 
Winter  Spring  Summer  Autumn N 
Hypertension  
 
 
  
M1 0.88+  0.82**  0.97  1.00 5975 
M5 0.88+  0.84*  0.97  1.00 5975 
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Diabetes  
 
 
  
M1 0.87  0.78  1.02  1.00 5975 
M5 0.88  0.79  1.01  1.00 5975 
Angina  
 
 
  
M1 0.92  0.82  1.08  1.00 5975 
M5 0.92  0.81  1.06  1.00 5975 
Stroke  
 
 
  
M1 1.00  1.29  1.02  1.00 5975 
M5 0.99  1.29  1.00  1.00 5975 
Chronic Lung Disease  
  
M1 1.16  1.20  1.20  1.00 5975 
M5 1.15  1.16  1.24  1.00 5975 
Arthritis  
 
 
  
M1 0.99  1.18  0.96  1.00 5975 
M5 0.99  1.20  0.96  1.00 5975 
Asthma  
 
 
  
M1 0.81  0.74  0.77  1.00 5975 
M5 0.76  0.70  0.76  1.00 5975 
+ p <0.10, * p < 0.05, ** p < 0.01, *** p < 0.001 
Notes: Model 1 includes controls for age and sex. Model 5 adds region, father’s 
education, father’s occupation, and respondent’s education. See Table 3.3 for the high-
risk cutpoints.  
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Table A3.10. Odds Ratios from Logistic Regression Models Predicting Measured Health 
Outcomes (Part A) and Self-Reported Chronic Conditions (Part B), Males and Females 
Aged 50+, India (2007-2008) 
Part A: Measured Health Outcomes 
 
 
Winter  Summer  Monsoon  Post Monsoon N 
Obese (BMI ≥30 kg/m2)  
  
M1 0.49  1.65  1.00  1.04 1376 
M5 0.50  1.95  1.00  1.21 1376 
Obese (BMI ≥25 kg/m2)  
  
M1 1.08  1.16  1.00  0.91 1376 
M5 1.09  1.14  1.00  0.87 1376 
Obese (BMI ≥23 kg/m2)  
  
M1 1.00  0.94  1.00  0.82 1376 
M5 1.01  0.88  1.00  0.74 1376 
High-Risk Waist Circumferencea  
  
M1 1.00  1.14  1.00  1.42 1376 
M5 1.11  1.30  1.00  1.42 1376 
High-Risk Waist Circumferenceb  
  
M1 0.83  0.81  1.00  1.10 1376 
M5 0.81  0.79  1.00  1.06 1376 
High-Risk Waist Circumferencec  
  
M1 0.73  0.99  1.00  1.21 1376 
M5 0.75  1.03  1.00  1.22 1376 
High-Risk Waist-to-Hip Ratio  
  
M1 1.15  1.00  1.00  1.23 1376 
M5 1.13  0.88  1.00  1.11 1376 
High-Risk Systolic Blood Pressure  
  
M1 1.38  1.57+  1.00  1.22 1376 
M5 1.38  1.37  1.00  1.07 1376 
High-Risk Diastolic Blood Pressure  
  
M1 1.40  1.58+  1.00  1.22 1376 
M5 1.48  1.46  1.00  1.18 1376 
High-Risk Blood Pressure  
  
M1 1.59+  1.75*  1.00  1.38 1376 
M5 1.61*  1.55+  1.00  1.22 1376 
High-Risk Pulse Rate  
  
M1 1.27  2.21**  1.00  1.10 1376 
M5 1.33  2.19**  1.00  1.16 1376 
Height, ≤10th Percentile  
  
M1 1.48  1.17  1.00  1.73 1376 
M5 1.70  1.00  1.00  1.62 1376 
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Height, ≤25th Percentile  
  
M1 1.12  0.99  1.00  1.38 1376 
M5 1.24  0.86  1.00  1.27 1376 
  
 
 
 
 
 
  
Part B: Self-Reported Chronic Conditions 
 
 
Winter  Summer  Monsoon  Post Monsoon N 
Hypertension  
 
 
  
M1 1.18  1.29  1.00  1.23 1376 
M5 1.14  1.13  1.00  1.15 1376 
Diabetes  
 
 
  
M1 0.46*  0.67  1.00  0.58 1376 
M5 0.42*  0.54  1.00  0.49* 1376 
Angina  
 
 
  
M1 0.60  1.12  1.00  1.16 1376 
M5 0.77  1.34  1.00  1.29 1376 
Stroke  
 
 
  
M1 4.88*  2.52  1.00  2.85 1376 
M5 4.77+  2.03  1.00  2.31 1376 
Chronic Lung Disease  
  
M1 1.22  3.98*  1.00  1.06 1376 
M5 1.12  4.65**  1.00  1.12 1376 
Arthritis  
 
 
  
M1 1.03  0.77  1.00  0.65 1376 
M5 0.90  0.62+  1.00  0.68 1376 
Asthma  
 
 
  
M1 1.80  1.08  1.00  1.76 1376 
M5 2.18*  1.21  1.00  2.10 1376 
+ p <0.10, * p < 0.05, ** p < 0.01, *** p < 0.001 
Notes: Model 1 includes controls for age and sex. Model 5 adds region, father’s education, 
father’s occupation, and respondent’s education. See Table 3.3 for the high-risk cutpoints.  
a
 > 102 cm (males), > 88 cm (females) 
b
 ≥ 90 cm (males), ≥ 80 cm (females) 
c
 ≥ 87 cm (males), ≥ 82 cm (females) 
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Figure A3.1. Month of Birth Distribution, Males and Females Combined, Ages 50+, SAGE 2007-2010 
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Note: Figures are based on samples of individuals aged 50+ non-missing on key characteristics of interest (see text and Tables A3.1-A3.4 for summary 
statistics and sample sizes). 
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